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This research makes use of the genome-scale metabolic information of the Arabidopsis 
thaliana (Arabidopsis) plant to better understand the systemic behaviour of a 
multicellular cell, using mathematical and in silico methods.  
To avoid combinatorial explosion resulting from the large network size, an appropriate 
subnetwork is first extracted. This results in an Arabidopsis flavonoid subnetwork that 
is self-contained, in the sense that all its exchange fluxes are accounted for and it is 
representative of flavonoid metabolism in the context of whole cell metabolism. This 
subnetwork is verified by comparing its compounds and reactions with a recently 
reconstructed and verified Arabidopsis network.  
The research focusses on anthocyanins, a major flavonoids subgroup responsible for 
colour pigmentation in plants. To determine the anthocyanin biosynthetic pathway 
(ABP), elementary modes (EMs) or non-decomposable pathways that allow the system 
to operate at steady state, are calculated. These EMs are classified into groups and those 
responsible for the formation of anthocyanin compounds are taken to constitute the 
ABP.  
The central analysis approach in the research is that of minimal cut sets (MCSs), a fairly 
new metabolic pathway analysis (MPA) concept. A review of various development 
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stages of the MCS concept and its relationship to other similar approaches is given for 
the first time in this thesis.  
MCSs provide a mathematically complete list of candidate genes for eliminating a 
certain objective function from a holistic perspective, without needing prior knowledge 
of genes. They are used to identify target genes for loss of colour pigmentation in plants. 
Other methods, such as reaction participation, are then used to study the implications 
that the elimination of these target genes would have on other processes in the cell. 
MCSs are also used to look at the fragility coefficient of the ABP genes and how crucial 
they are to the pathway. These analyses provide quantitative support for experimental 
results e.g., gene connectivity determines the number of EMs the ABP genes are 
connected to, and backs the pleiotropic characteristics of the “early” ABP genes and 
how it relates to where they occur in the pathway.  
The research also uses flux balance analysis (FBA) to simulate fluxes (reaction rates) 
for the different MCSs eliminating anthocyanin compounds. The FBA provides a 
quantitative measure of the relative impact that the different MCSs would have on the 
production and processes of other flavonoids and related compounds. Certain simulation 
outcomes correspond to experimental observations, e.g., the simulated fluxes from 
eliminating the MCS containing the CHS gene, support the observation that the 
suppression of the anthocyanin pathway, via CHS silencing, dramatically reduces 
flavonoids but does not affect scent (benzenoids) production.  
The research also develops a method for determining which genes are being expressed 
in a tissue, using EMs and MCSs in conjunction with information about compound 
products. This involves developing an algorithm and writing a program to determine 
which reactions are being expressed in a tissue. The algorithm and program worked 
both on an example network and on the flavonoid network used to determine reactions 
taking place in the Arabidopsis flower. Information obtained from the results includes 
identifying reactions that are critical to the flower as well as reaction sets that would 
represent gene sets. The program still needs further development to incorporate 
analytical clustering methods and a user-friendly interface. 
Keywords 
anthocyanin biosynthetic pathway; Arabidopsis thaliana; constraints-based  modelling; 
elementary modes; flavonoids; metabolic network; metabolic pathway analysis; 
minimal cut sets. 
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: Introduction Chapter 1
This chapter introduces the research and the motivation behind it. It describes the area 
of study, highlighting chapters where topics are adequately covered, and looks at the 
compounds studied, why they are important, and why Arabidopsis was chosen for their 
study. It also specifies the objectives of the research, presents an overview of the 
chapters and summarises the contributions made. 
A glossary of scientific terms used in the thesis is provided in Appendix B. 
 The Research 1.1
The development of high throughput experimental technologies and the associated 
increasing volume of genome-scale data being produced are changing biological 
research from concentrating on individual cellular components to viewing cells as 
systems. The metabolism of a cell characterises how it functions as a system. This is 
represented in the network of reactions that link the chemical components constituting 
the cell, to form its metabolic network.  
This research makes use of genome-scale metabolic information to gain more in-depth 
knowledge about the systemic behaviour of a multicellular biological cell, using 
mathematical and in silico methods. It makes use of constraints-based (Section 1.5) 
metabolic pathway analysis (MPA) (Section 2.4) methods, particularly the concept of 
minimal cut sets (MCSs) (Chapter 3), to study flavonoid (Section 1.6) metabolism from 
a whole cell perspective using the metabolic network of the Arabidopsis thaliana 
(Arabidopsis) plant (Section 1.8). To avoid the combinatorial explosion resulting from 
the large network size, an appropriate flavonoid subnetwork is first extracted. This 
subnetwork is self-contained in the sense that all its exchange fluxes are accounted for 
and it is representative of flavonoid metabolism from a whole cell perspective, thus can 
be analysed to elucidate the systemic metabolism of plant flavonoids. 
In general, the research contributes to systems biology (Section 1.2) by making use of 
constraint-based MPA (Section 2.4) methods and the increasing volume of genome-
scale data being produced from high throughput experimental techniques, to gain in-
depth understanding of the systemic metabolism of plant flavonoids and how the 
structure of the metabolic network is linked to the phenotypic roles of the genes 
concerned, where they occur in the network and the impact their elimination has on 
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other genes and processes in the cell. The holistic approach of these MPA methods take 
into account the structure of the whole metabolic network and all the reactions taking 
place in the cell, thus are subject only to a complete knowledge of the network itself. An 
algorithm is also developed, and a program written, for determining genes expressed in 
a tissue, using the outcomes from MCSs and elementary modes (EMs), together with 
that of experimental observations.  
 Systems Biology 1.2
Systems biology [1-3] is the holistic coordinated use of different methods to study 
biological systems. In contrast to the traditional reductionist approach of studying parts 
of a system in isolation, systems biology involves integrating large sets of different 
types of data into genome-scale reconstructions of biochemical reaction networks and 
then creating in silico computational models to compute the functional states of the 
reconstructed networks [4]. The ultimate goal of the systems-based approach is to 
establish the relation between the phenotypic characteristics of a biological system and 
the interdependent structure and dynamics of its components and how these interact. 
This confers a crucial role to networks because they embed these interactions and, as 
such, are responsible for observable cellular behaviour.  
Examples of networks used in biology include metabolic [5, 6] (Section 2.1), regulatory 
[7, 8] and signalling [9, 10] networks, of which metabolic networks are perhaps the best 
characterized. Systems biology for metabolic networks involves investigating the 
interaction between the components of cellular networks, applying experimental high-
throughput whole-genome techniques and integrating computational methods with 
experimental work. These processes, together, offer a better understanding of the 
cellular processes, how cells work, and how they react and adapt to internal and external 
environment perturbations. 
The cell is the fundamental unit of all organisms. How it functions depends on the 
structure and network of components that constitute it, of which the best understood 
network and focus of this study, is metabolism.  
 Cell Metabolism  1.3
Metabolism exploits the network of reactions that link the chemical components that 
constitute the cell and that enables cells to survive and reproduce; it is the process 
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through which cells produce energy and use the energy to maintain life and synthesise 
more cells. This process involves thousands of reactions performing chemical 
transformations through which cells convert thousands of organic compounds into 
biomolecules necessary to support their existence. By doing so, they direct metabolism 
along a map of pathways and networks. These networks [11, 12] can now be 
reconstructed and the genome-scale metabolic networks of sequenced organisms are 
becoming increasingly available online and accessible for use worldwide. One such 
network that has become available is that of the Arabidopsis plant and, as mentioned 
earlier, this network is analysed in this research using mathematical modelling. 
 Challenges of Model Building in Biology  1.4
As discussed by Palsson [13], mathematical model building in biology is faced with the 
basic challenges presented by the complex intracellular chemical environment [14] and 
the dual causality [15] of genetics and natural laws, causing three main problems: 
• The first problem is that the complexity of the intracellular environment makes 
it hard to define and formulate the fundamental kinetic equations describing the 
functions of the networks.  
• The second problem is that, assuming all the governing equations are defined, it 
is difficult to find the numerical values for all the parameters that appear in these 
equations.   
• The third problem is the fact that, even if the first two problems are overcome, 
the quest by organisms to survive leads to diversity, with evolution changing 
numerical values of the kinetic constants over time. In addition, the production 
of non-identical individuals is achieved through the genetics-related processes of 
replication and reproduction. So, even if the fundamental equations of the 
intracellular environment are formulated, in an out-bred population a perfect in 
silico model for an individual organism would not apply to other individuals in 
the population because of polymorphism in the genes which means that 
individuals and kinetic parameters are non-identical [16].   
Thus, mathematical model building in biology needs to accommodate both challenges: 
the physicochemical constraints under which cells operate, as well as the spatial and 
environmental constraints caused by natural selection and evolution. The next section 
discusses constraints-based modelling and how it tackles these challenges. 
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 Constraints-based modelling 1.5
Constraints-based modelling [17] tackles the model building challenges by taking into 
account the fact that cells are subject to governing constraints which are easier to 
identify. The modelling approach imposes the constraints and uses them to determine 
functional states that can and cannot be achieved by the network. Although this cannot 
precisely predict cellular behaviour (functional states), it leads to the formulation of 
solution spaces where cellular behaviour can be attained. 
Constraints-based modelling methods [18, 19] have proved useful for analysing 
complex biological systems. They lead to in silico analysis procedures that are helpful 
in analysing, interpreting, and occasionally predicting the genotype-phenotype 
relationship in terms of steady state modelling; dynamical phenomena such as circadian 
rhythms, on the other hand, would require more detailed kinetic modelling. The 
modelling process is a multi-step procedure that involves the reconstruction of the 
network and the application of MPA (Section 2.4). MPA involves stating constraints 
under which the reconstructed network operates, and determining which of the possible 
solutions in the solution space correspond to physiologically meaningful states. The in 
silico model building process is iterative, with the models providing a way to integrate 
data and systematically build hypotheses. A detailed account of the constraints-based 
modelling processes is covered in Chapter 2.  
Although an increasing number of constraints-based modelling studies have been 
directly applied to the genome scale metabolic network of certain microbes and 
unicellular organisms, only a limited number has been applied to that of multi-cellular 
organisms because of their large complex networks. This research overcomes the 
problem posed by the large size of the plant metabolic network by identifying a group 
of plant compounds to investigate, instead of dealing with a plant’s complete metabolic 
network. 
 Compounds of Study: Flavonoids  1.6
One group of compounds that has been of great interest in plant science is the flavonoid 
[20-22] compounds. Although constraints-based modelling (Section 1.5) has never been 
applied to flavonoids before, these compounds are well studied in plant science and thus 
have experimental information available for them which can be used to validate and 
iteratively improve the model.  
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 The importance of flavonoids 1.7
Flavonoids [20-22] are ubiquitous secondary plant metabolites that play a variety of 
roles in the reproduction and protection of plants; they are among the most studied and 
best understood compounds in plant science with a vast amount of literature available 
for them. There are over 5000 naturally occurring flavonoids that have been 
characterized. These have been divided into 6 sub-groups based on their chemical 
properties [23]. Because of their low toxicity, animals, including humans, are able to 
ingest them and benefit as well from their properties. 
Research has been done on the biosynthesis [24, 25] and metabolism [26] of flavonoids 
and their pathways are one of the best characterized in plants. A review of the history of 
their research can be seen in [27, 28]. This offers a great platform for furthering our 
understanding about their metabolic structure and functions. The knowledge would lead 
to better utilization of flavonoids as well as improved approaches in their metabolic 
engineering [21]. A recent review of available research in this area can be found in [29, 
30]. 
To give an idea of the important role that flavonoids play, two areas they are involved in 
are given below. This research deals with the first- the role of flavonoids, specifically 
anthocyanins, in plants.  
 Flavonoids in plant reproduction and defense 1.7.1
Flavonoids assist in plant reproduction by producing yellow or red/blue pigmentation 
[31] in flowers and fruits, which help to attract pollinators and seed dispersers. The 
main compounds involved are called anthocyanins [32-34], which also have antioxidant 
properties and so also protect plants against ultraviolet UV-B irradiation [35]; they 
constitute a major subgroup of flavonoids.  
Flavonoids also help protect plants from attack by microbes and insects as well as from 
UV light; for example, studies [36, 37] have shown that plants often produce more 
flavonoid compounds within their leaves and flowers, as a response to stress caused by 
an increase in UVB- radiation. This involves changes in the expression of many genes 
[38] and often happens at the cost of the primary productivity [39, 40] of the plant. It 
was found [41] that the light-induced synthesis of UV-protective flavonoids diverts 
substrates from primary metabolism to the formation of the secondary product. 
Understanding the metabolism and cellular processes involved in the production of 
6 
 
flavonoids could assist in finding ways for plants to produce them without it affecting 
their productivity. 
Anthocyanins [32-34] are the focus of this research. They provide a great platform for 
modelling because they are among the most studied and best understood compounds in 
plant science so there are ample experimental results [42-45] for comparing with model 
predictions. The overall agreement with experimental results that will be shown in this 
thesis opens an avenue of possibilities for using the mathematical analysis approach to 
direct biological research in other less understood pathways.  
 Flavonoids in the medical field 1.7.2
Flavonoids are also important in the medical field because of their beneficial effects on 
human health. They contain antioxidant properties [23], although recent studies [46] 
have found that these antioxidant properties do not apply in the human body. The health 
benefits that flavonoids provide against cancer disease are the result of mechanisms 
caused by the body trying to get rid of the flavonoids which they see as foreign 
compounds. In attempting to get rid of flavonoids, the body triggers “so-called Phase II 
enzymes that help eliminate mutagens and carcinogens” [46], so could prevent cancer. 
Flavonoids could also induce mechanisms that assist in killing cancer cells and 
inhibiting tumor invasion; they also appear to  increase the activation of existing nitric 
oxide synthase which prevents heart disease by keeping blood vessels healthy and 
relaxed, thus preventing inflammation and lowering blood pressure [46]. 
Although there is wide knowledge of the useful versatile functions of flavonoids in 
plants, not enough is known to determine the amount that needs to be taken [47] by 
humans but the recent studies [46] recommend relatively small amounts. Ingestion is 
recommended through consumption of flavonoids-rich food and beverages such as 
vegetables, fruits, berries, fruit juice, red wine and tea. 
 Organism Used: Arabidopsis thaliana 1.8
To focus on the structural functions of specific flavonoid genes and the interactions 
between the components of the metabolic network system and how these interactions 
give rise to the function and behaviour of certain flavonoid genes and their relationship 
to other flavonoids and related compounds, an appropriate coherent self-contained 
subnetwork needs to be extracted from the genome scale metabolic network of an 
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appropriate organism. The standard model plant, Arabidopsis thaliana (Arabidopsis), is 
used in this research because of the reasons set out below.  
Arabidopsis is a small flowering plant related to cabbage and 
mustard. It is one of the most studied organisms in plant 
sciences and genetics and is the first plant to have its genome 
fully sequenced [48]. It contains one of the smallest genomes 
in the plant kingdom which makes it a model organism, not 
only for genetic mapping and sequencing, but also for 
fundamental molecular and physiological studies of plant 
functions.  
Although Arabidopsis does not have any agricultural use, it plays the role for agronomy 
that the mouse and fruit fly (Drosphila) play in human biology. It may currently be the 
only plant in which a comprehensive network of secondary metabolism can be 
characterized within a single plant species [49].  
The above aspects and the fact that it is very similar to most other plants such that 
whatever properties it contains would most likely exist in all other flowering plants as 
well [50], make Arabidopsis an ideal organism for the research.  
Information for the research is obtained from the AraCyc database [51], available online 
and containing the full metabolic network of the Arabidopsis plant.  
 Source of Information: AraCyc Database 1.8.1
AraCyc [51-53] is a computationally predicted plant metabolism database containing 
information on biochemical pathways and reactions of Arabidopsis. It is supported by 
the Pathway Tools software developed by Peter Karp’s group at Stanford Research 
Institute (SRI) and is the most highly curated species-specific database present at the 
Plant Metabolic Network [54]. In addition, the AraCyc database [51] is one of 6 
databases classified as Tier 1 curation level in the larger BioCyc database system [55, 
56] containing a collection of 2037 Pathway/Genome Databases (PGDBs) where each 
PGDB describes the genome and metabolic pathways of a single organism. Being a Tier 
1 curation level means that the AraCyc database has received intensive literature-based 
curation, and is one of the most accurate databases.  
The AraCyc database has a large number of experimentally supported enzymes and 
metabolic pathways and, although it still contains a substantial number of 
Figure 1.8-1 :  
Arabidopsis thaliana  
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computationally predicted enzymes and pathways, we consider it to contain the most 
reliable and complete metabolic information that could appropriately be used for the 
research. Semi-automated and manually curated models of the Arabidopsis network 
have since become available and are discussed later in Section 5.1.  
The AraCyc database contains a mix of two types of information: 
i) Pathways of reactions and enzyme information computationally predicted using 
the multiorganism database, MetaCyc [57, 58], as a reference database. The 
predicted pathways are then manually reviewed and validated by a curator who 
assesses whether their computational prediction is justified, based on a number 
of cues from the literature. The pathways concluded to be not present in 
Arabidopsis are taken out. The resulting pathways are either experimentally 
confirmed or still to be confirmed.  
ii) Information extracted from peer-reviewed literature.  
The manual curation of the AraCyc database is still on-going with a new version 
released every now and then: at the start of the research, release used to be every quarter 
but at the time of writing, release of a new version is down to twice a year. The curation 
and upgrading process involves correcting and adding missing pathways and reactions 
and assigning new enzymes and genes to the AraCyc database.  
New flavonoid biosynthetic genes and enzymes are still being discovered [59-61]. For 
example, in March 2009, the AraCyc database version 5.0, contained 2,312 compounds, 
1,928 reactions, and 5869 enzymes, with 332 pathways, of which 87% were manually 
validated to exist in Arabidopsis and to be correct in relation to evidence from literature. 
The rest were based on computational predictions validated from cues in literature [62]. 
At the time of writing, the AraCyc database was up to version 8.0, and contained 2,825 
compounds, 2,689 reactions and 5520 enzymes with 446 pathways. The AraCyc 
metabolic pathway tools query page can be accessed at [63]. 
In response to the ongoing updating and curating of the metabolic pathways and 
reactions in AraCyc, the flavonoid subnetwork used in this research is correspondingly 
updated when a new version of the database comes out. 
Although the research has been based on the AraCyc database, the development of new 
reconstructions of the Arabidopsis network, as discussed in Section 5.2, is noted.  
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 Analysis Tools 1.9
• The CellNetAnalyzer (CNA) [64] is the main software tool used in this research 
for application of the MPA methods to the Arabidopsis flavonoid subnetwork. It 
is an advanced pathway analysis tool that runs in MatLab and that provides a 
comprehensive and user-friendly environment for structural and functional 
analysis of biochemical networks. The CNA is available for free via the web and 
was downloaded for use in the research.  
• Microsoft Excel is used in the reconstruction and extraction of the flavonoid 
subnetwork and in the analysis of outputs from CNA.  
• MatLab [65] is needed to run the CNA package and is also used to develop the 
algorithm programmes for the research study covered in Chapter 8.  MatLab is a 
widely used commercial high-level language and interactive environment for 
numerical computation, visualization, and programming.  
 Objectives 1.10
The general objective of the research is to employ mathematical and in silico methods 
and tools to analyse and make use of genome scale metabolic data of the model plant 
Arabidopsis in order to get a better understanding of the metabolism of flavonoids in the 
context of whole cell metabolism and be able to use this to relate to experimental 
observations and assist in experimental design. 
This is undertaken through the following more specific objectives: 
• To conduct a review of MCSs that investigates how they relate to EMs and other 
constraints-based (Section 1.5) methods; 
• To extract a self-contained flavonoid subnetwork from the full metabolic 
network of Arabidopsis. This deals with the problem posed by the complexity of 
the Arabidopsis network;  
• To analyse the structure of the flavonoid metabolic network in relation to the 
anthocyanin compounds. MPA (Section 2.4)  is used to determine the EMs that 
constitute the ABP and subsequently identify MCSs or where in the ABP genetic 
variation could occur to cause loss of floral pigmentation;  
• To apply further constraints to the flavonoid network and simulate fluxes 
through individual reactions for certain anthocyanin MCSs of interest. The 
enzyme fluxes are analysed and compared to gain an in-depth understanding, 
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and make predictions, of the functional capacity of the anthocyanin-related 
genes and their interplay with other flavonoids and related compounds. The 
predictions are compared with available experimental literature;  
• To develop an algorithm for determining gene expression in a specific tissue of 
interest, using knowledge from experimental observations on the presence and 
absence of compound products in the tissue.   
A summary of how these objectives are achieved is outlined in the next section- 
overview of chapters.  
 Overview of Chapters 1.11
The holistic perspective and completeness of EMs, MCSs and all the MPA (Section 2.4)  
methods employed in this research take into account the structure of the whole 
metabolic network and all the reactions taking place in the cell, thus are subject only to 
a complete knowledge of the network itself. 
This chapter 1 introduces the idea of the research, the background on systems biology 
and the use of constraints-based modelling (Section 1.5) to analyse genome scale 
metabolic data. It introduces the organism that is used, its significance and why it has 
been chosen for the research. It also provides an overview of the research and the 
contributions that it makes.  
Chapter 2 looks at the steps involved in constraints-based modelling: network 
reconstruction, MPA and concepts of importance in analysing the network and in the 
research. Associated literature and some work examples are also included.  
Chapter 3 presents a review of MCSs, the concept that plays a major role in the 
research. The review looks at how the concept of MCSs was developed and how it 
relates to EMs and other constraints-based methods. Other areas covered in the review 
include looking in detail at how MCSs work, how the concept has developed in relation 
to similar concepts including looking in some detail at concepts similar to MCSs, and 
also looking at the important contribution that MCSs can make to systems biology and 
areas such as metabolic and genetic engineering. 
Chapter 4 presents the reconstruction and extraction of the flavonoid subnetwork 
(FlavNet) for the research. It describes the reconstruction process and the considerations 
that have to be taken into account when extracting the FlavNet from the Arabidopsis 
network to deal with the problem posed by the complexity of the Arabidopsis network. 
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Chapter 5 verifies the reliability of our flavonoid subnetwork by comparing its 
compounds and reactions with those of a more recently reconstructed Arabidopsis 
network. 
In Chapter 6 the flavonoid metabolic subnetwork is analysed using MPA (Section 2.4); 
EMs are calculated and classified into groups and used to determine the anthocyanin 
biosynthetic pathway (ABP). Structural network analysis methods such as reaction rates 
and MCSs are used to investigate the properties of the ABP and relate the structure of 
the metabolic network to the phenotypic roles of the corresponding genes and where 
they occur in the ABP, e.g., identifying where in the ABP genetic variation could occur 
to cause loss of colour pigmentation.  
Chapter 7 takes the study of anthocyanins a step further by constraining the MCSs that 
eliminate the production of anthocyanins in the flavonoid network and simulating fluxes 
through individual reactions of interest to investigate the related genes further. The 
enzyme fluxes are analysed and compared to gain an in-depth understanding and make 
subsequent predictions of the functional capacity of the anthocyanin-related genes and 
their interplay with other flavonoids and related compounds in terms of the impact of 
their elimination. The predictions are validated by comparing with available 
experimental literature.  
Chapter 8 develops an algorithm and program for determining gene expression in a 
specific tissue of interest, using EMs and MCSs in conjunction with knowledge from 
experimental observations on the presence and absence of compound products in the 
tissue. 
Chapter 9 provides an overall conclusion of the research and possible studies that could 
be done in the future.   
 Contributions  1.12
This thesis contributes to Systems Biology by:  
i) Making use of the genome-scale metabolic information of the Arabidopsis plant to 
better understand the systemic behaviour of a multicellular cell, using mathematical 
and in silico methods. The research, not only contributes to the knowledge and 
understanding of the systemic functionality of a plant cell, but it also contributes to 
the sparse use of the ever increasing volume of genome-scale metabolic data that is 
now available from high throughput technologies. 
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ii) Carrying out a review study of MCSs (Chapter 3), the MPA concept that plays a 
major role in the research. This is the first review that has been done on MCSs and 
serves to provide readers who are not familiar with the concept, with information on 
its capability and potential in comparison to other methods. It contributes to gaining 
a deeper understanding of constraints-based  modelling methods and how they can 
be applied to study the functionality of genes in multi-cellular organisms 
 Material from this review work has been published in the special 
‘Metabolism and Systems Biology’ issue of the Metabolites journal [66]. 
iii) Reconstructing the full Arabidopsis network from the AraCyc database, and 
extracting a self-contained subnetwork (Chapter 4) to which constraints-based 
modelling (Section 1.5) analysis methods can be applied without the problem of 
combinatorial explosion. This is an ongoing process throughout the research, in 
relation to the ongoing curation of the AraCyc database.  
 Initial ideas for the work were presented at the MODSIM conference [67]  
 Material from Chapter 4, in combination with material from subsequent 
chapters, have been compiled into an article which has been published in the 
BMC Bioinformatics journal [68].   
iv) Verifying the self-contained flavonoid network extracted from the full Arabidopsis 
network by comparing the compounds and reactions to those contained in a more 
recently reconstructed and verified Arabidopsis network (Chapter 5). 
v) Using MCSs and structural network analysis to identify correlated gene targets for 
the loss of colour pigmentation in plants from a whole cell perspective (Chapter 6). 
Being able to correlate the predictions with experimental results provides credence 
to use these mathematical and in silico approaches to assist in achieving desired 
outcomes, especially for other less understood pathways. 
 Initial ideas for the work were presented at the MODSIM conference [67] 
  Material from Chapter 6 has been published in the BMC Bioinformatics 
journal [68]. 
vi) Applying FBA to FlavNet to investigate and provide a quantified measure of the 
impact that elimination of the ABP genes has on other flavonoids and related 
compounds (Chapter 7). This involves formulating a representative reference state, 
from available experimental results, to constrain the solution space and improve the 
prediction accuracy of the model.  
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 Initial ideas for the work were presented at the MODSIM conference [67]  
 Material from Chapter 7 has been published in the BMC Bioinformatics 
journal [68]. 
vii) Using knowledge from previous chapters to develop an algorithm and program that 
uses EMs and MCS to determine which reactions (and thus genes)1 are being 
expressed in a tissue from experimental information about compound presence in 
the tissue. The program was applied to an example network and to the flavonoid 
network to determine reactions taking place in the Arabidopsis flower. The results 
show the program works although further work is required to incorporate clustering 
methods and a user interface to make the program more user friendly.  
                                               
1reactions are catalysed by enzymes, so can be used to determine genes being expressed 
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: Background Chapter 2
This chapter looks at metabolic networks [5, 6] and the constraints-based  modelling 
(Section 1.5) processes and methods involved in their analysis: Section  2.2 looks at the 
first step in constraints-based  modelling- network reconstruction; Section 2.3 discusses 
the main concepts of importance in analysing the network; and Section 2.4 goes into the 
second part of constraints-based  modelling- MPA. It also introduces MCSs, the concept 
that serves a key part in the research. Associated literature and some work examples are 
also included.  
 Metabolic Networks 2.1
A metabolic network [5, 6] is a map of metabolic pathways and reactions.  It comprises 
the chemical reactions of metabolism (Section 1.3) that convert thousands of organic 
compounds into biomolecules necessary to support and maintain cells.  
In general, the metabolic network is a directed graph where the nodes represent 
compounds, and the edges chemical reactions [69, 70]. The boundary nodes are external 
biochemical inputs (substrates) or outputs (products) while the internal nodes are 
intermediate compounds with associated stoichiometric constraints to guarantee mass 
conservation (refer to Section 2.3.4). 
The directed graph can be in the form of a hypergraph or a bipartite graph. A hypergraph 
(a) containing multi-source and multi-target edges is more commonly used to represent 
biochemical reactions containing multiple substrates and products. By adding a set of 
nodes representing reactions (R) to the hypergraph, it can be transformed into a bipartite 
graph (b) (but the former representation is more accurate, refer to Section 3.2.3.2). 
a)    b) 
          
Figure 2.1-1: Directed graphs representing part of a small metabolic network. 
(a) hypergraph, (b) bipartite graph, R-reactions. 
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The constraints-based modelling (Section 1.5) approach used in this research to analyse 
and study a metabolic network, involves two main steps: the reconstruction of the 
metabolic network, and the analysis of its structural properties using MPA (Section 2.4). 
The next section discusses the reconstruction process. 
 Network Reconstruction 2.2
The reconstruction [71-73] of a genome-scale metabolic network relies on putting 
together information concerning all the biochemical reactions in the network from a 
variety of information sources. These sources include the genome, biochemistry and 
physiology of the organism of interest, as well as new experimental information 
describing metabolic pathways. Because the reconstruction process [74-76] usually 
starts with the annotated DNA sequence that identifies the enzymes present, it is not 
only “genome-scale”, combining identified collections of reactions to form pathways 
that make up the metabolic network of the organism, but one is also able to identify all 
reactions that the cell is capable of, if all genes are included in the reconstruction. To 
ensure that the reconstructed network is well-curated and of high quality, the 
components and links in the network need to be manually verified as subtle differences 
exist even between related organisms.  
The AraCyc database is still undergoing the above process for Arabidopsis and contains 
the latest update of the reactions and enzymes information for the full metabolic 
network of Arabidopsis. The network reconstruction for this research involves 
collecting all the balanced reactions in AraCyc together and building a directed graph 
which can then be mathematically represented and analysed. 
MPA (Section 2.4) for unicellular microbes has always been carried out using their 
genome-scale full metabolic networks because the networks have been small enough. 
However, for the multicellular Arabidopsis plant, the full metabolic network is too large 
and complex to be straightforwardly analysed and interpreted by certain MPA methods. 
The practical way is to extract, from the full network, a relevant metabolic subnetwork 
that is still representative of the metabolism of the whole cell. This requires the 
subnetwork to be cut out at strategic nodes in the network: the nodes can either be 
external nodes, or internal nodes that could justifiably become external nodes. External 
compounds are not considered to be in pseudo steady state and do not need to be 
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balanced by Equation 2.10 so, in order to choose the correct nodes to cut, it is essential 
to understand the concept of external compounds. 
 External compounds 2.2.1
There are various reasons why a compound may be taken as external for a subnetwork 
and not subject to conservation [77]; the reasons relate to the concept of buffering or 
having a reservoir for an external compound. For compounds to be justifiably external, 
they need to be of sufficient supply in the cell or be buffered by a plausible external 
reservoir. Consider the following metabolic map with a subnetwork (grey):  
 
Figure 2.2-1: A metabolic network with a subnetwork (grey) 
The above metabolic network shows different types of external compounds  
with the subnetwork highlighted in grey. 
The types of external compounds are indicated as letters A-E: 
A - Raw materials taken from the cell environment. These are external 
substrate compounds for the entire network, e.g. H2O, O2, CO2, nutrients such as 
inorganic phosphate and so on; 
B - Compounds obtained from, or delivered to, other subnetworks 
performing other biological functions (e.g. catabolism, photosynthesis, growth). 
This could include carrier molecules, sugars, nucleotides, amino acids, etc.; 
C - Final product compounds of the entire network, delivered by this 
subnetwork, e.g. biomass constituents; 
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D - Intermediate compounds connected to the “real” externals by reactions 
identified but not properly specified in the known raw network – unbalanced 
equations (often generic); 
E - Intermediate compounds for which the connecting reactions are 
completely missing from the known network. 
Externals of types A and C are fundamentally external: they appear in this role in the 
full and complete genome-scale metabolic network. Types D and E arise from 
incomplete knowledge of the full network. Type B are artefacts created deliberately 
when splitting into subnets.  
A strategy to choose type B externals would usually aim at keeping their total number to 
a minimum, or otherwise control the particular compounds chosen. These choices 
ultimately determine the contents of the subnetworks.  
 Subnetworks  2.2.2
The boundary of the network (or a subnetwork) is defined as the set of nodes 
(metabolites or compounds) that are exchanged with the outside and therefore need not 
be balanced by the network. In terms of metabolic reactions, there are two kinds of 
boundary nodes: 
i) Compounds that always occur on the same side of all the reaction equations 
containing them. These are true external compounds (input if on LHS, output if on 
RHS). 
ii) Compounds that occur on both sides of reactions, but do not need to be balanced 
because they can be exchanged with an external reservoir (e.g. H2O). 
A self-contained subnetwork is created by cutting, through the full network, internal 
nodes that could justifiably become external. Cutting internal nodes, in effect, assigns 
the compounds as external by removing the corresponding stoichiometric constraints 
and thus the need to be balanced. As mentioned earlier, for these compounds to be 
justifiably external, they need to be of sufficient supply in the cell or buffered by an 
external reservoir, for example, carrier compounds such as ATP and ADP.  
The above specifications are employed in reconstructing a complete, self-contained 
flavonoid subnetwork to which MPA (Section 2.4) is applied. However, before applying 
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MPA methods, it is necessary to understand the theory of constraints-based modelling 
(Section 1.5) and how the MPA analysis methods are derived. 
 Concepts of Importance in Network Analysis 2.3
The structural properties of metabolic networks, as shown in [64, 78, 79], are closely 
related to their phenotypic functions. These structural and functional properties are often 
called emergent properties [13, 69] because they emerge from the whole network, not 
from its individual components. As the network grows in size, the number of possible 
functional states that it can take grows faster than the number of components such that 
the same network can display many different phenotypic behaviours and carry out many 
functions. The cell does not utilize all functional states but selects and expresses a 
limited set depending on the selection pressures and objectives.  
The network functions are determined by the way in which the chemical reactions link 
or connect components together to form the networks. By representing the connections 
with a stoichiometric matrix, S (Section 2.3.2), mathematical in silico methods such as 
MPA (Section 2.4), can be used to analyse and study the structural and functional 
properties of the network.  
The main strengths of constraints-based (Section 1.5) methods like the EMs (Section 
2.4.2) and MCSs (Chapter 3) concepts of MPA (Section 2.4) are that, unlike quantitative 
metabolic modelling [80], they do not require any knowledge of the metabolite 
concentrations or the enzyme kinetics of the system, which are not easy to obtain. The 
steady state (homeostasis) [81, 82] assumption in MPA precludes the need for 
knowledge of nutrients at any time as long as that quantity remains constant; it also 
removes the need for specific rate laws since it simply requires that the total flux of any 
compound in the system is zero.  
For MPA and quantitative constraints-based methods like flux balance analysis (FBA), 
the lack of kinetic information is overcome by successively reducing the solution space 
containing the range of phenotypes possible in a metabolic system. This is carried out 
by successively imposing physicochemical2 constraints on the solution space.  
                                               
2
 to do with physics or chemistry, e.g., flux (v) has to be positive; certain metabolite enters but doesn’t 
leave system; etc. 
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A review of the history and advances in MPA and FBA can respectively be found in [83] 
and [84, 85].   
 Solution space and imposed constraints  2.3.1
The solution space contains all possible functions of the reconstructed network or all 
allowable phenotypes [17]. Constraints-based modelling (Section 1.5) successively 
applies constraints to the analysis of the reconstructed network to reduce the solution 
space and narrow attainable phenotypes. A summary of this is given by Palsson (2000) 
[13] and is shown below. 
 
Figure 2.3-1: Successive application of constraints. Source: Figure 3 of [13] 
S- stoichiometric matrix; v- flux/ reaction rate; k- Michaelis Menten constant 
The next sections will look at the concepts of importance in constraints-based  
modelling (Section 1.5) in relation to how constraints are successively applied to a 
metabolic network as shown in Figure 2.3-1 above.  
 The stoichiometric Matrix, S  2.3.2
The stoichiometry of a biochemical reaction network describes the architecture and 
topology of the network, and contains both chemical and network information. It refers 
to the molar ratios in which the substrates in the chemical reactions are converted into 
20 
 
products. These ratios remain constant under changing reaction conditions, thus 
providing a way to study the structural characteristics of the system by itself, regardless 
of what the environment or the internal states of the system are. 
The stoichiometric matrix, S, [86] consists of the stoichiometric coefficients of the 
reactions that comprise a network. Its columns represent the reactions and its rows 
represent the compounds or metabolites. S transforms the reaction flux vector, into a 
vector of time derivatives of the concentration vector. The matrix can therefore be used 
to generate mathematical and computer models to analyse, interpret and predict 
biological functions of a reconstructed network. Predictions lead to the formulation of 
hypotheses that can be tested experimentally, providing a basis for iterative model 
building and certain practical applications. 
Let us look closely at a reaction flux vector. 
 A reaction flux vector  2.3.3
A flux vector contains the reaction rates or the fluxes through reactions. For example: 
Consider the set of chemical reactions 
2A  B (2.1) 
A + C  3D (2.2) 
This means that “2 moles3 of A react to form one mole of B” etc., i.e., the stoichiometry 
coefficients sij are numbers with units (the number of moles). The subscript i relates to a 
compound and j to a reaction,  
e.g., sa1 = -2, sb1=1, sa2= -1, sc2= -1, sd2=3 
To formulate the kinetic equations that describe the reactions, consider a unit volume 
that contains a mass mi of reactant i (i.e., a mass concentration i ≡ density = mi). 
Let MA, MB be molecular masses of A, B, etc. 
Suppose that (in a unit volume) a mass ∆mij of reactant i is transformed per second by 
reaction j, then the total number of moles of reactant i that is transformed  
(per unit volume per second) is 
                                               
3
 the amount of pure substance containing the same number of chemical units as there are atoms in 
exactly 12 grams of carbon-12 (i.e., 6.023 X 1023) 
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But if sij moles of reactant i is needed to produce one “full” molar reaction unit, the 
fraction of this that takes place in a unit volume in a second is: 
iij
ij
j Ms
m∆
=ν
 
(2.4) 
This number has only an index j, because the same number has to be obtained for each 
reactant in equation j (the stoichiometry relation dictates that the mij have to have fixed 
ratios with respect to one another). 
The vj in (2.4) is called the flux of reaction j, and has dimensions [L-3T-1] 
If we define the molar concentration as  
xi = number of moles of reactant i per unit volume = 
i
i
M
m
 (2.5) 
 
It follows (using equation 2.4) that  ∑ ∑=
∆
=
∆
∆
j
jij
i
iji s
M
m
t
x
ν  (2.6) 
 
i.e.  vS
dt
xd
ˆ
ˆ
∗= ,  S≡ [sij] (2.7) 
where S is the stoichiometric matrix and vj the flux vector. This is the equation that is 
conventionally used to define the flux, vj, in elementary flux modes 
To make it easier to discuss and explain the concepts further, a small metabolic network 
example will be used: 
Consider the simple metabolic network below where some substrate A is transported 
across the system boundary, reacts with a cofactor cof to produce metabolite B
 
and a 
byproduct byp. It is also reversibly converted to C, which also gets converted to B
. 
 The 
byproduct byp and metabolite B are exported out across the system boundary.  
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Reaction map 
 
Figure 2.3-2: Example of a metabolic network. 
The amounts of matter that flow through each chemical reaction are the metabolic 
fluxes [72, 87] or reaction rates. Internal fluxes occur inside the network and are 
denoted by vi where the subscript i refers to the index of the internal fluxes. 
External/exchange fluxes occur across the system boundary and are denoted by be 
where the subscript e refers to the index of the external fluxes.   
Limited thermodynamic information can be used to determine whether a reaction is 
reversible or irreversible [88, 89]. A reversible internal reaction is considered as two 
fluxes occurring irreversibly in opposite directions so all internal fluxes can be 
considered as nonnegative: 
vi ≥ 0 (for all i ∈ Irreversible) (2.8) 
The external flux representing the net production and consumption of a metabolite by 
the system can also be constrained to one flux per metabolite so the number of external 
fluxes can never exceed the number of metabolites in the system. 
The above system allows for four internal fluxes (vi) and three external fluxes (be). The 
changes in concentrations dxi/dt of the metabolites A, B & C are simple functions of 
these fluxes. 
 Dynamic mass balance 2.3.4
All physical systems obey the law of conservation of mass which states that any 
disappearance of mass must be accompanied somewhere by the appearance of an equal 
amount of mass [90]. As shown in equation 2.6, the rate at which the concentration of a 
metabolite changes (dxi/dt) is the sum of the rates of reactions that produce it minus the 
sum of those that consume it (multiplied by the appropriate stoichiometric coefficients):  
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 (2.9) 
where sij are the reaction vectors that form the column of the stoichiometric matrix, S 
and vj is the flux vector. The reaction vectors are structural features of the network and 
are fixed. 
For a network consisting of n reactions of m metabolites, the dimensions of S would be  
m x n, i.e. in the above example, dim(x) =m=5, dim(v)=n=7,  so dim(S) = m x n = 5 x 7. 
The stoichiometric matrix, S, for the metabolic network example in Figure 2.3-2  is 
shown in Figure 2.3-3 below: 
byp
cof
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B
Abbbvvvv
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Figure 2.3-3: Stoichiometric matrix, S, of Figure 2.3 2 
The corresponding table of fluxes and related reactions of the above matrix for Figure 
2.3-2 are shown in Table 2.3-1 below: 
Table 2.3-1: The fluxes and chemical reactions for Figure 2.3 2 
Internal fluxes Chemical reactions 
v1 A+ cof = B + byp 
v2 A = C 
v3 C = A 
v4 2C= B 
Exchange fluxes Chemical reactions 
b1  A 
b2 B 
b3 byp 
 
 Steady state 2.3.5
When the boundary of a system is fixed, the system tends to evolve to some stable 
unchanging state called the steady state [91, 92]. At steady state the mass balance in the 
network (equation 2.6) can be represented by the flux-balance equation:  
vS ˆ*0 =
 
(2.10) 
where S is the stoichiometric matrix and  the reaction fluxes. The pathway structure 
and optimal performance of the network can be studied by successively imposing 
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constraints to the analysis of the network and reducing the solution space containing all 
possible functions of the network. The process is discussed in i) below, ii) & iii) of 
Section 2.3.6 and iv) of Section 2.3.7 and these can be related to Figure 2.3-1: 
i) Using the network example (Figure 2.3-2) Equation 2.10 is rewritten in the form 
of homogeneous linear equations representing a space where each axis 
corresponds to a reaction flux: 
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Figure 2.3-4: Rewriting the steady state mass balance equations 
 in the form of homogeneous linear equations  
representing a space where each axis corresponds to a reaction flux 
Each row of S represents the mass balance of the corresponding metabolite. 
This is a set of linear equations that constrains the values of the fluxes to the null space 
without fully determining them: they constitute the stoichiometric constraints in (2.10) 
that limit the steady state fluxes to a subspace that is a hyperplane. In a high-
dimensional space the axes correspond to the flux levels through the individual 
reactions. 
 This relates to step 1 of Figure 2.3-1: the stoichiometry and linear algebra 
 Convex analysis 2.3.6
The next constraints imposed on the network analysis relate to convex analysis [93]. 
Convex analysis  is an area of mathematics that enables the analysis of inequalities and 
systems of linear equations to generate a convex set of vectors that can be used to 
characterize all of the steady-state flux distributions [88] of a biochemical network 
based on equalities (Sv=0) and inequalities: 
ii) Internal flux constraints in Figure 2.3-2: the reactions are defined such that all 
fluxes are positive:  
+∞≤≤ 421 ,...,,0 vvv  (2.11) 
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Having positive fluxes converts the plane to a semi-finite plane called a cone. 
The edges of this cone become a set of unique, systemically defined extreme 
pathways (section 2.4.1) and all the points inside the cone can be represented as 
nonnegative combinations of these extreme pathways.  
This relates to step 2 of Figure 2.3-1: Reaction directions and convex analysis. 
iii) Further constraints are applied to the network based on the knowledge of the 
system and the availability of certain metabolites to enter and exit the system. 
For example:  
Internal fluxes: if the maximum limit was known, equation 2.11 becomes: 
max,0 ii vv +≤≤    i = [1,2,3,4] (2.12) 
Exchange fluxes: let’s say the substrate A is allowed to enter and exit the system 
whilst metabolite B and the byproduct are only allowed to exit, the constraints 
would be: 
Exchange flux constraints: 
+∞≤≤∞− 1b
 
(2.13) +∞≤≤ 20 b
 
+∞≤≤ 30 b
 
These flux constraints form capacity constraints on individual reactions; they 
limit the length of each edge and close the convex cone. This bounded convex 
cone (bounded null space) forms the solution space (Section 2.3.1) containing all 
possible network states.  
This relates to step 3 of Figure 2.3-1: Capacity constraints  
The properties of the resulting solution space can be studied using MPA methods 
(Section 2.4); a review of the history of convex analysis can be seen in [83, 87]. 
 Optimization 2.3.7
Linear optimization can be used to find a particular set of phenotype solutions of 
interest within the bounded null space.  
iv) The objective function, Z, is defined as: 
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where wi & we represent weights for the individual internal and external fluxes vi and be 
respectively. 
Based on known constraints, Z can be optimized using linear programming.  
By calculating and examining optimal metabolic flux distributions under various 
conditions, it is possible to generate quantitative hypotheses, in silico, that may be 
tested experimentally. The objective function Z could be growth rate, ATP production, 
yield of a desired product, nutrient uptake, and so on.  
 This relates to step 4 of Figure 2.3-1: Relative saturation levels. 
 Metabolic Pathway Analysis 2.4
A review of the history of MPA can be seen in [83, 87]. MPA developed from the need 
to assess the properties emerging from reconstructed biochemical networks, and 
generate hypotheses regarding the functions of the networks in the absence of detailed 
kinetic information. It is now being recognized as a central approach to the structural 
analysis of metabolic networks [94]. As defined in [95], “Metabolic pathways are the 
true functional units of metabolic systems.” The metabolic pathways defined here are 
the elementary modes (EMs) described in Section 2.4.2, which are uniquely complete 
non-decomposable pathways consisting of the minimal sets of reactions that allow the 
network to operate at steady state; they start from an external substrate(s) and end in an 
external product(s). These EMs are defined in the context of whole-cell metabolism and 
thus can be used to analyse the structural design and capabilities of the metabolic 
network. 
The solution space (Section 2.3.1), shown as the bounded convex subset in Figure 2.3-1 
discussed in iii) under section 2.3.6, can be analysed using MPA. There are two types of 
MPA approaches: extreme pathways (ExPa) [95] and elementary flux modes (EM) [96]. 
A comparison of these two approaches is provided in [97]. While they both use convex 
analysis to identify all possible and feasible metabolic routes for a given network at 
steady state, their difference lies in the type of exchange fluxes constituting the 
biochemical network. If there are reversible internal reactions, ExPa analysis first 
breaks them up into two separate reactions before calculating the pathways; EM 
analysis does not. So, although the set of EM is the same as the set of ExPas for a 
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network with only irreversible reactions, there will be more EM than ExPas in a 
network with both reversible and irreversible reactions, as illustrated in Figure 2.4-1. 
 
Figure 2.4-1: A simple example of a biochemical network (a)  
with its corresponding elementary modes (EMs) (b) and extreme pathways (ExPas) (c).  
The EMs and ExPa are indicated by black arrows. Source: [97] 
 
Each MPA approach has its advantages and disadvantages and as the understanding of 
their differences improves, the better they will be appropriately used to study the 
properties of biochemical networks. This research uses EMs for network analysis as it is 
a superset of ExPas, so ExPas are contained in the set of EMs as described in the brief 
overview below. 
 Extreme Pathways 2.4.1
Extreme pathways [98, 99] are unique sets of fluxes satisfying the steady-state mass 
balance constraints given by equation (2.10) and inequalities such as those in equation 
(2.11) & (2.12). They are irreducible, non-redundant subsets of elementary flux modes 
and form the edges of the solution space (convex cone) as illustrated in Figure 2.4-2 
below. ExPas can be used to characterize the phenotypic potential of a defined 
metabolic network and the relative flux levels through all the reactions necessary to 
convert substrates into products.  
28 
 
 
Figure 2.4-2: Extreme pathway analysis  
produces a set of vectors that define the convex solution space where the extreme pathways  
lie at the edges of the bounded null space of the flux cone. Source: [100] 
 Elementary flux modes 2.4.2
Elementary flux modes (EMs) [94, 96, 101, 102], are unique routes, or non-
decomposable pathways, that consist of the minimal sets of reactions that allow the 
network to operate at steady state.  
Each EM can be represented by a set of non-decomposable vectors satisfying equations 
2.10 and 2.11, and derived from the stoichiometric matrix (refer to Section 2.3.2) of a 
biochemical network using convex analysis (refer to Section 2.3.6). 
Because they are based on the structure of the network, EMs are defined in the context 
of whole-cell metabolism. So, if only these enzymes were operating in the network, the 
inhibition of one of them will result in the network being unable to achieve steady state. 
Any steady state flux pattern of the network satisfying equations 2.10 and 2.11 can be 
expressed as a unique set of non-negative linear combination of these EMs 
∑ ≥=
i
i
i EMv 0,)( αα  (2.15) 
In this respect, EMs can be used to carry out studies such as:  
• looking at the possible metabolic pathways in a network;  
• detecting non-redundant pathways;  
• investigating enzymes involved in the production of desired products;  
• predicting the effect of enzyme deficiency;  
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• identifying gene targets;  
• reducing perturbations to the system; and  
• so on.  
A review of the history of EMs can be found in [103]. 
 Examples of work using elementary flux modes 2.4.2.1
Example 1: Schuster et al. [101] used EMs to analyse the interplay between the 
pentose phosphate pathway and glycolysis.  
  The EMs obtained from their study involved different numbers of 
enzymes and were interpreted in terms of their importance for the different 
metabolic needs of the cell. They showed that EMs provide a way of detecting 
non-redundant pathways in metabolic networks.  
Example 2: Wilhelm et al. [104] used EMs to study the structural robustness of 
metabolic networks.  
  Wilhelm et al. found that the number of EMs can be used with other 
robust measures to determine structural robustness. They were able to 
quantitatively show that the metabolism of Escherichia coli, which needs to be 
able to adapt to a changing environment, was more robust than that of the human 
erythrocyte. 
Example 3: In another study, Van Dien and Lidstrom [105] used EMs as part of their 
study on a proposed metabolic network for Methylobacterium extorquens 
AM1.  
  Van Dien and Lidstrom used EMs to explore the flux space of the 
reaction network of a biomass synthesis reaction of 20 key precursor 
metabolites. The EMs were determined and analysed for three separate 
substrates; methanol, pyruvate and succinate.  
Results were compared to the metabolic network proposed for Methylobacillus 
flagellatum to compare the efficiency of carbon utilization in the two types of 
methylotrophic carbon utilization networks. 
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Findings: 
• The experimentally measured value of carbon yield per mole of methanol 
closely agreed with that implied by an optimal biosynthetic mode for growth on 
methanol, thus corroborating the proposed network stoichiometry; 
• When the corresponding reaction equations of null mutants for citrate synthase 
or succinate dehydrogenase, which did not grow on any substrate, were 
removed from the network, the remaining EM did not produce biomass; 
• Their models also showed that, on succinate, null mutants lacking either of 
phosphoenolpyruvate (PEP) carboxykinase or malic enzyme genes grew as 
normal but those lacking both did not grow; 
• The model for PEP synthase mutants did not agree with the experimental result 
using pyruvate as the substrate, which predicts the pathway’s likelihood of 
being downregulated in vivo; 
• The network for Methylobacillus flagellatum produced a higher yield of carbon 
per mole of methanol. 
The study is a good example of how EMs can be used to study the metabolic 
capabilities of biotechnologically relevant organisms that can have commercial 
worth. 
A concept that operates on EMs, and which plays a major role in this research is that of 
MCSs, which will be studied in detail in the next chapter. The use of MCSs and EMs in 
this research provides a good illustration of how they can be used to study the metabolic 
capabilities of biotechnologically relevant organisms that can have commercial worth. 
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: Minimal Cut Sets Chapter 3
This chapter focuses on MCSs, the concept that serves a key part in this research. It 
looks at the background and development of the MCS concept and where it fits in, in 
comparison with other similar methods.  
Contribution 
A review of MCSs to gain a deeper understanding of the background and development 
of the concept, where it fits in, in comparison with other similar methods and how it can 
be applied to study the functionality of genes in multi-cellular organisms.  
Material from this review work has been published in the special ‘Metabolism and 
Systems Biology’ issue of the Metabolites journal [66] and received favourable 
comments from referees as a timely first review of this topic. 
 Introduction 3.1
Minimal cut sets (MCSs) have been developed from EMs (Section 2.4.2) an MPA 
method that uses convex analysis (Section 2.3.6) to identify all possible and feasible 
metabolic routes for a given network at steady state.  
This chapter focuses on MCSs which, together with EMs, form dual representations of 
metabolic networks with both being able to be converted into each other [106]. The 
MCS approach identifies target genes for eliminating a certain objective function, 
whereby blocking the reactions corresponding to these target genes disables flux 
through the reactions related to the objective function and ensures than in all steady 
states that the system can achieve, the objective will be absent. The concept adds to the 
increasing importance of MPA (Section 2.4) methods, and the capacity to employ 
metabolic engineering and biological systems to produce industrially relevant 
compounds from renewable resources, by providing a means of finding suitable targets 
for repressing undesirable metabolic functions. The standard experimental methods of 
studying the effect of genes work in many cases but there can be a variety of ways to 
achieve the same result e.g., blocking one enzyme can present the same effect as 
blocking a set of enzymes. MCSs provide a mathematically complete set of target genes 
based on the structure of the network. Thus, to successfully apply a gene knockout, a 
MCS really needs to be used or you can end up with unexpected results in the case 
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where there are other genes involved in performing the same function without needing 
the targeted gene. 
MCSs can be considered the smallest “failure modes” in a system; they were first 
introduced in 2004 by S. Klamt and Gilles [107], motivated by their desire to gain 
deeper insight into the functionality and capability of an organism by further analysing 
the structure of its metabolic network. In particular, they looked at how potential failure 
modes in a metabolic network could render the network structurally incapable of 
performing certain functions. They subsequently developed an algorithm, which was 
later generalized [106], for computing MCSs and identifying crucial parts in the 
network structure and suitable targets for repressing undesired metabolic functions. The 
calculation and analysis of MCSs and EMs (Section 2.4.2) are features of the 
CellNetAnalyzer program [64].  
This chapter will look at the initial concept of MCSs and how it has developed into its 
generalised form. It will also look at applications of the concept and how it relates to 
other theories.  
 Defining Minimal Cut Sets 3.2
S. Klamt and E.D. Gilles [107] defined MCSs as follows: 
“We call a set of reactions a cut set (with respect to a defined objective reaction) 
if after the removal of these reactions from the network no feasible balanced flux 
distribution involves the objective reaction”; and  
“A cut set C (related to a defined objective reaction) is a minimal cut set (MCS) 
if no proper subset of C is a cut set.” 
In effect, an MCS (with respect to an objective reaction) constitutes the minimal set of 
reactions whose removal from the network prevents any feasible balanced flux 
distribution involving the objective reaction; MCSs are the minimal hitting sets of the 
target EMs [108] or the minimal sets of knockouts that disable the operation of a 
specified set of target EMs [109]. 
In terms of the network structure, a continued operation of the objective reaction would 
not be physiologically possible because it would lead to the depletion or accumulation 
of metabolite pools and the system would not be able to achieve steady state. 
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 The Initial Concept of MCSs 3.2.1
The algorithm for calculating MCSs was developed by S. Klamt and E.D. Gilles [107] 
and operates on EMs [94, 96, 102]. In fact, EMs and MCSs complement each other, as 
will be discussed later on.  
The theory behind the use of EMs (Section 2.4.2) for calculating MCSs is the fact that 
an EM is minimal, thus non-decomposable in terms of the reactions (enzymes) utilized; 
removing a reaction from an EM results in the system not being able to achieve steady 
state with the remaining reactions of the EM. So, if the objective reaction is identified 
for the network function of interest, and EMs are calculated for it, the MCSs would be 
the reactions that, if taken out, would result in the system not being able to achieve 
steady state with the remaining reactions in these particular EMs, i.e., cause the 
dysfunction of the system with respect to the objective reaction, so the corresponding 
network function is repressed. 
MCSs can be used for studying the fragility of a network structure and identifying 
suitable targets for metabolic functionalities. For example, we have used MCSs [68] to 
study the functionalities of anthocyanin [32-34] related genes in flowering plants. 
 Example Network to Illustrate MCSs 3.2.2
To illustrate the MCS concept, consider the example network (NetEx) used in [106] and 
shown in Figure 3.2-1  below. The characteristics and hypergraphical nature of the 
network are important in defining its MCSs. 
 
Figure 3.2-1: Network layout for an example network (NetEx) discussed in [106]. 
 Features to Note about NetEx 3.2.2.1
• The network consists of five internal metabolites and eight reactions, of which 
R4 and R5 are reversible; 
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• Reactions crossing the system boundaries are coming from/leading to 
buffered/buffer metabolites. 
• Consider the case where the synthesis of product P is of particular interest; then, 
the reaction PSynth is the objective reaction in the same context as a target 
reaction [104], whereby all flux vectors with a non-zero flux through reaction 
PSynth are of importance.  
• The first step would be to determine the qualitatively distinct possible ways of 
producing P; this is equivalent to calculating EMs (Section 2.4.2) as illustrated 
in Figure 3.2-2 below. 
 
 
 
Figure 3.2-2: EMs for NetEx.  
The EMs are represented by the solid blue arrows. Adapted from [106] 
As shown in the above figure, there are six EMs for NetEx, five of which involve the 
PSynth reaction (highlighted networks). In order to eliminate the production of P, all the 
EMs that involve PSynth need to be blocked. By definition, an EM is blocked by 
removing any of its constituent reactions, therefore, any combination of reactions, one 
taken from each EM, forms a cut set that disables flux through the EMs. For our 
network example, NetEx, a MCS for the objective reaction, PSynth, is a set of reactions 
whose knockout blocks the five EMs involving PSynth, thus disabling flux through 
PSynth at steady state.  
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 Other Definitions 3.2.3
The notion of MCSs does exist in other theories and research areas, particularly in 
relation to risk analysis. In developing the algorithm for MCSs, S. Klamt and E.D. 
Gilles [107] looked at previous similar definitions of MCSs that existed in other areas at 
the time. These included fault trees and graph theory which shall be discussed here; 
other similar concepts are looked at later in Section 3.5. 
 Fault Trees 3.2.3.1
Fault Trees are non-recursive Boolean networks studied in reliability and risk 
assessment of industrial systems [110, 111], which have similar definitions of MCSs. 
The Fault Tree diagrams use logic block diagrams to display the state of a system (top 
event) in terms of the states of its components (basic events). The basic events are 
‘entries’ at the lowest level which form the leaves of the tree; intermediate events are 
those produced by binary operations (e.g., AND, OR, XOR) of other events, and the top 
event, representing a usually undesired system failure, is at the top of the Fault Tree.  
An example of a Fault Tree can be seen in the left hand graph of Figure 3.2-3 below. 
The right hand side graph is a Reliability Block Diagram (RBD) version of the Fault 
Tree. RBDs inversely represent Fault Trees: in RBDs one is working in the "success 
space" and thus looks at system success combinations, while in a Fault Tree one is 
working in the "failure space" and looks at system failure combinations. 
 
Figure 3.2-3: Example of a Fault Tree with equivalent Reliability Block Diagram 
MCSs [112] for complex RBDs and Fault Trees are used to estimate their reliability. 
MCSs can also be used to convert a complex diagram/system into a Fault Tree by 
constructing the RBD of a system, determining the MCSs and then using them to 
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construct the Fault Tree. For example, consider an example system whose RBD is 
shown in Figure 3.2-4 below: 
 
Figure 3.2-4: RBD of an example network system. 
• MCSs obtained from the RBD are: {MCS1}; {7}; {5,6}; {2,3,4}; {2,3,6} and 
{3,4,5}  
• The Fault Tree is constructed by connecting the MCSs using the OR gate. 
Within each set that contains multiple blocks, the multiple blocks are connected 
with an AND gate. The equivalent Fault Tree is shown in Figure 3.2-5 below: 
 
Figure 3.2-5: Equivalent Fault Tree of RBD in Figure 3.2-4.  
Blocks 2a-6a, 3b are duplicates of their corresponding blocks. 
More about Fault Trees and RBDs and the software used in reliability engineering and 
related fields can be seen in [113, 114].  
The difference between MCSs in Fault Trees and those in metabolic networks is that 
unlike RBDs, there is no definite knowledge of which combinations of the removed 
reactions would cause the failure of the objective reaction So, Fault Tree algorithms 
cannot be used to determine MCSs in metabolic networks. 
 Graph Theory 3.2.3.2
Another similar definition of MCSs exists in graph theory [115] where cut sets serve to 
disconnect a graph. However, the definitions would have different results because, in 
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addition to the stoichiometric relations that need to be satisfied, metabolic network 
MCSs also need to take into account the hypergraphical nature of the metabolic 
networks where an edge (reaction) can link reactant nodes with product nodes. For 
instance, in the example network NetEx, reactions R6 and R7 have 2:1 
(reactants:product) relationships (hypergraph in Figure 3.2-6 below) with compound C 
being involved in both reactions; substrate and bipartite graphs only allow 1:1 
(reactant:product) relations as illustrated in the corresponding substrate and bipartite 
versions shown to the right of the hypergraph in the top row of Figure 3.2-6 below. 
 
Figure 3.2-6: Hypergraph with corresponding substrate and bipartite graphs 
The hypergraph shows the reactant and product nodes of R6 and R7 in NetEx, with corresponding 
versions of substrate and bipartite graphs. In the lower hypergraph, removing R3 means no C is 
formed and a consequential removal of R6 and R7, which means that PSynth cannot proceed 
If reaction R3 is eliminated as shown in the second row of Figure 3.2-6 above, product 
P in the hypergraph cannot be formed: you cannot get from A or B to P. However, you 
can still get to P from both A or B in the substrate and bipartite graphs so the resulting 
MCSs of the hypergraph will be different from that of the other graphs. 
 Determining MCSs 3.2.4
Referring to the example network NetEx in Figure 3.2-1, the MCSs for the objective 
reaction, PSynth, can be determined as follows: 
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i) Calculate EMs (Section 2.4.2)  [101] in NetEx and identify those that start from 
a buffered metabolite and lead to the formation of metabolite E or the objective 
reaction PSynth. Since EMs are non-decomposable, removing one of the 
reactions from these EMs (Section 2.4.2) will prevent the system from 
producing E or achieving the PSynth. 
There are six EMs in total, of which five lead to the formation of metabolite X 
and the objective reaction. 
ii) Determine how to prevent PSynth from taking place, i.e. stop the five EMs that 
involve PSynth from being functional. This can be done in various ways e.g. 
inactivating one or more reactions in the EMs by deleting genes of certain 
enzymes or other manipulations that inhibit the enzymes. Different numbers and 
combination of reactions can be removed to eliminate PSynth. 
The MCSs for a given objective reaction in a large metabolic network, however, cannot 
be done by a simple examination; an algorithm would be needed to compute the MCSs. 
The first algorithm was developed by Klamt and Gilles [107] although others have been 
developed since, to improve on the computational speed and efficiency; these are 
discussed in Section 3.2.6.  
 The MCS Algorithm 3.2.4.1
The MCS algorithm devised by Klamt and Gilles [107] relies on the fact that: 
• any feasible steady-state flux distribution in a given network, expressed by a 
vector of the net reaction rates, r, can be represented by a non-negative linear 
combination of EMs as illustrated in Equation 3-1 (adapted from [106]):  
 (3-1)  
• where N is the number of EMs; and 
• the removal of reactions from the network results in a new set of EMs 
constituted by those EMs from the original network that do not involve the 
deleted reactions [88]. 
Before MCSs are computed, the set of EMs is split into two disjoint sets: 
• the set of target modes (Et), i.e., all EMs (et,j) involving the objective reaction, t 
• the set of non-target modes (Ent), i.e., EMs not involving the objective reaction, 
nt 
∑ ≥=
N
i
ii Er )0(, αα
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 (3-2) 
The right-hand side of Equation 3-2 above, illustrates, respectively, the set of EMs (e,t,j) 
comprising the target modes (Et) and the set of EMs (ent,k) comprising the non-target 
modes (Ent) [106]. Since removing a set of MCSs ensures inactivation of all target 
modes Et,j, only non-target modes Ent,k could survive, which means that all remaining 
flux distributions r will show zero flux in the objective reaction, robjR.  
The pseudocode of the MCS algorithm for calculating MCSs initially developed by S. 
Klamt and E.D. Gilles is provided in [107] and further modified for the example 
network, NetEx, discussed in [106].  
For the NetEx network, the algorithm calculates seven MCSs in addition to the trivial 
MCS (PSynth itself). To illustrate, one of the MCSs (MCS2) is shown in Figure 3.2-7 
below: 
  
Figure 3.2-7: One of the MCSs for objective reaction PSynth 
The simultaneous blocking of reactions R1 and R7 will eliminate PSynth  
and block the production of P. 
The seven MCSs and the corresponding EMs are shown in the first two tables of Table 
3.2-1. 
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 Generalized Concept of MCSs  3.2.5
S. Klamt, in 2006 [106], redefined the MCS from that of the original concept expressed 
under Section 3.2 earlier, to “a minimal (irreducible) set of structural interventions 
(removal of network elements) repressing a certain functionality specified by a deletion 
task”. This new definition indicates the key role that the deletion task plays in the 
difference between the new generalized approach and the initial MCS concept.  
The deletion task can be specified by several Boolean rules that clearly represent and 
describe, unambiguously, the flux patterns or the functionality to be repressed. This 
increases the practical applicability of MCSs because they can now be determined for a 
large variety of complex deletion problems and for inhibiting very special flux patterns 
instead of just for studying structural fragility and identifying knock-out strategies.  
The refinements and extensions to the initial MCS concept offer a broader range of 
possible ways in which MCSs can be used to assess, manipulate and design biochemical 
networks. A comparison of the concept versions is covered later in Section 3.2.7. 
 Further Refined Concept of MCSs 3.2.6
Further refinement of MCSs has also been undertaken [109] to deal with their limitation 
of disabling desired functionalities along with the targeted ones. To address this 
limitation, Hädicke and Klamt [109] generalized MCSs to Constrained MCSs (cMCSs) 
that take into consideration side constraints and allow for a set of desired modes, with a 
minimum number preserved, to be defined. 
This generalization provides a flexibility for cMCSs to be applied to existing methods, 
for example, Minimal Metabolic Functionalities [116, 117], OptKnock [118], and 
RobustKnock [119] can be reformulated as special cases of cMCSs. As demonstrated in 
[109], the cMCSs approach offers great flexibility in defining and solving knock out 
problems. 
The next section compares the three concepts, to get a better understanding of MCSs 
and how they have developed. 
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 Comparing MCS Concepts 3.2.7
 Same Properties 3.2.7.1
Some properties between the initial and generalized/ refined concepts of MCSs remain 
the same. For example: 
• There will always be a trivial MCS- the objective reaction itself; 
• Some reactions, such as the biomass synthesis or biomass constituents, are 
actually not biochemical reactions but pseudo-reactions whose stoichiometries 
define which metabolites are consumed for their synthesis, so, unlike reactions, 
their stoichiometries are not constant because they depend on the defined 
biomass composition. These pseudo-reactions are not related to a single gene or 
enzyme and thus cannot be repressed by inhibitions such as gene deletions; 
• The definition of the MCSs: each MCS provides a minimal (irreducible) set of 
deletions or EMs (Section 2.4.2) from the set of target modes that will achieve 
the elimination of the objective reaction. 
  Different Properties 3.2.7.2
• A deletion task T is a set of constraints that characterize the stationary flux patterns 
(reactions) r to be repressed while D, derived from T, characterizes the target modes 
(EMs) to be targeted by MCSs. As such, D (for the target modes) and T (for the flux 
vectors r) are, in most cases such as in the earlier MCS concept, identical.  
• In the generalized MCS concept, however, the deletion task D can either differ from 
T or T must be transformed into several Di that lead to sub-tasks. So, instead of only 
dealing with a simple deletion task T where all non-trivial flux distributions for an 
objective reaction are blocked, other more complicated deletion tasks and 
intervention goals are possible.  
• In the initial MCS concept, the MCSs are based on EMs, whereas the generalized 
MCS concept [106] sees EMs and MCSs as dual representations of network 
functions, which can be converted into each other, i.e., MCSs are EMs in a dual 
metabolic network [120].  
• The generalized MCS concept offers a wider range of capacity to assess, manipulate 
and design biochemical networks. MCSs are no longer restricted to the removal of 
reactions as shown in Figure 3.2-2 but can also contain network nodes such that 
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more general deletion problems can be tackled. The MCSs that involve the removal 
of other network parameters besides reactions are shown in the lower two tables of 
Table 3.2-1 below, which also contains MCSs from removing reactions only, as 
discussed in Section 3.2.4.1.  
Table 3.2-1: NetEx EMs and the types of MCSs for the objective reaction PSynth. 
The table shows the EMs and different types of MCSs of NetEx, for the objective reaction 
PSynth: 1a) Initial MCS concept: removing reactions only; 1b) Generalized MCS concept: 
removing metabolites only, and 1c) reactions and metabolites together. Note: a non-zero in the 
EM cell indicates the reaction occurs in the EM; a “1” in the MCS indicates the reaction 
constitutes the MCS. Adapted from [106]. 
Elementary modes EM2-EM6 (grey) involve the objective reaction PSynth. 
 R1 R2 R3 R4 R5 R6 R7 PSynth A B C D E 
EM1 0 1 0 1 1 0 0 0 0 1 0 1 0 
EM2 1 1 1 0 0 1 0 1 1 1 1 0 1 
EM3 1 0 1 −1 −1 1 0 1 1 1 1 1 1 
EM4 0 1 1 0 −1 0 1 1 0 1 1 1 1 
EM5 0 0 1 −1 −2 0 1 1 0 1 1 1 1 
EM6 0 2 1 1 0 0 1 1 0 1 1 1 1 
MCSs of NetEx for the objective reaction PSynth 
1a) Initial concept: MCSs removing reactions only 
MCS0 
       
1      
MCS1 
  
1 
     
     
MCS2 1 
     
1 
 
     
MCS3 
     
1 1 
 
     
MCS4 
 
1 
 
1 
    
     
MCS5 
 
1 
  
1 
   
     
MCS6 1 
  
1 1 
   
     
MCS7 
   
1 1 1 
  
     
1b) Generalized concept: Minimal cut sets removing metabolites only 
MCS8 
         
1 
   
MCS9 
          
1 
  
MCS10 
            
1 
MCS11 
        
1 
  
1 
 
1c) Generalized concept: Minimal cut sets removing reactions and metabolites 
MCS12 
      
1 
 
1 
    
MCS13 
   
1 1 
   
1 
    
MCS14 1 
          
1 
 
MCS15 
 
1 
         
1 
 
MCS16 
     
1 
     
1 
 
From Table 3.2-1 above, we can compare the number of MCSs obtained from removing 
reactions only (initial MCS concept) or other parameters (generalized concept). The 
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least number of MCSs occurs when removing metabolites (1b), which implies that 
metabolites are more crucial for the production of P; this is evident when we look at the 
set of EMs which shows three metabolites as essential for PSynth compared to one 
essential reaction. This is because removing a metabolite results in eliminating all the 
reactions connected to it, thus eliminating the corresponding EMs, so MCSs from 
deleting metabolites would be more effective. MCSs could also be derived from a 
combination of reactions and metabolites, although these methods could quickly 
become computationally challenging [121, 122]; computational complexity is discussed 
later in Section 3.3. 
Constrained MCSs provide further flexibility by providing the capacity to specify, not 
only functionalities to be disabled, but also those that need to be preserved; the 
combination of these desirable and undesirable functionalities are represented by 
appropriate sets of target EMs (Section 2.4.2) and desired EMs. This allows for 
systematic enumeration of all equivalent gene deletion combinations and subsequently 
assists in determining intervention problems and robust knockout strategies for coupled 
product and biomass synthesis. 
For example, consider our network example NetEx (Figure 3.2-1) which has six EMs; 
say the objective is to suppress the synthesis of P in order to maximise the production of 
X; the set of target modes would be T= {EM2, EM3, EM4, EM5, EM6} with the eight 
MCSs as shown in the first set of MCSs in Table 3.2-1 above. The resulting intervention 
problems are shown in Table 3.2-2 below: 
Table 3.2-2: Intervention problems and resulting MCSs for NetEx. 
Intervention Problems Target modes T Desired 
modes 
D1 
n1 MCSs 
I1) No synthesis of 
undesired product P 
EM2, EM3, EM4, EM5, EM6   MCS0={Psynth}, MCS1={R3}, 
MCS2={R1,R7}, MCS3={R6,R7}, 
MCS4= {R2, R4}, MCS5={R2,R5}, 
MCS6={R1,R4,R5}, 
MCS7={R4,R5,R6} 
I2)  No synthesis of 
undesired product P 
and production of X 
with maximal yield 
possible 
EM2, EM3, EM4, EM5, EM6 EM1 1 MCS0={PSynth}, MCS1={R3}, 
MCS2={R1,R7}, MCS3={R6,R7}, 
The above NetEx example is a very simple case and a more comprehensive example can 
be seen in [109] which describes cMCSs in detail. 
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 Computational Complexity 3.3
Although recent studies [122] have shown that it is easy to check that a given set of 
reactions constitutes a cut, finding a MCS for a given set of target compounds becomes 
impractical in large networks. This stems from the fact that finding all EMs that use a 
particular reaction is nondeterministic polynomial time hard (NP-hard) [123]. 
 Deterministic and Non-Deterministic Polynomial 3.3.1
Complexity 
In computational complexity theory [124, 125], deterministic polynomial (dP) and non-
deterministic polynomial time (NP) are two classes of decision problems that classify 
computational problems according to their inherent difficulty in terms of their 
solvability by a computer. The computation problem can be stated by a set of 
mathematical instructions consisting of problem instances and solutions to these 
problem instances and the big O notation is useful for analysing the run time for class 
dP and NP problems. 
The big O notation can specify the efficiency of algorithms such as the time (T) (or the 
number of steps) it takes to complete a problem of size n. For example the time might 
be found to be T(n) = 6n2-2n+5. As n grows large, the n2 term will come to dominate, 
so that all other terms can be neglected. The coefficients also become irrelevant if T(n) 
is compared to other orders of expression e.g., n3 or n4; U(n) = n3, will always exceed 
T(n) when n gets larger than 6. The number of steps, on the other hand, depends on the 
details of the machine model on which the algorithm runs, although different types of 
machines generally vary by only a constant factor in the number of steps needed to 
execute an algorithm. So the algorithm has order of n2 time complexity denoted by the 
big O as: 
T(n) ∈ O(n2) (3-3)  
Note: The following two right-hand side big O notations have dramatically different 
meanings: 
f(m) ∈ O(mn) 
g(n) ∈ O(mn) (3-4)  
The first case states that f(m) exhibits polynomial growth e.g. f = 2n2, while the second, 
assuming m > 1, states that g(n) exhibits exponential growth, e.g., g = 2n which always 
eventually overtakes polynomial growth as the size of n increases.  
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Class dP consists of those decision problems whose solution can be obtained using a 
deterministic algorithm that runs in polynomial time, i.e., runs in O(nk) steps for some 
non-negative integer k, where n is the input size. A deterministic algorithm only has one 
choice in each step taken to execute the problem, i.e., it would have the same output for 
every run on the same input instance for the problem. 
Class NP consists of those decision problems for which there exists a nondeterministic 
algorithm that runs in polynomial time with two phases: a) the guessing phase where a 
nondeterministic algorithm is used to generate an arbitrary string of characters that may 
or may not correspond to a solution of the input, and b) the verification phase which 
uses a deterministic algorithm to check and verify that the generated string is a valid 
solution or reject it otherwise. Both phases need to be completed in polynomial time 
(O(nj)) where j is a non-negative integer.  
The computational complexity increases as the size increases. Some mathematicians 
believe that the complexity of the hardest NP problems (NP-complete) is such that no 
polynomial-time algorithms or supercomputers could solve them (dP is not equal to 
NP). Others believe it is possible to build a computer capable of trying every possible 
solution to a problem simultaneously (dP equals NP) which, if true, means that it would 
be possible to solve any problem regardless of its complexity and all encryption 
methods would be rendered worthless. The complexity of EMs (Section 2.4.2) and 
MCSs in metabolic networks is covered in [121, 122] and they are found to be NP-hard. 
In other words, they are at least as hard as any non-polynomial problem and may be 
harder. In addition to finding EMs NP-hard, it has also been shown [122] that finding 
cuts of minimum size without computing all EMs is also NP-hard. This doesn’t help 
from the point of view of genetic intervention where it is desirable to find a MCS of 
minimum size, thus a need for computational methods to address the problem.  
 MCS Computational Methods 3.3.2
Four MCS computational methods have been developed since the first two (original and 
general MCS concepts [11,12]); mainly to improve the computational complexity of 
obtaining MCSs but they also open MCSs and EMs to a wider area of application: 
i) The first method was presented by Imielinski and Belta [126] and considers 
obtaining cut sets from the computation of sub-EMs which are EMs of a 
submatrix of the stoichiometry matrix (Section 2.3.2) [86]; the submatrix in turn 
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is formed by taking a subset of the rows of the stoichiometry matrix. In other 
words, the sub-EMs are flux configurations that place only a subset of species in 
the system at steady state. Because the sub-EMs naturally emerge from the 
intermediate steps of the tableau algorithm for EM computing [101], it means 
that the sub-EMs can be obtained from a network of any size, hence overcoming 
the problem where the metabolic network is too large and complex that it 
becomes NP-hard to find MCSs. A possible drawback is that there is no 
guarantee that all the cut sets will be found and their minimality is also not 
guaranteed so the cut sets would need to be checked for minimality and further 
reduced to MCSs where necessary. Development of this computational 
framework is described in detail in [126] as well as its application to a genome 
scale metabolic model of E.coli. 
ii) The second method is by Haus et al. [108] and involves modifying existing 
algorithms to develop more efficient methods for computing MCSs. Their first 
algorithm is a modification of Berge’s algorithm [127] and computes MCSs 
from EMs, thereby improving on the time and memory required for 
enumeration; the second algorithm is based on Fredman and Khachiyan [128] 
and directly computes MCSs from the stoichiometric matrix, with the 
hypergraph of EMs containing the blocked reactions being generated on the side. 
iii) The third method, contributed by Ballerstein et al. [120], also determines MCSs 
directly without knowing EMs. Their computational method is based on a 
duality framework for metabolic networks where the enumeration of MCSs in 
the original network is reduced to identifying the EMs in a dual network so both 
EMs and MCSs can be computed with the same algorithm. They also proposed a 
generalization of MCSs by allowing the combination of inhomogeneous 
constraints on reaction rates. 
iv) The fourth method includes an approximation algorithm for computing the 
minimum reaction cut and an improvement for enumerating MCSs, recently 
proposed by Acuña et al. [122]. These emerged from their systematic analysis of 
the complexity of the MCS concept and EMs, in which it was proved that 
finding a MCS, finding an EM containing a specified set of reactions, and 
counting EMs are all NP-hard problems.  
The algorithm and enumeration improvement aim to avoid having to compute 
EMs in order to obtain reaction cuts; instead of a MCS that disables too many 
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EMs, it would be desirable to find a MCS that cuts the target reaction but leaves 
certain reactions intact or as many EMs as possible intact. These types of MCSs 
are NP-hard. The developments in [122] provide the capacity to analyse the 
complexity of the underlying computational tasks that would assist in 
determining which tasks can be tackled. 
 Applications of MCSs 3.4
MCSs were developed as an extension of the metabolic pathway analysis methods and 
thus provide a different, if not improved, approach for studying similar network 
properties. The application of MCSs, as Klamt describes [106] it, can be grouped into 
two types, depending on how the cuts are provoked in the network:  
i) If the cut occurred naturally, e.g., a reaction malfunctioning due to spontaneous 
mutation, the MCS would serve as an internal failure mode with respect to a 
certain functionality and could be applied to study structural fragility and 
robustness on a local and global scale.  
ii) If, on the other hand, the cut is a deliberate intervention e.g., gene deletion, 
enzyme inhibition or RNA interference, then the MCS would be seen as a target 
set that could, for example, be suitable for blocking metabolic functionalities, 
and thus have significant potential in metabolic engineering and drug discovery. 
These applications can be extended to enable the MCSs to be used for 
assessing/verifying, manipulating and designing biochemical networks.  
Because a complex network provides many alternate pathways, there are generally 
several different MCSs for a single collection of objective reaction(s). All of these 
MCSs would be effective but their efficiencies would differ. In this respect, MCSs can 
be used in conjunction with other metabolic pathway methods to gain more information 
on the structural capability of the network in relation to the objective function. Since the 
mathematics guarantees that the collection of MCSs in an appropriately sized self-
contained network (refer to NP-hard discussion under Section 4.2) is complete, we can 
use quantitative analysis to compare and investigate the effect that each MCS has on the 
remaining non-target set of EMs. Along with other different MPA (Section 2.4) 
methods, these effects can be utilized in exploring things such as which MCSs would 
achieve loss-of-function most efficiently and whether this was related to the position of 
the genes in the pathway. Other investigations could include correlating different MCSs 
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to different structures and/or situations. We could also analyse the properties of the 
genes concerned and the impact that their suppression would have on other processes in 
the network. Studies of these kinds are reported in detail in Sections 6 and 7. 
The next part looks at areas in which MCSs have been applied. 
 Fragility Analysis 3.4.1
One area in which MCSs have been applied is fragility. Fragility is the vulnerability of a 
system to failure due to external or internal perturbations. It is inversely related to 
robustness [129], the capacity for a system to maintain its functions despite 
perturbations [130]. Prior to the use of MCSs for measuring structural fragility, EMs 
have been used to study the robustness of networks [98, 131]; they have also been used 
in more recent studies on pathway knockout and redundancy in metabolic networks 
[132].  
The application of MCSs to measure fragility can be found in [68, 106, 107]. The 
fragility coefficient, Fi, defined as the reciprocal of the average size of all MCSs in 
which reaction i participates [107], is used as a quantitative measure for determining 
how essential the reactions are: the lowest value of Fi would be closest to 0 where 
reaction i is one of many reactions occurring in a MCS, and the highest is 1 where 
reaction i is the only reaction in a MCS and therefore essential for the objective 
function. The average fragility over all the reactions is taken as the overall structural 
fragility of the network. 
For example, in the network example NetEx, reaction R1 has two MCSs: the first MCS 
is MCS2 which has 2 reactions and the second is MCS6 which consists of 3 reactions; 
the fragility coefficient (F1) for R1 would therefore be 2/(2+3) which would be 2/5 or 
0.4. The specific fragility coefficients of reactions in NetEx with respect to the 
production of P are as follows: 
Table 3.4-1: Fragility coefficients of the NetEx reactions with respect to P formation. 
 
R1 R2 R3 R4 R5 R6 R7 Psynth 
Fi 0.4 0.5 1 0.375 0.375 0.4 0.5 1 
The above Table 3.4-1 shows that reaction R3 is essential for the production of P as is 
obviously the case for Psynth. This indicates that the loss of function of R3 would 
automatically render the other reactions meaningless for the production of P. 
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S. Klamt and E.D. Gilles [107] applied MCSs in their study of the central metabolic 
network of E.coli, earlier investigated by Stelling et al to study robustness using EMs. 
They found the number of MCSs to vary for different compound substrates that E.coli 
was growing on. For example, there were more MCSs, including the largest MCS for 
growth, on glucose than on acetate for which the lower number of MCSs were 
predominantly smaller. This indicated that E.coli growth on glucose was less fragile 
than on acetate.  
In the generalized MCS concept [106], Klamt further discussed their work on using 
MCSs to measure structural fragility of a network function. The results of the previous 
work [107] and other work [133, 134] showed that environmental conditions, such as 
the type of substrates or availability of oxygen, greatly affected network properties like 
the essentiality of a gene/reaction, so it is important for a network structural fragility 
analysis to clearly define environmental conditions in addition to the deletion task 
describing the network functionality being considered. 
 Network Verification 3.4.2
MCSs can be used to verify a network because the minimal sets of target 
reactions/genes they provide are mathematically complete in relation to the structure of 
the network. Thus, the simultaneous removal of genes making up each MCS should lead 
to the elimination of the objective function. If the prediction is incorrect in an 
experiment and the phenotype is still viable, it means that the network structure is 
incorrect or incomplete.  
So, the set of MCSs could be systematically used to verify a given network structure by 
experimentally checking the phenotype predictions of MCSs in an organism: correct 
predictions would provide verification of the network whilst false predictions could be 
pursued to identify missing reactions/genes or compounds in the network structure. For 
example, say there is a reaction E = A + B in the network example NetEx (Figure 3.2-1) 
that has not been identified, applying MCS3 could reveal that there is a missing reaction 
in the network because compound E would still be formed and P synthesized. 
Past work on network verification has been done using FBA [135, 136] and EM analysis 
[131]. These were used to verify phenotype predictions for single mutants of E.coli, the 
predictions of which were found to highly agree with real mutants. In such cases the 
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single mutation is lethal if the reaction involved is essential (a single reaction 
constituting a MCS) for the objective function, and depends on the chosen substrate.  
 Observability of Reaction Rates in Metabolic Flux 3.4.3
Analyses 
Another use of the MCS concept is in finding the necessary information that can be 
used to make stationary network fluxes observable. As shown in [137], EM analysis 
(considering all reactions in the network as reversible) supports the identification of the 
set of known/measured flux measurements that would enable unknown non-measured 
reaction rates (ru) to be calculated or observed in a steady state flux distribution. The 
process includes first calculating all EMs and selecting those where the unknown 
reaction rate exists (ru≠0); the set of rates to be measured are then constructed such that 
they contain at least one of the reactions participating in each of the selected EMs. 
These sets of rates to be measured are in fact the MCSs with respect to the reaction rate 
(ru is the objective reaction) so, the sets of possible measurements will be minimal and 
non-redundant. As such, the MCSs can be screened to determine the most appropriate 
sets of measurement for FBA [84, 138].  
Take NetEx (Figure 3.2-1) as an example: considering all reactions as reversible and ru 
as PSynth, nine EMs are calculated, six of which lead to the synthesis of P. Taking 
PSynth as the objective reaction, there would be 10 MCSs for screening, as shown in 
Table 3.4-2 below: 
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Table 3.4-2: EMs and MCSs of NetEx where all reactions are reversible 
 
R1 R2 R3 R4 R5 R6 R7 PSynth 
EM1 1 0 1 -1 -1 1 0 1 
EM2 0 1 0 1 1 0 0 0 
EM3 1 0 0 0 1 1 -1 0 
EM4 0 2 1 1 0 0 1 1 
EM5 0 1 1 0 -1 0 1 1 
EM6 1 1 1 0 0 1 0 1 
EM7 0 0 1 -1 -2 0 1 1 
EM8 1 -1 0 -1 0 1 -1 0 
EM9 2 0 1 -1 0 2 -1 1 
         
 
R1 R2 R3 R4 R5 R6 R7 PSynth 
MCS1 
  
1 
     MCS2 
       
1 
MCS3 
 
1 
 
1 
    MCS4 1 
     
1 
 MCS5 
     
1 1 
 MCS6 
 
1 
  
1 
 
1 
 MCS7 1 
  
1 1 
   MCS8 1 1 
  
1 
   MCS9 
   
1 1 1 
  MCS10 
 
1 
  
1 1 
  
The above Table 3.4-2 shows EMs and MCSs of NetEx (all reactions are 
reversible): A zero in an EM row indicates that the corresponding reaction is not 
involved in the EM corresponding to that row; a ‘1’ in a MCS row indicates that the 
reaction in that column constitutes the MCS corresponding to that row, e.g., R3 
constitutes MCS1. 
 Pathway Energy Balance Constraints 3.4.4
To assist FBA, EMs have been used to place thermodynamics constraints at the pathway 
level [139] where a directionality criterion for net mass flux in the form of negative 
Gibbs free energy change (∆G) is applied to a pathway, as opposed to a reaction: the 
EMs matrix E is a PxN pathway composition, where P is the number of pathways. To 
formulate pathway level constraints G, the reaction-specific parameters are first 
collected into an Nx1 vector (∆g) and then an element-by-element multiplication is 
performed with each of the P (N-dimensional) rows of E to form G. The EMs ensure 
that the sequence of reactions in the entire pathway is in one direction and assist FBA in 
identifying the objective function(s) driving the metabolic behaviour of tissue cells, 
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especially multi-functional ones [139]. The relationship between MPA (Section 2.4) and 
FBA is discussed in detail in [140]. 
 Target Identification and Metabolic Interventions 3.4.5
Along with their role in obtaining a deeper understanding of the structural fragility of 
cellular networks, MCSs can also be seen as minimal target sets for efficiently 
repressing cellular functions. The generalized concept [106] allows MCSs to tackle a 
larger variety of practical deletion problems, which include the repression of undesired 
metabolic functions, redirecting fluxes into a desired product, and inhibiting sub-
optimal flux distributions. These in effect identify targets for metabolic interventions.  
For example, as illustrated in the intervention in Table 3.2-2 of NetEx, the set of MCSs 
can be identified (cMCSs) that would repress the synthesis of P and redirect fluxes to 
maximize the production of X. MCSs provide the capacity to identify an optimal 
intervention strategy by providing, from a structural perspective, the most efficient set 
of manipulations to achieve a certain deletion task. In addition to being efficient, an 
ideal MCS would be one that is small and therefore does not affect or weakly affects 
other network functions; also an MCS that does not involve network functions that are 
hard to eliminate e.g., a reaction with many isozymes. 
The growing importance of MCSs in metabolic engineering is evident in [106, 107, 
109], for example, [109] presents a model that uses MCSs to search for gene deletion 
strategies that would increase the production of microorganisms. In their approach, 
Hädicke and Klamt [109] address the limitation that MCSs have of disabling desired 
functionalities along with the targeted functionalities, by generalizing MCSs to cMCSs 
that allow for a set of desired modes, with a minimum number preserved, to be defined. 
This generalization can be applied to existing methods which can be reformulated as 
special cMCS problems, providing the capacity for systematic enumeration of all 
equivalent gene deletion combinations and determining robust knockout strategies for 
coupled product and biomass synthesis, altogether offering great flexibility in defining 
and solving knock out problems. Other examples of MCSs in metabolic engineering can 
be seen in [108, 120], discussed earlier in Section 3.2. 
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 Similar concepts 3.5
 Bottlenecks 3.5.1
Bottlenecks characterize a point of congestion in a system that happens when workloads 
arrive at a given point more quickly than can be handled at that point. In a metabolic 
network consisting of enzymes (nodes) and substrate-product metabolite fluxes 
(directional edges), three topological centralities that are used to measure the 
importance of nodes in controlling information transfer are: in degree which refers to 
the number of links forwarded to the node under consideration, out degree which refers 
to the number of links going out of the node, and betweenness which measures the 
number of “shortest paths” [141] going through the node. Bottlenecks are those nodes 
that have many “shortest paths” going through them, much like major bridges and 
tunnels on a highway map.  
For example, the bottleneck nodes a and b in Figure 3.5-1 below, control most of the 
information flow because they form an essential highway to get information from the 
blue to the yellow nodes so, if either of nodes a or b is knocked out, the network would 
collapse. In effect, bottlenecks indicate essentiality of the nodes. 
 
Figure 3.5-1: Example of a bottleneck in metabolic networks 
The essentiality of the bottleneck nodes is illustrated in the above graph which shows 
that they are “AND” nodes, traversed in series and you cannot get from the input nodes 
to the output except through node a “AND” node b. The in degree of node a is 4 and the 
out degree is 1; these centralities only consider the partners connected directly to a 
particular node, whereas the betweenness considers a node’s position in the network 
and, as shown for a, is much higher e.g. 28. Thus, bottlenecks in metabolic networks 
could be defined as nodes with a high betweenness centrality.  
One importance of bottlenecks is in relation to whole genome duplication (WGD) [142, 
143], where studies have shown that genes encoding hubs and bottleneck enzymes tend 
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to express highly and evolve conservatively and thus were preferentially retained as 
homeologs [144]. Other studies include identification of novel targets for metabolic 
engineering of microorganisms used for sustainable production of fuels and chemicals 
[145] where the set of hub and bottleneck genes/enzymes were found to be a better 
strategy than manipulation of a single gene/enzyme. 
In relation to MCSs, although MCSs can similarly determine the essentiality of 
enzymes, they do so in terms of repressing an objective function, represented by an 
objective reaction(s). For example, to use MCSs to calculate the essentiality of 
reactions/enzymes for a whole network, the objective function to repress would be the 
formation of all end products in the network, which would likely lead to combinatorial 
problems [146] in larger networks. For the example network, NetEx, (refer to Figure 
3.2-1), the objective reactions to repress in order to block all products are R5 and 
PSynth. In relation to the 6 EMs shown in Table 3.2-1, there are 16 MCSs for repressing 
the reactions R5 and PSynth. These MCSs are shown in Table 3.5-1 below with the 
corresponding fragility coefficients for each reaction: 
Table 3.5-1: MCSs for NetEx, where all the EMs form the objective function.  
MCSs R1 R2 R3 R4 R5 R6 R7 PSynth Total 
MCS1 0 0 1 1 0 0 0 0 2 
MCS2 0 0 1 0 1 0 0 0 2 
MCS3 0 1 1 0 0 0 0 0 2 
MCS4 0 1 0 1 0 0 0 0 2 
MCS5 0 1 0 0 1 0 0 0 2 
MCS6 0 0 0 1 0 0 0 1 2 
MCS7 0 0 0 0 1 0 0 1 2 
MCS8 0 1 0 0 0 0 0 1 2 
MCS9 1 0 0 0 1 0 1 0 3 
MCS10 1 0 0 1 1 0 0 0 3 
MCS11 1 0 0 1 0 0 1 0 3 
MCS12 1 1 0 0 0 0 1 0 3 
MCS13 0 0 0 0 1 1 1 0 3 
MCS14 0 0 0 1 1 1 0 0 3 
MCS15 0 0 0 1 0 1 1 0 3 
MCS16 0 1 0 0 0 1 1 0 3 
Total 4 6 3 7 7 4 6 3 
 
Fj 0.33 0.43 0.5 0.39 0.39 0.33 0.33 0.50 
 
 
The above Table 3.5-1 shows MCSs for NetEx, where all the EMs form the 
objective function. A “1” in the row of a MCS indicates inclusion of that 
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reaction in the MCS, e.g., MCS1 consists of reactions R3 and R4, which means 
that simultaneous blocking of R3 and R4 would collapse NetEx.  Fj shows the 
fragility coefficients of the reactions. 
 
Table 3.5-1 shows no reaction with a fragility coefficient [107] of 1, indicating that 
there are no essential reactions/enzymes (bottleneck) that, when blocked, would cause a 
collapse of the network NetEx. Bottlenecks would require a fragility coefficient of 1 
because they represent an essential reaction that forms a bridge or tunnel to get from the 
input side of the network to the output. MCSs don’t necessarily have to, as shown by the 
fragility coefficients in Table 3.5-1 above, which can be used to extract information on 
the relative importance of reactions/enzymes.  
For example, ignoring the outermost reactions connected to the products (R5 and 
PSynth) in NetEx, R3 is the reaction with the highest fragility coefficient of 0.5. When 
we look at the corresponding EMs, R3 is also involved in the highest number of 5 EMs. 
Characterising that as a bottleneck does not seem unreasonable when looking at the 
NetEx diagram. In fact, adding the number of 1’s in the EM table is somewhat like the 
“betweenness” index that bottlenecks are based on.  
However, there is a significant difference: EMs are not just shortest paths in the 
network; they are paths that are “short” in the sense of being irreducible, but their more 
important feature is that they cover all the mutually independent paths from substrates 
to products compatible with steady state. So, they reflect a lot more about the 
functioning of the network, not just the topology. Such betweenness in bottlenecks or 
derived from EMs, is basically what the fragility coefficient [107] expresses from 
MCSs. In effect, the fragility coefficient serves the same purpose as betweenness from 
the perspective of how fragile the structure of the network is at each reaction/enzyme 
but in a more comprehensive manner because it takes into account all MCSs that each 
reaction is involved in; in this respect the betweenness derived from MCSs is much 
more informative for metabolism than the simple bottleneck concept. 
 Bow-Ties 3.5.2
The analysis of the connectivity structure of genome-based metabolic networks of 65 
fully sequenced organisms [147] revealed that the global metabolic network was 
organized in the form of a bow-tie [147, 148]. Metabolism has also been described as 
several nested bow-ties and large-scale organizational frameworks such as the bow-tie 
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were necessary starting points for higher-resolution modelling of complex biological 
processes [149]. Studies and detailed information on the bow-tie topological features of 
metabolic networks and their functional significance can be seen in [147-151]. 
The concept of bow-ties regards the metabolic network as a directed network. As 
illustrated in Figure 3.5-2 below, bow-ties [147-151], show similarity in structure to 
bottlenecks, except there is a difference in how the nodes are connected: the nodes that 
make up a bow-tie are “OR” nodes, i.e. they are traversed in parallel, while the nodes of 
a bottleneck are “AND” nodes, traversed in series.  
 
Figure 3.5-2: A simplified example of a bow tie. 
 
As illustrated above, the bow-tie structure of a directed graph has 4 components [147-
151]:  
(1) The input domain (substrate subset (SS)), which contains substrates that can be 
converted reversibly to intermediates or directly to metabolites in the giant 
strong component (GSC), but those directly connected to the GSC cannot be 
produced from the GSC. 
(2) The knot or GSC, which is the metabolite converting hub [150], where protocols 
manage, organize and process inputs, and from where, in turn, the outputs get 
propagated. The GSC follows the graph theory definition [152] and contains 
metabolites that have routes (can be several) connecting them to each other; it is 
the most important subnet in the bow-tie structure. 
(3) The output domain (product subset (PS)), which contains products from 
metabolites in the GSC and can also have intermediate metabolites but the 
products cannot be converted back into the GSC [147]. In other words, the 
reactions directly linking substrates to the GSC and the GSC to the products are 
irreversible. 
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(4) The resulting metabolites that are not in the GSC, SS or PS form an isolated 
subset (IS), the simplest structured of the four bow-tie components [147], which 
can include metabolites from the input domain SS or the output domain PS but 
those metabolites cannot reach the GSC or be reached from it.  
The bow-tie decomposition of a network can assist with the problem of combinatorial 
explosion [146] encountered when calculating EMs and MCSs in large sized metabolic 
networks. For example, suppose that EMs are calculated separately for each of the three 
subnets (SS, GSC and PS), a typical EM for the full network can then be reconstituted 
by joining a substrate mode and product mode to one of their connecting GSC modes. 
The large number of ways in which this can be done is a manifestation of the 
combinatorial explosion [146], and demonstrates that the bow-tie splitting will 
substantially reduce the computational effort of calculating EMs and the resulting 
MCSs.  
More explicitly, the reactions constituting MCSs of a whole network can be classified in 
terms of the blocked reactions’ locations in the bow-tie decomposition: 
(1). All substrate reactions (SS subnet) plus GSC reactions blocking any cyclic EMs that 
could take place without inputs from the substrate reactions. In this case, no product 
reactions (PS subnet) need blocking; 
(2). All product reactions (PS subnet) plus GSC reactions blocking the cyclic EMs- in 
this case no substrate (SS subnet) need to be blocked; 
(3). All GSC reactions that connect the SS to the PS subnet. No substrate or product 
reactions need to be blocked; 
(4). A combination of SS reactions plus GSC reactions reached from the unblocked SS 
reactions. PS reactions don’t need to be blocked; 
(5). A combination of PS reactions plus GSC reactions that could reach the unblocked 
PS reactions. SS reactions don’t need blocking. 
These classifications can be used to investigate the question of whether a bow-tie 
decomposition can be derived from a known MCSs table. For example, a plausible 
strategy to identify GSC reactions is as follows: 
• From all MCSs, eliminate any that involve reactions that are known to belong 
to SS or PS; 
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• Order the remainder by increasing size and/or decreasing mean fragility 
coefficient; 
• Choose a cutoff value in this sequence, and allocate all reactions that belong to 
MCSs in the top section of the sequence to the GSC.  
If the bow-tie structure is pronounced, there should be a clear separation between the 
small, high fragility coefficient MCSs that belong to the GSC and the rest; otherwise the 
choice of a cutoff may be problematic. An MCS analysis may be helpful to examine if a 
bow-tie structure exists and partially detect members of its main components, but not to 
make a full partitioning. 
Noting that bow-ties can assist with combinatorial explosion [146] by decomposing 
large networks into subnets that can be analysed by MCSs and EMs, we conclude that 
despite some overlap in the concepts and applications of bow-ties and MCSs, there is no 
clear cut correspondence between the two network descriptions. While bow-ties try to 
extract subsets of nodes that are of importance in the metabolic network, the EM and 
MCS approaches focus on comprehensive sets that are in different ways essential. 
Moreover, EMs are, by construction, the “constituents” of a steady metabolic state. So 
they, and MCSs, reflect the stoichiometry underlying the network and describe the 
metabolism, not just the topology of the network. In this respect, MCS (and EM) 
analysis is more powerful than bow-ties that just characterize network topology. 
 Weak Nutrient Sets 3.5.3
‘Weak nutrient sets’ is a concept analogous to MCSs, that was developed by Imielinski 
et al. [153] to demonstrate the duality between weak producibility and the existence of 
certain extreme semi-positive conservation relations (ESCRs) in a media. ESCRs were 
defined as the simplest semi-positive linear combinations of species concentrations that 
were invariant to all metabolic flux configurations. A biochemical species was called 
producible in a constraints-based (Section 1.5) metabolic model if a feasible steady-state 
flux configuration existed that sustained its nonzero concentration during growth.  
Weak nutrient sets are analogous to MCSs in a metabolic network in that a MCS C for 
an objective reaction j is a set of reactions whose elimination renders flux through j 
infeasible at steady state so, a necessary and sufficient condition for C to be a cut set for 
j is that C is a hitting set for all j-containing EMs. Similarly, U is a weak nutrient set for 
species or metabolite i if and only if U is a hitting set for all of the i-containing ESCRs. 
59 
 
The ‘weak nutrient sets’ algorithm identified all minimal nutrient media that left an 
arbitrary metabolite weakly producible with respect to a given metabolic network. 
Details of the concept and its application can be seen in [153].  
 Flux Balance Analysis 3.5.4
Flux balance analysis (FBA) [84, 85, 154] shares a common underlying mathematical 
framework with MCSs and EMs except that, while EMs identify all possible and 
feasible non-decomposable metabolic routes for a given network at steady state, FBA 
derives a feasible set of steady-state fluxes optimizing a stated cellular objective e.g, 
optimizing the biomass production per substrate uptake. EM analysis establishes a link 
between structural analysis and metabolic flux analysis (MFA) where 
thermodynamically and stoichiometrically feasible stationary flux distributions for a 
network can be obtained from the linear combinations of the EMs.  
Calculating EMs and MCSs for larger networks can lead to problems with 
combinatorial explosion [146]. However, because they are unique for a given network 
structure, they provide the full range of potential functionalities of the metabolic system 
and are therefore useful for investigating all physiological states that are meaningful for 
the cell in the long term. FBA, on the other hand, is more efficient, providing good 
predictions of mutant phenotypes and using linear programming to obtain a single (not 
necessarily unique) solution to an optimization problem. However, because it focuses on 
a specific behaviour, FBA cannot cope with cellular regulation without additional 
constraints; it fails whenever network flexibility has to be taken into account, e.g., in the 
analysis of pathway redundancy or in quantitative prediction of gene expression [131]. 
We conclude that MCSs and EMs offer a convenient way of interpreting metabolic 
functions while FBA can be used to explore the relationship between the metabolic 
genotype and phenotype of organisms. MCSs, EMs and FBA can also be used together 
to interpret shifts in metabolic routing that could occur in response to environmental and 
internal/genetic challenges. Because they are mathematically equivalent, the predictions 
from the three methods would be the same except that MCSs enable the systematic 
search of more than one mutation. 
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 Conclusions 3.6
MCSs are an extension of MPA (Section 2.4) methods and provide a way of identifying 
target genes for eliminating a certain objective function from a holistic perspective that 
takes into account the structure of the whole metabolic network and all the reactions 
taking place in the cell. The objective function can be represented by a set of EMs 
which is then used to calculate the MCSs used for studying structural fragility and 
identifying knock out strategies from a whole cell perspective. Such exhaustive 
characterization is very hard to achieve experimentally because, regardless of how many 
examples of a phenomenon one has observed, there might always be others not yet 
observed. This aspect of completeness by MCSs and EMs, subject only to a complete 
knowledge of the network itself, makes it possible to make quantitative assessments in 
terms of discrete properties e.g. being able to count the number of EMs, MCS etc., and 
using them to determine the relative importance of reactions and their corresponding 
enzymes/genes. This kind of quantitativeness is on a different level with that of kinetic 
network modelling where actual concentrations, fluxes etc. are calculated as continuous 
functions. 
In order to obtain the complete set of EMs and MCSs, however, the fact that they are 
NP-hard (Section 3.3) will first need to be addressed as they can be impossible to 
determine if the network size gets too large (refer to Section 4.2 for more detail).  This 
research overcomes this problem by constructing a smaller self-contained subnetwork as 
discussed in Section 4.3. 
The concept of MCSs is fairly new and still being explored; looking in detail at how it 
has developed in relation to similar concepts, it is easy to see its importance in systems 
biology (Section 1.2) and how it can contribute to fields such as metabolic engineering.  
Without needing prior knowledge of genes, MCSs can provide a complete list of loss of 
function(s) target genes that can then be investigated by other methods to analyse the 
properties of those genes and the impact that their suppression would have on other 
processes in the network. Thus, MCSs can assist in finding ways of producing 
industrially relevant compounds from renewable resources, not only for economical but 
also for sustainability reasons; the MCS concept also opens an avenue for developing 
new novel systems biology (Section 1.2) methods for use in genetic engineering. 
For this research, MCSs are used, in conjunction with FBA and other MPA (Section 2.4) 
methods, to get a better understanding of the capability of anthocyanin [32-34] genes 
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and their relationship with other genes from a whole cell perspective. This knowledge 
was used to carry out studies that included identifying where in the ABP genetic 
variation could occur to cause loss of colour pigmentation in plants, etc. These are 
covered in the subsequent chapters.  
Before the research can be carried out though, the appropriate metabolic network has to 
be reconstructed from the Arabidopsis thaliana (Section 1.7) database. Reconstruction 
of a metabolic network involves taking into account certain considerations and 
processes, as described in the next chapter. 
62 
 
: Reconstruction of the research Chapter 4
network 
The research network is constructed through a number of steps that start with the 
reconstruction of the full network of the Arabidopsis plant and culminates in the 
extraction of the flavonoid subnetwork. This chapter describes the reconstruction of the 
full Arabidopsis network and the steps taken to extract the flavonoid subnetwork used 
for the research. 
Contribution 
The extraction of a self-contained subnetwork from the AraCyc database. 
The genome-scale metabolic network used for this research is that of the multicellular 
plant organism, Arabidopsis (Section 1.8), which means a large complex network 
(Section 4.1). To avoid combinatorial explosion [146] when analysing the large network 
and the problem posed by the fact that EMs and MCSs are NP-hard (Section 3.3), an 
appropriate self-contained subnetwork that is representative of the full network of 
Arabidopsis is extracted. The approach involves the reconstruction of the Arabidopsis 
network and culminates in the extraction of a self-contained flavonoid network that 
represents flavonoid metabolism from a whole cell perspective. 
This reconstruction and extraction process involves continous work because of the 
ongoing curation (Section 1.8.1) of the AraCyc database, which means that a new 
version is provided every now and then. At the start of the research, the AraCyc version 
was 4.0 and contained 1701 reactions and 1902 compounds, and at the time of writing, 
the AraCyc database used was Version 8.0 and contained 2689 reactions and 2825 
compounds. For every release of a new AraCyc version during the course of the 
research, a corresponding reconstruction and extraction of the flavonoid subnetwork is 
undertaken, followed by the re-calculation and re-analysis of the research studies. 
 Ideas from this were presented at the MODSIM conference [67]; and  
 material from this chapter, combined with material from subsequent chapters,  
has been published in the BMC Bioinformatics journal [68].   
63 
 
 The Arabidopsis network 4.1
The full Arabidopsis network is contained in the AraCyc database (refer to Section 
1.8.1) which holds a collection of pathways with all known metabolic reactions and 
enzymes for Arabidopsis. These are empirical pathways in the sense that they are 
compiled from independent experimental results based on a reductionist4 approach, so 
the database is not really a network but contains reactions and collections of pathways 
that are not linked to each other. Thus, all these reactions have to firstly be collected and 
organized into a network where all the reactions are appropriately linked to each other 
as well as being in a computer-readable format. A description of how this is done is 
covered in Section 4.3. 
To illustrate the information contained in the AraCyc database, Figure 4.1-1 shows part 
of the metabolic map of Arabidopsis. Highlighted, as an example, is the empirical5 
biosynthetic pathway for ferulate and sinapate compounds containing all the enzymes 
and reactions related to their synthesis. Such pathway enzymes and reactions, together 
with individual reactions, are contained in the AraCyc database.  
 
Figure 4.1-1: Part of the metabolic map of Arabidopsis 
                                               
4
 approach that deconstructs biological systems into individual components and their associated 
interactions 
5
 Empirical pathways are determined from perceived ideas of how metabolic compounds are formed. 
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 Ideal approach 4.2
The ideal approach, as with MPA (Section 2.4) studies on microbes [12, 135], would be 
to use the full Arabidopsis network to determine EMs (section 2.4.2). The full network 
is compiled by taking the reactions and enzymes from the empirical pathways and 
reconstructing the full metabolic network as a system from which metabolic pathways 
or EMs can be calculated. The resulting EM-derived pathways would then be based on 
the structure of the network itself and not from pre-conceived ideas of how compounds 
are formed.  
However, it is not easy to use certain analytical methods to analyse the full metabolic 
network of the multicellular Arabidopsis plant on an ordinary computer because the 
network is too large and complex. For example, AraCyc Version 8.0 involves 2,825 
compounds occurring in 2,689 reactions. This large number of compounds and reactions 
leads to combinatorial explosion when used to determine EMs [155-157] and MCSs 
(Chapter 3). The fact that EMs and MCSs are NP-hard (Section 3.3) means that their 
complexity grows quickly with size which poses a problem with a large network as it 
becomes impossible to determine them. However, this does not exclude their solvability 
in a small network. Having a small flavonoid subnetwork that is self-contained 
overcomes the complexity problem but still provides a network that represents 
flavonoid metabolism from a whole cell perspective, thus can be used to calculate the 
corresponding complete set of EMs and MCSs. 
 Research approach 4.3
The research approach is to first isolate a relevant self-contained flavonoid subnetwork 
where all exchange fluxes are accounted for and to which MPA (Section 2.4) methods 
can be applied. This makes sense, considering that the focus of the research is on 
flavonoids, secondary compounds which constitute a limited subset of secondary 
metabolism, so there is no need to use the full metabolic network. As long as the 
subnetwork contains the complete set of all flavonoid-related compounds and is self-
contained, it should be representative of flavonoid metabolism in the context of whole 
cell metabolism.  
For the subnetwork to be complete and self-contained, it needs to contain all relevant 
reactions from the full network, including the correct external compounds. The external 
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nodes are not subject to conservation so must represent plausibly buffered compounds 
in the cell.  
 Collecting all reactions for Arabidopsis 4.3.1
In order to isolate a subnetwork, all the reactions for the reconstructed Arabidopsis 
metabolic network need to be collected and organized into a Systems Biology Markup 
Language (SBML) [158] computer-readable format. 
The reactions are collected using a set of custom designed AWK [159] scripts that 
parses AraCyc data into an SBML [158] network specification, integrating reaction 
direction information dispersed in reaction, enzyme and pathway tables of the database 
[77]. The resulting SBML file contains the list of all metabolites known to exist in 
Arabidopsis, thus representing its full network. These are then used to reconstruct a 
smaller self-contained6 subnetwork that only contains those compounds and reactions 
relevant for the research but still representative of whole cell metabolism. 
 Reconstructing the flavonoid subnetwork 4.3.2
The reconstruction of the flavonoid subnetwork could be visualized as extracting or 
actually cutting the subnetwork out of the full Arabidopsis network. This involves 
collecting the set of reactions and enzymes related to flavonoid metabolism from the 
full network. The list of pathways identified in the database as connected with flavonoid 
metabolism gives an initial list of the core reactions. This list is expanded as appropriate 
by:  
• identifying the compounds related to the reactions of these pathways; 
• determining whether these compounds are accounted for and can be taken as 
external metabolites; and 
• adding further pathways and reactions for those compounds that cannot be taken 
as external metabolites. 
A detailed description of this process is provided in the subsequent sections. 
Microsoft Office Excel and other tools are employed in carrying out the process which 
is repeated until all external metabolites are accounted for and a self-contained 
flavonoid network is acquired. 
                                               
6
 could be taken on its own as representative of the metabolism of the whole cell 
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Figure 4.3-1: A picture representation of the subnetwork extraction process 
 Collecting flavonoid related reactions 4.3.2.1
As part of the parsing process, a preliminary classification of ‘external’ is applied to all 
compounds that consistently appear as either initial substrates or final products in all 
reactions. The classification of external compounds is discussed in Section 2.2.1 and 
provides the basis of the following heuristic approach [77], carried out to extract the 
flavonoid subnetwork from the full Arabidopsis network:  
i) First, a list of external compounds that are plausibly buffered for the purposes of 
flavonoid metabolism is drawn up. Guidelines for this are taken from the 
catabolism-anabolism interface as described, for example, by Palsson (2006) 
[160] Figure 3.2 where the 11 biosynthetic precursors important for the 
degradation of substrates in catabolism and the origin of anabolism are taken as 
external. To this list were added generally recognized carrier molecules such as 
ATP and ADP which carry high-energy bonds (Palsson (2006) Table 3.1) [160].  
Additionally, the following categories of compounds are included in the list: 
nutrients and small environment molecules, nucleoside phosphates, amino acids, 
and a number of ubiquitous compounds such as chorismate, choline, UDP-
glucose and malonyl-CoA. Such compounds are easily recognized in the 
network by the large number of reactions in which they participate. 
The preliminary classification of nodes in the above network, is augmented by 
taking all those that correspond to compounds on this list, as external as well. 
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The connectivity (i.e. the number of reactions in which it participates) for each 
node in the network is also recorded. 
ii) Next, the subnetwork is reconstructed starting from a prototype network for 
flavonoid production. The prototype is compiled from all reactions participating 
in empirically known pathways explicitly listed in the AraCyc pathways table as 
flavonoid related.  
This prototype is then extended by comparing node classification and connectivity7 for 
the full and prototype networks. Microsoft Excel is used for the comparison. 
 Extracting the flavonoid subnetwork 4.3.2.2
To collect all flavonoid-related reactions from the full Arabidopsis network, an Excel 
file is set up to contain four spreadsheets with information extracted from the AraCyc 
database. The information contained in the four spreadsheets are:  
1. All metabolites or compounds in the AraCyc database sp1 
2. All metabolites from balanced reactions in the AraCyc sp2 
3. All metabolites from balanced reactions, taking into account the external 
metabolites table sp3 
4. All metabolites related to flavonoid metabolism sp4 
The information in the spreadsheets includes metabolite names, whether they are 
internal compounds, and their associated connectivity. Using Excel features, spreadsheet 
2 (sp2) is compared to sp1 to check for inconsistencies in terms of whether a metabolite 
is external in the balanced reactions database (sp2) but internal in the raw database 
containing all the metabolites in AraCyc (sp1) or vice versa; these inconsistencies are 
then checked against sp3 to ensure that it contains reliable information on internal and 
external metabolites with which sp4 can be checked.  
1. Spreadsheet 4 (sp4) is important because it contains the flavonoid-related 
compounds that would constitute the subnetwork. By comparing sp4 with sp3, the 
following processes are carried out to ensure that sp4 contains a complete set of 
reactions that is representative of a self-contained flavonoid subnetwork:  
                                               
7
 the number of reactions in which a metabolite participates 
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2. If a node is external in sp4 (the prototype), but internal in sp3 (the balanced full 
network), its links in the full network are traced back to an acceptable external. 
If a node is internal in both, but has a larger connectivity, Cf, in the full network 
than its connectivity, Cs, in the subnetwork, then: 
• If Cf >>Cs, the node is reclassified as external because there are many 
processes outside the subnet-work to account for buffering it. 
• Otherwise all its connections are traced back as above. 
3. All reactions encountered in the ‘traceback’ are added to the prototype. 
4. Classification, comparison and ‘traceback’ steps are iterated until all connectivities 
and classifications in the subnetwork agree with those in the full network.  
There is no guarantee that iterations will converge, but if they do, all subnetwork 
internal nodes will be completely disconnected from the full network and all boundary 
nodes will represent plausible reservoirs. This is considered a coherent subnetwork. In 
the case of the Arabidopsis flavonoid subnetwork, convergence was obtained for a 
subnet of 181 compounds and 165 reactions (refer to Figure 4.4-1). All these 
compounds and reactions are relevant for maintaining a coherent flavonoid subnetwork. 
 Results 4.4
 The flavonoid subnetwork 4.4.1
The extracted flavonoid subnetwork shown in Figure 4.4-1 below is quite complex, 
containing all cell compounds and reactions related to flavonoid metabolism and 
necessary to sustain it as an independent network. Because of the complexity of the 
network and having to fit it all on a small space, the common compounds involved in 
many reactions in the cell (AMP, ADP, ATP, O2, CO2, CO-A, GLC, GLT, H+, H2O, 
NADP, NADH, NADPH, Pi, PPI,  SUC, TDP, UDP)8 are not shown in Figure 4.4-1 
although they are all taken into account in the calculations and analyses.  
The SBML network specification of the flavonoid network is provided as input for the 
CellNetAnalyzer (CNA) program (Section 1.9) [64],  the software tool used to conduct 
the MPA studies in this research. 
                                               
8
 refer to the Abbreviations table (page x) for details 
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 Features of the AraCyc flavonoid subnetwork  4.4.2
The flavonoid subnetwork shown in Figure 4.4-1 below consists of 181 metabolites and 
165 reactions, so has more metabolites than reactions. This illustrates a common feature 
of plant secondary metabolites where “decorating” (glycosylating, acylating, and 
methylating) enzymes are of low substrate specificity, enabling a single reaction to 
utilize multiple substrates to produce different products [161]. 
In addition, the 360 EMs calculated from the flavonoid network is quite low compared 
to previous studies that concentrated on the primary metabolism of microbes [88, 101]. 
These previous studies had more reactions than metabolites and, consequentially, very 
high numbers of EMs, for example the 2.4 million EMs calculated from 112 reactions 
and 89 compounds in Escherichia coli [94].  
A list of all the 360 EMs is not included because it requires a lot of space to list all the 
reactions for each EM but an e-copy can be made available on request9. The low 
number of EMs in the flavonoid subnetwork indicates that the network is highly 
constrained, which makes sense considering that the number of reactions determines the 
dimension of the EM subspace, while the number of internal compounds represents the 
number of constraints. One biological interpretation of this observation is that the 
network mainly comprises secondary metabolites which have more specific functions. 
Consequently, the metabolites in the flavonoid network are involved in fewer reactions, 
compared to primary compounds fundamental to plant growth and thus involved in 
many reactions.  
 
                                               
9
 Request can be made through email to author: sangaa@xtra.conz 
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Figure 4.4-1: The Arabidopsis flavonoid subnetwork.  
Compounds are drawn as rectangular and oval shapes. Black refers to internal metabolites, blue to external substrates and green to external products,  
while dotted lines specify the metabolite taking part in other reactions outside the subnetwork
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 Conclusions 4.5
The AraCyc database contains a collection of empirical metabolic pathways of all the 
reactions and enzymes in Arabidopsis. The reconstruction process uses these reactions 
and enzymes to reconstruct the full Arabidopsis metabolic network as a system from 
which metabolic pathways, in the form of EMs, can be calculated based on the structure 
of the network. The flavonoid subnetwork is extracted from this full network.  
The continuously progressing curation process proved to be a substantial challenge for 
the study reported here. With every revision, published at intervals between 3 and 6 
months, the subnet extraction process described in this chapter was repeated, and 
relevant aspects of the analyses reported in subsequent chapters updated accordingly. 
This also accounts for some minor numerical discrepancies between the work reported 
in this thesis, and those in the published articles referred to in those chapters. 
The final reconstruction and extraction process has produced a subnetwork of 181 
compounds and 165 reactions, relevant for maintaining a coherent Arabidopsis 
flavonoid subnetwork (FlavNet). FlavNet has more compounds than reactions, 
consistent with flavonoids being secondary metabolites. Secondary plant metabolites 
have more specialised functions and FlavNet correspondingly shows characteristics of a 
highly constrained network. 
These speculations could be further investigated by looking at other extracted pathways 
representing different types of metabolism and comparing the number of reactions and 
EMs to see if they support the theory.  This provides possibilities for future studies but 
this research will focus on the flavonoid subnetwork that has been reconstructed and of 
which the 360 EMs calculated provide a basis for the methods used in the studies in the 
subsequent chapters. 
However, before we get into the specific studies, we will verify our flavonoid 
subnetwork by comparing it to other newly reconstructed metabolic networks of 
Arabidopsis that have become available. 
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: Verifying the AraCyc flavonoid Chapter 5
subnetwork 
This chapter looks at other reconstructed Arabidopsis models [162-164] and makes 
comparisons with our reconstructed AraCyc flavonoid subnetwork to verify that its 
compounds and reactions are compatible with recent Arabidopsis models. 
Contribution 
Validating a self-contained flavonoid network extracted from the AraCyc database, by 
comparing to a more recently reconstructed and verified Arabidopsis network.  
The AraCyc is the most highly curated species-specific database present at the Plant 
Metabolic Network and one of the six most accurate databases in the BioCyc database 
system (Section 1.8.1). However, its improvement is still ongoing and, in its current 
form, the AraCyc database still contains pathways with incomplete reactions and 
enzyme/gene assignments as well as missing some pathways. Because the new 
reconstructed Arabidopsis networks are aimed at providing more accurate Arabidopsis 
networks, an appropriate one is compared with our flavonoid subnetwork to provide 
validation.  
 Background 5.1
As described previously in Section 4.1 and 1.8.1, the AraCyc database [165], from 
which we have reconstructed our flavonoid subnetwork, consists of a collection of 
pathways of known reactions and enzymes for Arabidopsis. These pathways are mainly 
automatically predicted using the MetaCyc [53, 166] database and manually validated to 
remove pathways considered to be non-Arabidopsis. This manual curation process 
includes correcting pathways and adding missing pathways. The resulting database 
contains a mix of information from peer-reviewed literature and from computational 
prediction.  
In its current form, the AraCyc database still contains pathways with incomplete 
reactions and enzyme/gene assignments as well as missing some pathways. Users can 
contribute to improving its content through the data submission page and, although the 
database may not be 100% accurate, it is manually improved and validated on an 
ongoing basis. 
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Our AraCyc flavonoid subnetwork, extracted as described in the last chapter, can be 
seen in Figure 4.4-1 and consists of 181 metabolites and 165 reactions.  
The Arabidopsis metabolic network has neither been studied in great detail nor at a 
large scale, even though it has been widely used as a model plant. However, renewed 
interest in the Arabidopsis plant has led to new reconstructions of its network [162-
164], their main aim of which is to provide more accurate Arabidopsis networks by 
providing and using methods for verifying the compounds and reactions predicted to be 
present in the model plant. We consider the information and results from these more 
recently reconstructed network, and use the most appropriate network to verify our 
flavonoid subnetwork, FlavNet. 
 Recently reconstructed Arabidopsis networks  5.2
There are three new models of the Arabidopsis metabolic network that have become 
available recently, referred herewith as the  “AraGEM” [162], “Poolman” [163] and 
“Radrich” [164] models. The first two are manually curated whilst the Radrich model is 
semi-automated. These three models are looked at to identify the most appropriate 
model for comparing with our flavonoid subnetwork, FlavNet. 
The AraGEM model [162] is a reconstructed primary metabolic network of Arabidopsis 
that distinguishes between cell compartments, whilst the Poolman model [163]  is a full 
metabolic Arabidopsis model that can be utilized for characterizing possible flux 
behaviour states. The Radrich model [164], on the other hand, utilizes the integration of 
two different databases, Kegg [167] and AraCyc, to reconstruct the Arabidopsis 
network, as well as a string similarity algorithm to help identify the same compounds 
with different names in different databases [164, 168]. 
Taking into account the different aspects of the three new Arabidopsis models above, 
the time limitation and the arduous task involved in trying to compare different genome-
scale metabolic models without standardised formats, nomenclatures and annotations, 
the Radrich model is considered the most appropriate for verifying our self-contained 
FlavNet, a secondary metabolic network of Arabidopsis. It would be useful to compare 
FlavNet with the manually curated Poolman model but this would require more time 
and work and so could be undertaken separately in future work where other metabolic 
reconstruction methods such as [75] could be used to assist in comparing names of the 
differently reconstructed Arabidopsis metabolic networks.  
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 Method 5.3
There are three different Arabidopsis models representing different levels of certainty in 
the Radrich model [164, 168]. The certainty is based on the compounds and reactions 
being identified in different database sources:  
1) A core network containing compounds and reactions that have been reliably 
identified in the AraCyc and Kegg databases to have the same descriptions and therefore 
are the same; 2) An intermediate network containing compounds and reactions 
identified in one of the two databases but not the other, and with a strong connection to 
the core network so their absence from the other network is attributed to some minor 
inaccuracies; 3) A complete model containing all the remaining compounds and 
reactions in the Arabidopsis network.  
The first two models are mainly used for comparison with the flavonoid subnetwork, 
FlavNet: 
• The metabolites and reactions in FlavNet are listed and compared with those in 
the Radrich core and intermediate model using MS Excel; 
• The proportion of metabolites and reactions compatible with the Radrich models 
are calculated to determine how the flavonoid subnetwork compares with the 
Radrich models. 
 Results 5.4
 Compounds missing from Radrich networks 5.4.1
Table 5.4-1 below shows the 64 metabolites in our flavonoid subnetwork that are 
missing from the Radrich core network. Like the metabolites looked at before, the 
reactions not highlighted are only missing from the Radrich core network, the ones in 
yellow are missing from both the core and intermediate networks and those highlighted 
in blue are missing from all three Radrich networks, which implies that these blue 
highlighted metabolites must be new metabolites in the AraCyc database since the 
Radrich networks were compiled.  
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Table 5.4-1: FlavNet compounds missing from Radrich core and intermediate networks 
The reactions not highlighted are only missing from the Radrich core network,  
the ones in yellow are missing from both the core and intermediate networks and 
 those highlighted in blue are missing from all three Radrich networks 
Missing metabolites (i) Missing metabolites (ii) 
1 345-TRIHYDROXY-37-DIMETHOXYFLAVONE 33 CPD-7417 
2 3-5-ADP 34 CPD-7630 
3 3-BENZOYLOXYPROPYL-GLUCOSINOLATE 35 CPD-7708 
4 3-HYDROXYPROPYL-GLUCOSINOLATE 36 CPD-7714 
5 CAFFEATE 37 CPD-7842 
6 CPD-10413 38 CPD-7866 
7 CPD-10510 39 CPD-79 
8 CPD-10893 40 CPD-8004 
9 CPD-10894 41 CPD-8007 
10 CPD-10900 42 CPD-8009 
11 CPD-11018 43 CPD-8011 
12 CPD-12112 44 CPD-8012 
13 CPD-12218 45 CPD-8013 
14 CPD-1822 46 CPD-8033 
15 CPD1F-420 47 CPD-8034 
16 CPD1F-431 48 CPD-8094 
17 CPD1F-461 49 CPD-8095 
18 CPD1F-462 50 CPD-8096 
19 CPD-513 51 CPD-8097 
20 CPD-514 52 CPD-8098 
21 CPD-520 53 CPD-81 
22 CPD-5521 54 CPD-8941 
23 CPD-6441 55 CPD-8942 
24 CPD-6442 56 CPD-8943 
25 CPD-6443 57 CPDQT-26 
26 CPD-7035 58 PHENYLACETALDEHYDE 
27 CPD-7087 59 PROTON 
28 CPD-7088 60 QUERCETIN-337-TRISSULFATE 
29 CPD-7137 61 QUERCETIN-33-BISSULFATE 
30 CPD-7138 62 QUERCETIN-34-BISSULFATE 
31 CPD-7149 63 SALICYLOYL-COA 
32 CPD-7214 64 SINAPOYL-COA 
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 Reactions missing from the Radrich networks 5.4.2
Table 5.4-2: FlavNet reactions missing from Radrich core and intermediate networks 
 Missing reactions (i) Missing reactions (ii) 
1 2.1.1.82-RXN 43 RXN-7700 
2 2.1.1.83-RXN 44 RXN-7782 
3 2.3.1.103-RXN 45 RXN-7784 
4 2.4.1.114-RXN 46 RXN-7828 
5 2.6.1.58-RXN 47 RXN-7834 
6 2.8.2.26-RXN 48 RXN-7921 
7 2.8.2.27-RXN 49 RXN-7922 
8 2.8.2.28-RXN 50 RXN-8035 
9 FLAVONOL-3-SULFOTRANSFERASE-RXN 51 RXN-8036 
10 ISOCHORSYN-RXN 52 RXN-8088 
11 MANDELONITRILE-LYASE-RXN 53 RXN-8089 
12 PHENYLPYRUVATE-DECARBOXYLASE-RXN 54 RXN-8169 
13 RXN-10130 55 RXN-8170 
14 RXN-10131 56 RXN-8171 
15 RXN-10132 57 RXN-8176 
16 RXN-10138 58 RXN-8204 
17 RXN-10244 59 RXN-8205 
18 RXN-1103 60 RXN-8262 
19 RXN-1104 61 RXN-8263 
20 RXN-1126 62 RXN-8264 
21 RXN-11269 63 RXN-8265 
22 RXN-11270 64 RXN-8266 
23 RXN-1241 65 RXN-8267 
24 RXN-1241-NADP 66 RXN-8268 
25 RXN1F-443 67 RXN-8270 
26 RXN1F-444 68 RXN-8271 
27 RXN1F-474 69 RXN-8332 
28 RXN1F-475 70 RXN-8333 
29 RXN-2001 71 RXN-8334 
30 RXN-2002 72 RXN-8335 
31 RXN-2003 73 RXN-8336 
32 RXN-2006 74 RXN-8713 
33 RXN-2007 75 RXN-8714 
34 RXN-2008 76 RXN-8715 
35 RXN-2009 77 RXN-91 
36 RXN-2224 78 RXN-92 
37 RXN-5482 79 RXN-9724 
38 RXN-6722 80 RXN-9725 
39 RXN-6723 81 RXNQT-4161 
40 RXN-6724 82 RXNQT-4162 
41 RXN-7650 83 TYROSINE-AMINOTRANSFERASE-RXN 
42 RXN-7653 84 RXN-7834  
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Table 5.4-2, shows the 84 reactions in FlavNet that are missing from the Radrich core 
network. The reactions not highlighted are only missing from the Radrich core network, 
the ones in yellow are missing from both the core and intermediate networks and those 
highlighted in blue are missing from all three Radrich networks.  
From the 84 FlavNet reactions that cannot be verified against the Radrich core network, 
34 are also missing from the full Radrich network compiled from the compounds and 
reactions in the AraCyc database so one would have expected it to have all the 
compounds and reactions in Flavnet. The reason these FlavNet compounds and 
reactions were not found in the Radrich full network could have been: 
• because they are new metabolites and reactions that have been added to the 
AraCyc database since the Radrich networks were compiled; 
• their names have changed since they were used in the Radrich study. 
 Comparing the flavonoid subnetwork with Radrich 5.4.3
networks 
In summary, our reconstructed Flavonoid subnetwork, FlavNet, contains 181 
metabolites and 165 reactions, of which the Radrich core (and intermediate) networks 
contains 116 (134) metabolites and 80 (115) reactions respectively as illustrated in Table 
5.4-3 below. 
The table shows how FlavNet compares to the core and intermediate Radrich networks 
in terms of the proportion of metabolites and reactions that occur, noting that FlavNet is 
compiled using the latest AraCyc version (AraCyc 8.0) which came out in April 2011 so 
is bound to contain metabolites that were not present when the Radrich networks were 
compiled in 2010. However, comparison with the Radrich networks still provides some 
form of verification for FlavNet. 
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Table 5.4-3: Number of FlavNet metabolites and reactions found in Radrich networks 
 
 Radrich Core Radrich Intermediate 
 
Flavonoid 
subnet 
missing found % same missing found % same 
Metabolites  181 65 116 64% 47 134 74% 
Reactions 165 85 80 49% 50 115 70% 
 Conclusions 5.5
More than half of the metabolites and reactions (74% and 70% respectively) in our 
reconstructed FlavNet can be verified against the Radrich intermediate Arabidopsis 
network, compiled by integrating the Kegg [2] and AraCyc (Section1.8.1) databases.  
64% and 49% of these occur in the Radrich core network containing compounds and 
reactions reliably identified to be in both Kegg and AraCyc. 
The reason that certain compounds and reactions in FlavNet are not found in the 
Radrich Arabidopsis network may be that the Radrich network was compiled using an 
earlier version of AraCyc while FlavNet is reconstructed from the latest version (8.00) 
of AraCyc. A comparison with an earlier version of FlavNet could be carried out to see 
if this is indeed the case but the aim is to verify the latest FlavNet version used for the 
research and the results provide this to a certain extent. 
So, we can say that FlavNet, the Flavonoid network used for this research, is not only a 
reliable subnet (70%+ the same with the Radrich intermediate model) but, due to the 
ongoing curation and improvement of AraCyc, is also compiled from the latest 
information on Arabidopsis. 
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: Structural network analysis: Chapter 6
applied to anthocyanins 
This chapter describes a study on anthocyanins using structural network analysis to link 
the structure of the metabolic network to the phenotypic roles of genes and where they 
occur in the anthocyanin biosynthetic pathway (ABP).  
Contribution 
This study uses minimal cut sets and structural network analysis to identify correlated 
gene targets for the loss of colour pigmentation in plants from a whole cell perspective 
based on the full metabolic network of Arabidopsis.  
The approach is from the perspective of emergent properties of the underlying 
metabolic network of the ABP.  The study explores the link between the phenotypic 
roles of anthocyanin-related genes, and where they occur in the pathway sequence. 
Also, it explores their relevance to the ABP and how they link with other processes in 
the cell including potential regulatory genes. This could assist in prioritizing target 
enzymes for different objectives. Being able to correlate the predictions with 
experimental results opens an avenue of possibilities by giving credence to use the 
mathematical in silico approach to assist in achieving desired outcomes, especially for 
other less understood pathways. 
 Material from this chapter is published in the BMC Bioinformatics journal [68]. 
 Introduction 6.1
The most obvious and perhaps best characterized role of flavonoids, as mentioned 
before in Section 1.6, involves anthocyanins [32-34], a major subgroup of flavonoids 
that assists plants in attracting pollinators and seed dispersers by providing red to blue 
pigmentation in plant tissues.  
Because of their role in pigmentation, changes in the expression of anthocyanins [32-
34] are easily observed. One example is where flowers have been found to lose their 
anthocyanin colour pigmentation in response to hawkmoths, who preferred paler 
flowers, being the major pollinator [45]. It is reasonable to expect that such loss-of-
function adaptations are relatively unconstrained because they can be achieved in many 
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ways. For example, the suppression of any one of the enzymes catalysing a series of 
reactions that make up a pathway, such as the ABP, will remove its final product- 
anthocyanin. So it comes as a surprise that an experimental study by Whittal et al [45] 
found that for independent events causing loss of colour in different populations of 
Aquilegia, the particular subset of genes that were suppressed, was strongly correlated. 
They also observed that the enzymes/genes10 concerned (DFR and ANS) were co-
regulated, one of similar findings of co-regulation in the ABP genes, for example, those 
by Durbin et al. [169] who showed that colour phenotypes in plants were closely 
associated with changes in the regulation of gene expression. 
This study complements the biological investigations from a mathematical and in silico 
perspective. Rather than observing genes and inferring network properties, we start 
from a known self-contained network containing all reactions necessary for the 
synthesis of flavonoid compounds. Without needing knowledge about the genes 
involved, MPA (Section 2.4)  [96, 101] tools are used to investigate the role of flavonoid 
genes in plant colour pigmentation, first, in parallel to the biological investigations 
mentioned above, but then expanding into other studies that provide further information. 
In their work, Whittal et al. remarked that the DFR and ANS enzymes corresponded to 
steps that were late in the ABP. This led them to interpret their finding as a consequence 
of pleiotropic functions for enzymes such as CHS and CHI that occur earlier in the ABP. 
While this explanation seems plausible enough in terms of a linear pathway, it needs to 
be recognized that, like all empirical pathways, the ABP is in fact embedded in a 
complex biochemical network. This raises additional questions, for example: Even if the 
early enzymes perform other functions, would their loss destroy those functions or are 
there alternative paths available? Instead of blocking a “late” gene, would it not be more 
efficient to block an “early” gene to avoid the unnecessary production/use of 
intermediate enzymes or compounds? Is the number of reactions in which an enzyme 
participates an adequate measure of whether it is essential, or can more refined 
measures be employed? 
In order to answer such questions, a more quantitative approach based on the 
biochemical network analysis methods is clearly needed. As explained earlier (Section 
2.4), MPA methods are based on EMs which are non-decomposable pathways or routes 
that lead from an external substrate to an external product with the network maintained 
                                               
10
 enzymes are used interchangeably with genes here as genes produce enzymes. 
81 
 
at steady state. The EMs consist of minimal sets of reactions that allow the system to 
operate at steady state [88, 170]; they are based on the structure of the network and thus 
defined in the context of whole-cell metabolism. 
By performing a comprehensive mathematical analysis of the extracted subnetwork 
structure, this EM-based study enables the prediction of all possible modes or pathways 
compatible with the network structure. Such exhaustive characterization is very hard to 
achieve experimentally because, regardless of how many examples of a phenomenon 
one has observed, there might always be others not yet observed. However, the 
mathematical analysis provides a complete set of all possible EMs or pathways. It is this 
aspect of completeness, subject only to a complete knowledge of the network itself, that 
makes it possible to make quantitative assessments e.g. of the relative importance of 
genes and reactions. 
 Classification of EMs calculated from the flavonoid 6.2
subnetwork. 
As described in Section 4.4.2, 360 EMs (refer to Section 2.4.2) are calculated from the 
flavonoid subnetwork, FlavNet. From the 360 EMs, 204 lead to non-flavonoid products, 
whilst 156 lead to flavonoid compounds of which there are seven subclasses. These are: 
i) anthocyanins; (ii) flavanols; iii) flavanones; iv) flavones; v) flavonols; vi) 
leucoanthocyanidin and vii) proanthocyanidins. Details of these flavonoids can be seen 
in [22, 32, 171]. Four non-flavonoid groups are identified:  i) lignin [172]; ii) 
benzenoids [173, 174]; iii) amides; and iv) coumarins [175, 176]. The rest of the non-
flavonoid compound products are classified as others: compounds that form ambiguous 
products, either because the products are also substrates in the synthesis of other 
compounds (e.g., chorismate [177] and tyrosine [178, 179]), or the EMs form futile 
cycles.  
Figure 6.2-1 below classifies the EMs into different flavonoid and non-flavonoid groups 
according to the phenotypic functions of the products in the network as described 
above. 
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Figure 6.2-1: classifies the EMs into different flavonoid and non-flavonoid groups  
according to the phenotypic functions of the products in the network. 
As shown in the above figure, 7% of the total number of EMs in the subnetwork lead to 
the formation of anthocyanins and their derivatives. This amounts to 24 EMs which are 
taken to constitute the ABP. 
 The anthocyanin biosynthetic pathway 6.3
The anthocyanins [32-34], as shown in Figure 6.2-1, form one of the flavonoid 
subclasses of products identified from the EMs calculated from the flavonoid 
subnetwork.  
To study the role of anthocyanin genes in the loss of colour pigmentation, the set of 
EMs that directly lead to the formation of anthocyanin compounds is identified from the 
set of EMs calculated from the flavonoid subnetwork, FlavNet, described in Section 
4.4.1, and taken to constitute the ABP. There are 24 EMs directly leading to the 
formation of anthocyanin compounds and these are used to extract the nodes 
(metabolites) and lines (reactions) that constitute the ABP. A detailed part of the 
subnetwork showing the subset of nodes or metabolites involved in the 24 EMs relevant 
for the ABP is shown in Figure 6.3-1.  
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The ABP nodes extracted from the reconstructed  
flavonoid subnetwork of Arabidopsis. 
 
Figure 6.3-1: The ABP part of the self-contained FlavNet subnetwork  
showing the subset of nodes or metabolites in the 24 EMs that constitute the ABP. The compound 
groups that are not directly related to anthocyanins, are shown as greyed-out side branches from 
the ABP. Highlighted is an example of one anthocyanin EM leading to the formation of cyanidin 3-
O-sophoroside. The names of compounds and reactions are as assigned in the AraCyc database. 
Enzymes: CHS: Chalcone Synthase; CHI: Chalcone isomerase; F3H: Flavanone 3-hydroxylase; 
F3'H: Flavanone 3'-hydroxylase; DFR: Dihydroflavonol reductase; ANS: Anthocyanidin synthase; 
LDOX: Leucoanthocyanidin dioxygenase; FLS: Flavonol synthase; UDPG: UDP-glycosyl 
transferase; 3-UGT: Anthocyanidin 3-O-glucosyltransferase; 5-GT: Anthocyanin 5-O-glucosyl 
transferase (Hexosyltransferase); Ss5MaT1: Anthocyanin 5-O-glucoside 6-O-malonyltransferase 
(Acyltransferase); 2.4.1.- Hexosyltransferases; 2.3.1.- Acyltransferases: Transferring groups other 
than aminoacyl groups. 
(Pg) indicates enzymes corresponding to reactions related to pelargonidin-type compounds;  
(Cy) indicates enzymes corresponding to reactions related to cyanidin-type compounds.  
CHS NARINGENIN-CHALCONE-SYNTHASE-RXN
CHS
Chalcones
CHI
CHI APIGNAR-RXN
Flavanones F3'H(i) RXN-7652
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The above Figure 6.3-1 is not a coherent self-contained subnetwork, as discussed earlier 
for Figure 4.4-1, but merely an extract for display purposes. The compound groups that 
are not directly related to anthocyanins, are shown as greyed-out side branches from the 
ABP. Highlighted is an example of one anthocyanin EM leading to the formation of 
cyanidin 3-O-sophoroside. The names of compounds and reactions are as assigned in 
the AraCyc database.  
Using the ABP information, various methods designed for EM-based network structural 
analysis are applied to FlavNet to identify and compare candidate genes that could be 
targeted for eliminating colour pigmentation. 
 Structural network analyses 6.4
The subnetwork is analysed using CNA (Section 4.4.1) [180].  
It is important to note that reactions and compounds constitute metabolic networks so 
the EMs and subsequent methods used in the study are based on reactions as opposed to 
enzymes or genes. In order to compare with experimental observation, the reactions are 
related to their corresponding enzymes (interchangeable here with genes). However, 
these methods do not claim any knowledge of enzymes/genes or situations in which 
reactions occur. So, although it is necessary to discuss MCSs in terms of enzymes for 
relating to experimental observations, the MCSs are based on the reactions themselves 
which are considered independently of their corresponding enzymes/genes. A 
consequence of this is that the same enzymes are considered separately in relation to 
their different reactions. This is especially important in the MCSs study and will be 
explained further under that section (Section 6.4.2).   
Three different criteria were used to prioritize enzymes targeted for suppression of 
colour pigmentation as discussed in the next three sections.  
 Reaction participation (connectivity) 6.4.1
Reaction participation quantifies the pleiotropic property of an enzyme by looking at the 
general superficial structure of the network in terms of the number of EMs a reaction 
participates in. We use this reaction information to determine the connectivity of the 
ABP genes.  
For example, the pleiotropic considerations such as those used by Whittal et al. can be 
quantified by counting the number of EMs in which each ABP enzyme/gene and its 
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associated reaction participates. The result quantitatively shows the importance of the 
genes in terms of their connectivity to other reactions and processes. 
 Minimal Cut Sets (MCSs) 6.4.2
MPA (Section 2.4) provides a more specific tool for investigating loss of function than 
mere participation counting: this is the concept of minimal cut sets, specifically covered 
in Chapter 3.  
As explained in Chapter 3, a MCS [107] is defined in relation to a particular network 
function and provides a functional analysis of the network using information from EMs. 
Because EMs represent the minimal sets of reactions that allow the network to operate 
at steady state, they contain the whole set of elements required by the system to function 
properly. The EMs can therefore be used to compile a list of all the ways in which a 
particular network function can be eliminated. The network function is represented by 
the key reaction(s) that constitute it, designated as “objective reaction(s)”; each 
associated MCS consists of a minimal set of reactions elsewhere in the network that, 
when blocked, will remove any flux through the objective reaction(s).  
The “objective reactions” for our study are those that directly form the anthocyanin 
compounds responsible for the function of colour pigmentation. In effect, these MCSs 
provide the full set of ABP gene candidates for genetic changes for loss-of-function, 
thereby preventing anthocyanin production. Because a complex network provides many 
alternate pathways, there are generally several different MCSs for a single collection of 
objective reaction(s). 
Because the mathematics guarantees that the collection of MCSs is complete, we can 
use quantitative analysis to compare and investigate the effect that each MCS has on the 
remaining non-target set of modes. Along with other different MPA (Section 2.4) 
methods, these effects were utilized in exploring the cut set(s) that would achieve loss-
of-function most effectively and efficiently, and whether the position (“early” versus 
“late”) of the genes in the ABP made a difference to the efficiency and effectiveness of 
the MCSs.  
 Fragility coefficient 6.4.3
Another method used in considering the best candidates for loss of colour pigmentation 
is the fragility coefficient calculated using the MCSs. The fragility coefficient (fc) 
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provides a measure of how essential reactions are for a specific objective. The number 
of modes that a gene is involved in is a good indication of its importance but it is also 
conceivable that a gene involved in only a small number of modes may nevertheless be 
crucial for those modes. In effect, if a gene is part of a larger MCS, its fc will be lower 
as its malfunction will be less crucial for the objective reaction(s). 
The fc of a reaction is defined as the average of the reciprocals of the number of 
reactions participating in an MCS [107]. For the study we want to look at the fragility 
coefficient of the ABP genes and how crucial they are to the pathway. 
 Results and Discussions 6.5
 Gene participation (connectivity) 6.5.1
The first network property looked at is the connectivity of the anthocyanin genes as 
shown in Figure 6.5-1 below. The graph shows the importance of the anthocyanin genes 
in terms of their connectivity to other reactions and processes. The graph starts with the 
“early” genes on the left hand side and finishes with the “late” genes on the right hand 
side, in relation to their position in the ABP sequence. 
Gene Participation 
 
Figure 6.5-1: EM Participation of ABP genes  
for the two Arabidopsis anthocyanidin 3-O-glucosides (anthocyanin) compounds with the 
genes on the graph corresponding to their positions in the ABP sequence: the earliest gene 
in the ABP sequence (CHS) starts on the left. 
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The above results agree with those of Whittal et al. [45] regarding the pleiotropic 
function of the “early” genes and its decrease as you move down the ABP; it provides a 
more quantitative representation of their observations by actually determining the 
number of EMs to which the genes are connected. The “earliest” genes CHS and CHI 
are related to 156 EMs while the “latest” genes together only occur in the 24 EMs 
responsible for anthocyanin formation. The information provides a quantitative support 
for the explanation of “late” genes being targeted for loss-of-function mutations. 
However, it is not enough to say that gene connectivity is a deciding factor in 
determining which genes to target for loss-of-function because being pleiotropic does 
not mean for certain that the gene will not be targeted for loss-of-function, and vice 
versa. Moreover, the absence of a single enzyme may not be enough to prevent 
pigmentation. A MCS, on the other hand, is directly focused on a specific objective 
function, so by specifying the objective as loss-of-function, it can be used to determine 
target gene sets that would guarantee loss-of-function.  
 Candidates for loss of colour pigmentation 6.5.2
Table 6.5-1 shows the set of MCSs or ABP gene candidates for genetic changes needed 
to eliminate anthocyanin production. The reactions directly forming the anthocyanin 
compounds (PELUDP-RXN and RXN1F-775) are identified as the objective functions 
for which the MCSs are determined.  
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Table 6.5-1: ABP MCSs with corresponding ABP gene(s) and reactions. 
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In the last column of Table 6.5-1, parallel enzymes are listed by a single representative: 
ANS & LDOX as ANS; 3-UGT & UDPG as 3-UGT (Refer to Figure 6.3-1 for 
explanation of abbreviated enzymes) 
The 22 MCSs shown in Table 6.5-1 above identify the different alternative 
combinations of ABP genes to block, in order to eliminate colour pigmentation. The last 
column shows the ABP gene(s) involved in each MCS with the second last column 
showing the number of EMs (123 non-anthocyanin EMs) not affected by each of these 
cut sets. This is shown graphically in Figure 6.5-2 which shows the impact that each 
MCS has on the remaining flavonoid EMs, and hence provides a means of prioritizing 
MCS candidates by their effect on other processes.  
 
Figure 6.5-2: Graph showing the number of EMs not affected by each MCS. 
The MCS numbers on the x-axis correspond to the MCS numbers in the  
left hand column of Table 6.5-1. 
As shown in the above figure, at the top of the list is MCS15 which does not affect any 
other mode except the 24 anthocyanin EMs. As shown in Table 6.5-1, this MCS consists 
of UDPG and 3-UGT, the genes associated with the objective functions so they would 
be the best genes to block to eliminate anthocyanin production without affecting other 
EMs or the production of other compounds. The second best cut set is MCS13 (genes 
ANS & 3-UGT) with 138 EMs not affected. One of the genes (3-UGT) corresponds to 
the objective function. 
The MCS result illustrated in Figure 6.5-2 could be used together with the previous 
results represented in Figure 6.5-1 which showed the connectivity of these genes in 
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terms of the number of EMs that they participate in along with their sequential positions 
in the ABP. The gene participation graph shows the pleiotropic function of the genes, 
CHS and CH, earliest in the ABP which are involved in all flavonoid EMs. As you 
move down the pathway sequence, the number of EMs in which the genes are involved 
decreases; the latest genes (UDPG/3-UGT) are only involved in the anthocyanin EMs.  
Figure 6.5-2 also shows that, next to MCS15, the two genes in MCS13, ANS 
(LEUCPEL-RXN) and 3-UGT (RXN1F-775), would cause minimum disturbance 
because they are only involved in 33 EMs- the 24 anthocyanin modes plus an additional 
9.  
Then again, it could be more efficient to block an ‘early’ gene and avoid the 
unnecessary use of intermediate enzymes or compounds.  This argues for MCS11 (ANS 
& 3-UGT) and MCS14 (DFR & 3-UGT) with 135 non-affected EMs. While these 
eliminate 6 additional modes, they may compensate for it by moving the cut higher up 
the pathway, although these MCSs contain at least one objective function gene. The 
next five MCSs that do not contain any objective function genes but still make good 
candidates are: MCS8 (ANS/LDOX) with 132 non-affected EMs, MCS9 (DFR & ANS) 
and MCS10 (DFR & 3-UGT) with 129 non-affected EMs, MCS5 (ANS, DFR) with 126 
non-affected EMs, and MCS6 (DFR) with 123 non-affected EMs. The number of non-
affected EMs then drops to 60s or lower. 
The above analysis gives independent insight into the reasons for the observed 
molecular convergence in the evolution of colour pigmentation losses by providing a 
complete listing of all options open to the plant for suppressing anthocyanin production, 
as well as characterization of the impact each mutation has on the production of other 
compounds. It shows a more quantitative and therefore more differentiated 
characterization of the enzyme roles through the exhaustive nature of the mathematical 
analysis of network structure. fc could provide further information on target genes by 
looking at how essential they are to the pathway. 
 How essential are the ABP genes? 6.5.3
The two bottom rows of Table 6.5-1 respectively show the fc and the reactions 
corresponding to the genes in the first row (also shown in Figure 6.5-1). A graphical 
representation of the ABP genes’ fc’s is shown in Figure 6.5-3. 
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Figure 6.5-3: Fragility coefficients (fc) of the ABP genes.  
The fragility coefficients are in relation to the production of each of the anthocyanidin 
glucosides. Refer to second last row of Table 6.5-1 for details of fc values 
 When compared with Figure 6.5-1, the above figure also shows CHS and CHI as 
crucial to the ABP but, unlike gene participation, shows later genes, DFR and 
ANS/LDOX along with UDPG/3-UGT, as more essential for anthocyanin production 
than the earlier F3H and F3’H genes. It is to be expected that 3-UGT/UDPG are more 
essential as they directly form the anthocyanin compounds but DFR and ANS/LDOX 
are more essential than the earlier genes F3H and F3’H because they are involved in 
MCSs with fewer reactions, so the network structure identifies them as more crucial for 
anthocyanin formation. 
Considering all the issues highlighted in the analyses so far, the genes ANS/LDOX and 
DFR corresponding to MCSs 5 and 9 could be considered as having favourable 
characteristics: they participate in a low number of EMs so don’t affect the production 
of too many compounds; they occur earlier in the pathway and; they are more essential 
for anthocyanin production (higher fc) than other earlier genes. This supports the 
observation by Whittall et al. [45] of the genes ANS and DFR being targeted and co-
regulated for eliminating floral pigmentation in Aquilegia.  
The genes making up the MCSs need to be suppressed together to be effective so the 
concept of MCSs goes well with that of a regulatory gene regulating the expression of a 
set of structural genes. Several regulatory genes are known to regulate the expression of 
sets of structural genes in the ABP e.g., DFR and all later genes are co-regulated in 
Petunia and ANS onwards in antirrihinium [169]. These sets are larger than the 2-
member sets determined in this study. That may be because the observations in [169] 
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relate to colour changes rather than complete loss and to study it in detail would need 
the use of different objective functions; this could be done in a future study. 
 Conclusions 6.6
This study shows that structural network analysis methods can be used together to 
elucidate the functionality of reactions and, subsequently, genes in relation to the 
structure of the network. The analysis methods provide quantitative support for 
experimental results; e.g., gene connectivity provides quantitative support to the 
experimental observation [45] of the pleiotropic11 characteristic of the “early” ABP 
genes and how they are involved in the production of many other flavonoid compounds 
involved in UV-protection, edaphic 12tolerance, male fertility, herbivore and pathogen 
resistance and several other non-floral functions [181-183] by determining the number 
of EMs the ABP genes are connected to.  
MCSs on the other hand can be used to identify target genes that would guarantee loss-
of-function and, together with the other structural analysis methods, is able to 
investigate characteristics such as the essentiality of ABP genes in the production of 
anthocyanin compounds and colour pigmentation, in relation to where they are in the 
pathway. 
                                               
11
 having an effect on many other phenotypic characteristics or traits beside the production of anthocyanin 
12
 relating to, or being influenced, by soil e.g., drainage, texture 
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: Functional Network Analysis: Chapter 7
applied to anthocyanins  
This chapter takes the study of anthocyanins a step further by simulating fluxes 
(reaction rates) for the MCSs that eliminate the production of anthocyanins, and using 
the fluxes to study the impact that the elimination of the ABP genes has on other 
flavonoid compounds and other processes in the cell.  
Contribution 
This study applies FBA to FlavNet to investigate the impact that elimination of the ABP 
genes has on other flavonoids and related compounds. The process involves formulating 
a pragmatic way of using available experimental results to establish a representative 
reference state that constrains the solution space to plausible flux values that are not in 
conflict with measured values in actual cells, thereby improving the prediction accuracy 
of the model. The fact that there are feasible solutions to this reference state also 
provides validation of the model. The relative impact of MCSs is looked at by 
normalizing simulated fluxes for the different MCSs to their values in the reference 
state (dividing each MCS reaction rate by its rate from the reference state).  
The study provides a quantified measure of the impact that the different MCSs would 
have on the production and processes of other flavonoids and related compounds.  
 Material from this chapter is published in the BMC Bioinformatics journal [68]. 
 Introduction 7.1
The previous study used structural network analysis to study the functionality of the 
ABP genes. In addition to structural considerations, the effects of losing a set of 
enzymes on other functions of the biochemical network are relevant in studying a loss-
of-function adaptation. This can be done using reaction rates. 
In this study, reaction rates are used where, for certain identified MCSs, fluxes between 
enzymes are simulated, compared and investigated.  
FBA is used to investigate how each MCS candidate would affect the rate of production 
of associated metabolites. Where possible, the analysis results are compared and related 
to results from biological studies. 
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 Functional Network Analysis 7.2
 Reaction rates/fluxes 7.2.1
A reaction rate is the rate at which a reaction converts reactants into products; it 
represents the metabolic flux [135] through a reaction. For this study, the reaction rates 
or fluxes are used to explore the impact that each MCS has on other processes in the cell 
by simulating metabolic fluxes for the different MCSs and normalizing them against a 
reference state.  
Conceptually, such impacts could be assessed by comparing the metabolic fluxes, 
before and after a particular MCS is imposed, by setting the fluxes through its reactions 
to zero through all EMs in a metabolic state that is precisely defined by measured fluxes 
for an individual cell. This is not practically possible because measured fluxes are not 
available to uniquely determine a metabolic state for the flavonoid subnetwork. Even if 
they were, the detailed quantitative results would strictly only apply to the single state 
used for the calculation. 
However, a basic premise of constraints-based modelling (Section 1.5) is to use partial 
experimental knowledge to narrow down the flux space to a compatible range, within 
which there is still scope for the many varied individual states produced by different 
environments, cell types, tissues, etc. 
In the same spirit, the approach is to establish a reference state chosen to be merely 
representative and plausible in the sense that flux values are not in conflict with 
measured values in actual cells. 
 Preliminary constraints 7.2.1.1
Optimization (e.g. of biomass production) is often used to identify the most realistic 
representation of the metabolic state of a cell within the constrained region of flux 
space. This is not applicable for flavonoids because they are secondary metabolites not 
needed for basic life functions in a cell. Fortunately, however, the chosen subnetwork 
also supplies the ingredients for synthesizing the lignin macromolecule, which is a 
significant constituent of plant biomass. This allows us to relate some flux values to the 
well-measured overall biomass growth rate.  
Literature values for lignin monomer ratios show some variation according to plant 
species, tissue, developmental state and environmental stress, and similarly the lignin 
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fraction of the biomass is variable. We make the following assumptions based on a 
survey of the literature [172, 184-186]: 
• The lignin composition [185] is taken as: 
370 CONIFERYL-ALCOHOL + 238 SINAPYL-ALCOHOL + 60 
COUMARYL-ALCOHOL 
• Taking the lignin biomass constituent as 15% [172, 184] of the total biomass and 
the growth rate as 0.18 per hour (h-1) [187], the lignin macromolecule 
(synthesized according to the above equation) is taken to contribute to 0.027 h-1 
of the primary growth of the plant.  
• We assume that the flavonoid reaction rates are proportional to the measured 
concentrations of flavonoid products.  
This assumption is not justifiable in general. Concentrations are related to the 
balance between fluxes rather than individual flux values, and also, it is the rate 
of change rather than the concentration itself that is determined by flux values. 
However, no measurements of how concentrations change were available. 
Bearing in mind that synthesis by the metabolism is the only source of 
flavonoids, it seems plausible to take the concentration observed at a particular 
moment as indicative of the rate at which it was synthesised. This is further 
supported by noting that we only consider relative flux values between largely 
similar metabolic states and that, as a result, no quantitative assumption e.g. of a 
proportionality constant is needed. The assumption is only proposed as a 
working hypothesis, to be further evaluated in the light of its results in 
comparison with experiments. 
• The molar mass of the compounds are used to convert mg/kg to mmol/kg and 
these are used as reaction rates per hour. Since we are looking at relative rates 
and thus only evaluate ratios between rates with and without an MCS imposed, 
the units will cancel out, including the arbitrary (h-1)  time unit used for the 
reaction rates. 
Rates are compiled in this way for one type of plant: grapes (Table 7.2-1) [188, 189] 
while information from other plant types (Table 7.2-2) [190-193] are used to constrain 
the values of the reaction rates so they occur within a realistic range.  
The main reason for using information from grapes and other plants beside Arabidopsis 
is the lack of Arabidopsis flavonoid data required for the model; flavonoid information 
on grapes was the most comprehensive that could be obtained at the time of study. 
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However, this also provides the opportunity to test if the model is indeed representative 
of, and can be used for, investigating the metabolism of any plant, not just Arabidopsis. 
Table 7.2-1 and Table 7.2-2 contain the constraint values used for the subnetwork. These 
are considered preliminary values that can be modified as more information becomes 
available. 
Table 7.2-1: Flavonoid fluxes compiled from literature on grapes 
The constraints sources  are as referenced  in the table, and used  
to generate network input fluxes that are then kept constant for the different MCSs. 
  Reactions mg/kg FW 
Reaction Rate 
(mmol/kg*h) 
Growth rate: lignin composition [187] mue  2.70E-02 
Flavonoid products: Grapes [188, 189] 
 
 
Anthocyanins     
 cyanidin 3-glucoside (cpd1f-766) RXN1F-775 28.9 6.43E-02 
cyanidin 3-p-coumaroylglucoside (cpd-7866) RXN-8204 1.4 2.35E-03 
Flavonols 
kaempferol-3-glucoside (cpd1f-453) RXN1F-461 97.7 1.64E-01 
quercetin-3-glucoside (cpd1f-437) RXN1F-462 37.3 8.03E-02 
Flavan-3-ols (proanthocyanidins) [40.4] [1.43E-01] 
epiafzelechin: CPD-10413 RXN-9724  3.58E-02 
2,3-cis-epicatechin: CPD-7630 RXN-9725   3.58E-02 
afzelechin: CPD-1962 RXN-1481  3.58E-02 
2,3-trans-catechin: CPD-1961 RXN-1484   3.58E-02 
 
Table 7.2-2: Fluxes for other compounds from literature on other plants 
Other products: Other plants  [190-193] Rxn Rate Range [min, max] 
luteolin (5734-TETRAHYDROXYFLAVONE)     [0, 5.02E+01] 
apigenin (cpd-431)   [0, 1.44E+01] 
methylsalicylate     [0, 1.15E-02] 
methylbenzoate   [0, 2.27E+01] 
4-coumarate      [0, 1.84E+00] 
Caffeate   [0, 3.10E-01] 
Ferulate     [0, 4.50E-01] 
The above constraint fluxes are arbitrary values collected from a variety of sources, so 
serve more to test the capacity of the model to calculate a feasible state when constraints 
are applied. Taking these constraints as well as the fixed lignin biomass production rate, 
CNA (Section 1.9) is allowed to calculate a feasible state of the network and this is 
taken as the reference state discussed next. 
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 Reference state 7.2.2
The values of all input fluxes calculated in this reference state are listed in Table 7.2-3 
below and subsequently used for the MCS simulations as described below. 
Table 7.2-3: Feasible input fluxes of external substrates. 
These input fluxes are kept constant for the different MCSs. 
External input reaction Reaction Rate 
(mmol/kg*h) 
CAFFEATE-O-METHYLTRANSFERASE-RXN 8.40E+01 
CONIFERIN-BETA-GLUCOSIDASE-RXN 4.51E+01 
BENZYL-ALC-DEHYDROGENASE-RXN 2.98E+01 
RXN-5482 1.44E+00 
CINNAMYL-ALCOHOL-DEHYDROGENASE-RXN 9.26E+01 
TYROSINE-DECARBOXYLASE-RXN 1.01E+02 
PHEAMINOTRANS-RXN 9.26E+01 
MANDELONITRILE-LYASE-RXN 2.98E+01 
UDP-GLUCOSE-4,6-DEHYDRATASE-RXN 2.41E+00 
DAHPSYN-RXN 9.07E+01 
TYROSINE-AMINOTRANSFERASE-RXN 6.17E+01 
PHENYLPYRUVATE-DECARBOXYLASE-RXN 5.00E+01 
Due to the varying origins of the constraints used and the arbitrary selection of a single 
feasible state, results based on this reference state are only expected to be indicative, not 
quantitatively significant. Some reassurance is obtained from the fact that the resulting 
flux balance system does have feasible solutions, so that the constraints are at least not 
mutually contradictive. A further measure to reduce reliance on details of the reference 
state is that only flux ratios are considered, not absolute values.  
It is also noted that the reference state is not meant to represent any particular 
physiological state, but rather a generic representation of all the capabilities of the 
flavonoid subnetwork that enables the analysis and use of relative fluxes to study the 
impact of different MCSs. In the final analysis, the results themselves as reported in the 
next section give further support to the appropriateness of this approach. 
 MCS Simulated States 7.2.3
The MCS states are simulated by constraining the fluxes through the reactions 
constituting each MCS to zero, while maintaining the initial constraints and external 
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inputs at the same values as for the reference state. It is conceivable that blocking the 
reactions in a MCS might change the fluxes exchanged with the full network, provided 
that such changes are compatible with flux balances in the full network. If we did allow 
changes to these inputs, we would be allowing all possibilities from the full network 
whereas we wanted to concentrate on testing their feasibility with just the subnet. So 
while we have only studied a specific case, to extend that would actually necessitate 
dealing with the complete network which does not seem practical. Also, a test to see 
what difference this would make was carried out (results not included) to simulate 
fluxes without constraining the total flux, i.e. not applying the influx constraints in 
Table 7.2-4. The resulting relative fluxes remained more of less the same.  
By keeping the influx into the network constant, the reaction rates for each MCS can be 
compared against the reference state. Table 7.2-4 below shows the list of constraints and 
influxes constant. 
Table 7.2-4: Constraints and constant influxes 
Reactiion 
Reaction Rate 
(mmol/kg*h) 
CAFFEATE-O-METHYLTRANSFERASE-RXN 8.40E+01 
CONIFERIN-BETA-GLUCOSIDASE-RXN 4.51E+01 
BENZYL-ALC-DEHYDROGENASE-RXN 2.98E+01 
RXN-1481 3.58E-02 
RXN-5482 1.44E+00 
RXN-1484 3.58E-02 
CINNAMYL-ALCOHOL-DEHYDROGENASE-RXN 9.26E+01 
TYROSINE-DECARBOXYLASE-RXN 1.01E+02 
PHEAMINOTRANS-RXN 9.26E+01 
RXN1F-775 6.43E-02 
RXN1F-461 1.64E-01 
RXN1F-462 8.03E-02 
MANDELONITRILE-LYASE-RXN 2.98E+01 
UDP-GLUCOSE-4,6-DEHYDRATASE-RXN 2.41E+00 
DAHPSYN-RXN 9.07E+01 
TYROSINE-AMINOTRANSFERASE-RXN 6.17E+01 
RXN-9724 3.58E-02 
RXN-9725 3.58E-02 
RXN-8204 2.40E-03 
mue 2.70E-02 
PHENYLPYRUVATE-DECARBOXYLASE-RXN 5.00E+01 
 
99 
 
The MCS simulated fluxes are normalized to their values in the reference state by 
dividing each MCS reaction rate by its rate from the reference state. This cancels out the 
units so we are looking at the relative impact of the MCSs on a typical (reference) state 
of a plant cell.  
A similar analysis was done without the constraints, to check that the relative impact is 
not just specific to the chosen reference state; it was found that the flux ratios were 
generally the same whether the preliminary constraints were used or not. So, even if 
knockouts affect the total input flux into the flavonoid network, as might plausibly be 
expected to happen, the relative impacts as discussed in the next section are expected to 
remain similar. 
 Results and Discussions 7.3
 Compound groups in the flavonoid subnetwork 7.3.1
To represent the results, the external metabolite products from the flavonoid subnetwork 
(Figure 4.4-1) are grouped into seven flavonoid groups and four non-flavonoid groups. 
The flavanoid groups are flavanols, flavanones, flavones, proanthocyanidins, 
leucoanthocaynidins, anthocyanins and flavonols which is further split into two groups: 
flavonols1 consisting of kaempferol derivatives and flavonols2 consisting of quercetin 
derivatives. The average relative fluxes through the end reactions of the EMs producing 
these external products enable us to study the impact that the MCSs have on other 
processes. 
 Implications of eliminating the ABP genes 7.3.2
 In the absence of detailed data on metabolic fluxes in a particular tissue of Arabidopsis 
under particular conditions, a reference state (Section 7.2.2) is compiled in which as 
many fluxes as possible are constrained to values that are plausible in the sense of 
having been measured for other species or tissues. While this reference state is 
somewhat artificial, it is important because the assumptions that constitute it are based 
on real experimental facts and therefore provide an initial benchmark for the credibility 
of the subnetwork or the model.  
The reference state addresses all situations represented by the subnetwork. For example, 
it takes the presence of lignin-related compounds as an indication of flavonoid 
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metabolism being closely linked with plant growth and as such uses them to constrain 
the subnetwork to account for plant biomass and primary growth. Other real-life based 
constraints on the metabolism of flavonoid compounds together form validation of the 
subnetwork model which is further justified by the fact that it gives a feasible solution, 
in other words it contains no contradictions in terms of flux balances. 
The initial assumptions that constitute the reference state do constrain the subnetwork 
and it may be that certain assumptions may not apply in certain environmental situations 
or in certain plant cells so the reference state should be seen as representing what the 
flavonoid subnetwork is realistically capable of, rather than any specific state. As such, 
it allows exploration of the effects of a given MCS on all functions of the subnet, not 
just those that are active in particular conditions.  
In the second step of the simulation, the inputs to the subnet are kept fixed at the values 
required for the reference state. The rationale behind this is that those inputs are 
supplied by the rest of the metabolic network and, in effect, it is assumed that the rest of 
the metabolism is not affected by readjustments inside the flavonoid subnetwork.  In the 
absence of information about such effects, this assumption is at least a reasonable 
starting point when comparing plants growing under the same external conditions but 
with or without colour pigmentation.  
 Figure 7.3-1 (a & b) show the relative fluxes simulated for different MCSs and 
demonstrate the effect that eliminating colour pigmentation, by suppressing certain ABP 
genes, has on other reaction rates. 
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Figure 7.3-1: Relative Fluxes (Reaction Rates) 
a) – Average reaction rates producing the flavonoid product compound classes 
Average relative fluxes (reaction rates) producing the external flavonoid compound classes 
for each MCS. Flavonols1: kaempferol derivatives; Flavonols2: quercetin derivatives. 
b) – Average reaction rates producing the non-flavonoid compound groups 
Average relative fluxes (reactions rates) producing the non-flavonoid compound groups for 
each MCS. 
The extra information about MCSs that is provided by the reaction rates are:  
• MCS 1 and 2 eliminate anthocyanin production by respectively constraining the 
CHI and the CHS reactions to zero (refer to Table 6.5-1). As shown by the 
relative fluxes in Figure 7.3 1a), this also effectively eliminates all other 
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flavonoids (fluxes=0) except for the flavanone liquiritigenin and the non-
flavonoid compound products. Benzenoids are hardly affected;  
• MCSs 4 and 16 have, to a lesser extent, similar effects as MCSs 1 and 2 but with 
an additional increase in flavone fluxes especially by MCS16 which also shows 
a corresponding flux increase in leucoanthocyanidins. All other flavonoids are 
eliminated;  
• MCSs 13 & 15 show an increased reaction flux for proanthocyanidins (PAs) and 
flavonols and would make likely candidates for stages in plants such as early 
berry development [174], where  PA and flavonol promoters are activated but 
not the anthocyanins.  
• MCSs 17 to 22 are good candidates to consider for when you are looking at 
ways to eliminate pigmentation that will also eliminate quercetin related 
flavonols (and PAs as well for MCSs 18 & 21) but increase fluxes of 
kaempferol related flavonols. 
In general, the reaction rates show that non-flavonoid compounds are not much affected 
by the elimination of anthocyanins. Even for MCSs 1 and 2 which require the 
elimination of the early ABP genes that result in the elimination of most of the 
flavonoids, benzenoid production is not affected. This provides a quantified explanation 
of experimental observations such as that by Spitzer et al. [44] where they showed that 
the suppression of the anthocyanin pathway, via CHS silencing, dramatically reduced 
flavonoids but did not affect scent (benzenoids) production.  
 Discussions and conclusions 7.4
The above FBA provides a quantified measure of the impact that the different MCSs 
would have on the production and processes of other flavonoids and related compounds. 
They provide a more informative way of considering favourable target genes for 
eliminating colour pigmentation, and show that MCS options that appear similar in 
terms of structural measures, can have opposite quantitative impacts.  For example, 
looking at genes ANS & DFR (MCSs 5 & 9) that were considered favourable target 
genes for eliminating colour pigmentation from the previous network structural 
analysis, the FBA shows that the effect of their MCSs on reaction fluxes is mainly to 
decrease PA.  MCSs 13 & 15, on the other hand, lead to an increase in fluxes through 
the reactions mainly producing PAs and flavonols. Both effects have been observed in 
different systems.  This additional information suggests that different MCSs suit 
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different cell types or environmental conditions and could be utilized to identify which 
MCS would work best to achieve a certain outcome.  
While the reference state used for the reaction rate analysis is admittedly only one out of 
a possible range of feasible states, the general principle demonstrated by the results is 
that various MCSs that are by construction equivalent regarding a set of target products, 
can have quite different repercussions on the flux distribution in the rest of the network. 
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: Gene expression from compound Chapter 8
presence. 
This chapter demonstrates the use of EMs and MCSs to determine which genes are 
being expressed in a tissue, from experimental information about compound products 
present in the tissue. 
Contribution 
Based on the knowledge and understanding obtained from previous chapters, this study 
develops an algorithm and subsequently writes a program that uses EMs and MCSs to 
determine which genes are being expressed in a tissue, from experimental information 
about compound products. 
 Background 8.1
Although the metabolic network contains all gene-related reactions and metabolites for 
that organism, in real life, only certain genes or enzymes are expressed in certain 
tissues. So, for a particular tissue, only the EMs containing the reactions that are related 
to the genes being expressed in those tissues, are active to produce the corresponding 
compounds. Consequently, different compound products are found in different tissues, 
depending on which genes are being expressed. In real life situations, different genes or 
enzymes are expressed in different tissues so certain compounds would be found in 
certain tissues but not others. Each compound product, however, would have the same 
EMs (Section 2.4.2) [94] and MCSs (Chapter 3) [106], it is just a matter of determining 
which of these are activated for a certain cell in relation to the genes or enzymes that are 
expressed or suppressed. 
Based on this idea, we could use experimental results of compounds that are found in a 
particular tissue, or are conversely absent, to identify the viable EMs [94, 96, 102] and 
MCSs [66, 106, 107] for certain tissues and, subsequently, genes that are being 
expressed in terms of the reactions that are taking place. This would be cheaper and 
easier to use than practical experimental methods such as microarrays which need 
advanced experimental technology to carry out and are hard to repeat. 
The metabolic network of an organism is constructed from knowledge and information 
about the full genome of the organism whereby the metabolites and reactions are 
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identified according to their corresponding genes and enzymes. Information on genes is 
available online at resources such as the Kyoto Encyclopaedia of Genes and Genomes 
(KEGG) and The Arabidopsis Information Resource (TAIR) [51].  
Knowledge about when and where a gene is expressed in a cell often provides an idea of 
its biological role. To get a better understanding of the possible functions of genes, 
DNA microarrays [194] have traditionally been used to measure the expression levels of 
large numbers of genes simultaneously or to study and determine the roles of genes 
[195-197]. The DNA microarrays could contain virtually all the genes in a 
microorganism, and thus have been used to study gene expression on a very large scale.  
The pattern of genes expressed can provide information on the state of the cell, a fact 
that has shifted interest towards the study of gene sets from microarrays instead of 
individual genes, as it is a formidable task defining the role of each gene in the full 
genome of an organism; it is easier to biologically interpret a microarray experiment if 
differentially expressed genes show similarity in their functional description or occur 
together in a metabolic pathway to form gene sets.  
A gene set is a group of functionally related genes, usually identified from a priori 
biological knowledge, for example, genes that are defined by functional categories or 
that occur in a known biological pathway.  
New methods for studying gene sets have been developed, for example, [198] presents a 
method specifically designed for defining gene sets using pathways and taking into 
account the interrelationship of genes in terms of the topology of pathways. MCSs 
could similarly define gene sets but instead of genes, take into account the 
interrelationship of metabolites and reactions in the metabolic network, so would 
correspond to gene sets where each reaction is uniquely associated with a gene. A 
review of the analysis methods for gene sets can be seen in [199, 200].  
 Method and Approach 8.2
For a certain tissue at a certain metabolic state, there are sets of ‘present’ and ‘absent’ 
metabolite products. Each product contains ≥ 1 EM and MCS which are complementary 
to each other.  
The EMs are calculated in relation to compounds present in the tissue:  
• EMs: E1, E2, .., EM; different M for each product p 
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Each EM forms a route consisting of a non-reducible set of reactions that lead to the 
formation of the compound so, in effect, form a candidate expression vector for the 
compound present in the tissue. 
MCSs are calculated in relation to compounds absent from the tissue: 
• MCSs: C1, C2, .., CQ; Q = q(em); m=1,2,.., M; different Q for each em. 
Each MCS represents the minimum set of reactions that would be blocked in the tissue, 
based on the absent compound. 
 Binary matrices for EMs and MCSs 8.2.1
Consider a binary matrix to represent these EMs and MCSs: 
i) Binary matrix of EMs 
• A matrix indicating whether a reaction occurs or does not occur in EMs of 
products present in a tissue of interest:  
o a one (1) represents the presence, and  
o a zero (0) the absence, of a reaction in the corresponding EM responsible 
for the formation of p in a tissue:  
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• where N is the number of reactions in the tissue- the same for all EMs;  
• while M is the number (can differ for different products) of EMs for product p-; 
and 
• 



=
     EMiin not  is jreaction  :0
EMiin  occurs jreaction :1
 pij   
ii) Binary matrix of MCSs 
• A matrix indicating whether a reaction does or does not constitute MCSs related 
to the absence of product p from the same tissue:  
o a one (1) in a MCS row indicates that the corresponding reaction needs 
to be simultaneously blocked with other ones in that MCS row, to 
suppress p, in order for p to be absent from the tissue;   
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o a zero (0) indicates the reaction does not need to be blocked for that 
MCS to suppress the formation of product p. 
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• Where N is the number of reactions in the tissue- the same for all EMs;  
• Q is the number of MCSs for a particular EM, m, one of the EMs responsible for 
the formation (objective function) of p; and 
• 



=
    iset cut in not  is jreaction  :0
iset cut  sconstitute jreaction  :1
 q(m) ij  
For a compound to be present in a particular tissue, at least one of the EMs responsible 
for producing that compound has to be active which means that the corresponding 
reactions/genes for that/those EM(s) would be expressed in that tissue. If products A and 
B are present in a tissue, it means that at least one mode of product A and one of B must 
be active. 
For a compound to be absent, all MCSs need to be activated to block all EMs, such that 
the corresponding genes would not be expressed.  
Based on the above idea, we could use experimental results of compounds that are 
found in a particular tissue and vice versa, to identify the viable EMs and MCSs and, 
subsequently, the genes expressed in that tissue in terms of their corresponding 
reactions. 
The idea is to use both the EMs of compound products present in the tissue and the 
MCSs of compounds absent, to determine the reactions/genes for the Expression matrix 
X.  
 Compiling the Expression matrix 8.2.2
The EMs of all the compounds present in the tissue of interest can be combined to form 
a matrix of combined EMs (cEMs) which is then reduced back to binary. Each column 
of this matrix would constitute EMs guaranteed to produce all the products present in 
the tissue.  
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• Where p is a metabolite product present in the tissue; and  
• X is the product of the number of EMs for all the present products ( mi1∏ ). 
For example, let’s say there are: 
• three metabolites {A, B, C} present in a tissue; and 
• two absent metabolites {D, E}. 
Consider the three metabolite products A, B & C present in the tissue; product A has 3 
EMs, product B has 2 EMs and C has 2 EMs. A cEM that would produce all three 
metabolites could be obtained by adding together an EM from each product set (note 
that these may overlap) as illustrated in Figure 8.2-1. 
 
Figure 8.2-1: Combining EMs of three compound products 
 
The resulting number of cEMs would be 3 x 2 x 2 = 12, so there would be 12 cEMs in 
the binary matrix where each row vector represents a cEM guaranteed to produce the 
three compounds A, B & C. 
However, it is important to note that some of these cEMs would not actually be viable 
because their calculation does not take into account the “absent” compounds so some 
might actually be responsible for forming compounds that are absent in the tissue! This 
is also true for EMs responsible for a single compound. 
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In this respect, MCSs can be employed to identify viable cEMs and EMs because the 
reactions constituting a cEM or EM cannot be present in the tissue if they also constitute 
a MCS.  
 Use of MCSs to Verify Elementary Modes 8.2.3
For each “absent” compound, a MCS (refer to Chapter 3) could be determined which 
contains the minimal sets of reactions to suppress in order to prevent the production of 
that compound. The cEMs can then be verified by multiplying its transpose by the 
MCSs of each absent compound: 
V=MCS (q(m)) x EM(p)T= 
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(8.4) 
The elements of the product matrix (V) indicate the compatibility of the EMs with the 
MCSs: 
• A ‘0’ indicates that the MCS is compatible with the EM, i.e., the reactions taking 
place to produce the present compound are not the reactions being blocked to 
eliminate the absent compound. This means that the cEM is a valid Expression 
vector; 
• A ‘1’ or ‘non-zero’ (if V is not reduced to a binary matrix) in the column 
indicates that the cEM is not compatible with the MCS because the reactions 
producing the present compounds also need to be blocked to eliminate the absent 
compound. 
Whether the above process is practical will depend on how many EMs there are 
associated with each product with the total number of combinations: multiplying all the 
counts could become astronomical. This will be discussed later. 
 An Example Network 8.2.4
To clarify and check the above processes more, we will apply them to an example 
network that has 6 metabolites and 8 reactions:  
R1: A=B; R2: B=D; R3: A=C; R4: D=C; R5: D; R6: D=E; R7: A+D=F; R8: B+D=F 
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Figure 8.2-2: An example network, ExNet 
 
ExNet has 3 external products: C, E & F.  
EMs can be calculated for the three products that guarantee the production of each 
compound:  
Number of EMs calculated = 14: 
• 4 EMs for C: {R5, R4}; {R3}; {R8, R2, R4}; {R1, R2, R4} 
• 3 EMs for E: {R5, R6}; {R8, R2, R6}; {R1, R2, R6} 
• 8 EMs for F: {R5, R7}; {R1, R5, R8}; {R2, R4, R8}; {R1, R2, R8};  
{R2, R6, R8}; {R8, R2, R7}; {R1, R2, R7}; {R2, R5, R8};  
Now, say that of the 3 compound products, C & E are found in a tissue but not 
compound F. This indicates that the reactions needed to produce compounds C & E are 
taking place in the tissue so the related genes are being expressed, whilst the reactions 
for compound F are not taking place and the related genes are being suppressed. 
 Transpose of cEMs matrix for compounds C & E 8.2.4.1
The transpose of the matrix of cEMs for compounds C & E is shown in Table 8.2-1 
below. The matrix contains 12 possible combinations of EMs (cEMs) that would 
produce compounds C & E together:  
• For each column vector (cEM): 
o the reactions with a one (1) form the set of reactions in that cEM that 
would lead to the formation of both compounds C & E; 
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o A zero (0) indicates the reactions are not involved in that cEM. 
• Each column in the cEMsT is a candidate expression vector X representing an 
EM (route) containing candidate reactions that would guarantee the formation of 
both compounds C & E. 
Table 8.2-1: Transpose of matrix of cEMsT for products C & E 
 cEM1 cEM2 cEM3 cEM4 cEM5 cEM6 cEM7 cEM8 cEM9 cEM10 cEM11 cEM12 
R1 0 0 1 0 0 1 0 0 1 1 1 1 
R2 0 1 1 0 1 1 1 1 1 1 1 1 
R3 0 0 0 1 1 1 0 0 0 0 0 0 
R4 1 1 1 0 0 0 1 1 1 1 1 1 
R6 1 1 1 1 1 1 1 1 1 1 1 1 
R7 0 0 0 0 0 0 0 0 0 0 0 0 
R5 1 1 1 1 0 0 1 0 0 1 0 0 
R8 0 1 0 0 1 0 1 1 1 0 1 0 
 MCS matrix of the absent compound F 8.2.4.2
The absence of compound F indicates that at least one of its MCSs is activated, i.e., the 
reactions constituting a MCS are simultaneously blocked. Each MCS row in the MCS 
matrix as illustrated in Table 8.2-2 below, contains the minimal set of reactions that 
would need to be simultaneously blocked to eliminate the formation of compound F. 
Table 8.2-2: MCSs for compound F 
 
R1 R2 R3 R4 R5 R6 R7 R8 
MCS1 0 1 0 0 1 0 0 0 
MCS2 0 0 0 0 0 0 1 1 
MCS3 1 0 0 0 1 0 0 1 
MCS4 1 1 0 0 0 0 1 0 
MCS5 1 0 0 1 1 1 1 0 
• Each row of Table 8.2-2 above is a candidate MCS vector containing the 
minimal set of reactions that would need to be simultaneously blocked to 
eliminate the production of compound F; 
• a ‘1’ indicates the reaction is blocked.  
 Verifying combined elementary modes 8.2.4.3
Multiplying Table 8.2-2 (the MCSs in for eliminating compound F) with Table 8.2-1 
(the transposed matrix of combined EMs (cEMsT) responsible for producing C & E), 
produces a product matrix V that can be used to verify the combined modes (cEM) in 
terms of the compound F being absent in the tissue. The product matrix V 
([MCSF]*[cEMC,E]T) is shown in Table 8.2-3 below: 
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Table 8.2-3: Product matrix V indicating cEM candidates in relation to MCSs 
 
cEM1 cEM2 cEM3 cEM4 cEM5 cEM6 cEM7 cEM8 cEM9 cEM10 cEM11 cEM12 
MCS1 1 2 2 1 1 1 2 1 1 2 1 1 
MCS2 0 1 0 0 1 0 1 1 1 0 1 0 
MCS3 1 2 2 1 1 1 2 1 2 2 2 1 
MCS4 0 1 2 0 1 2 1 1 2 2 2 2 
MCS5 3 3 4 2 1 2 3 2 3 4 3 3 
The resulting values in the above product matrix V indicate the following: 
• A zero (0) indicates that the MCS is compatible with the cEM, e.g., for our 
example network it means that the reactions needed to be blocked to eliminate F 
are not needed for the formation of compound products C & E, and vice versa; 
• A one (1) or non-zero indicates that the cEM clashes with the MCS so the cEM 
is not viable. 
In this respect, the product matrix V is also the verification matrix and can be interpreted 
to indicate which cEMs are valid in terms of forming compounds C & E without 
forming compound F.  
A column vector (cEM) containing at least one 0 element in the product matrix V in 
Table 8.2-3, represents a viable cEM because there is a MCS for blocking compound F, 
that does not clash with this particular cEM for forming compounds C & E. 
So, for our example network ExNet, the viable expression vectors or cEMs are those 
containing zeroes in Table 8.2-3 above: 
• cEM1, cEM3, cEM4, cEM6, cEM10 & cEM12 in relation to MCS2 for which 
R7 & R8 are blocked;  
• cEMs 1 & 4 in relation to MCS4 for which R1, 2, 7 are blocked. 
The non-viable cEMs are cEM2, cEM5, cEM6, cEM8, cEM9, cEM11 so these can be 
deleted.  
The resulting expression matrix X would then be as shown in Table 8.2-4 below: 
Table 8.2-4: The resulting expression matrix X 
 cEM1 cEM3 cEM4 cEM7 cEM10 cEM12 
R1 0 1 0 0 1 1 
R2 0 1 0 1 1 1 
R3 0 0 1 0 0 0 
R4 1 1 0 1 1 1 
R5 1 1 1 1 1 0 
R6 1 1 1 1 1 1 
R7 0 0 0 0 0 0 
R8 0 0 0 1 0 0 
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 Combinatorial explosion 8.3
As mentioned before, the practicality of the process will depend on the number of EMs 
because, as illustrated in Figure 8.2-1, combining the EMs involves a multiplication 
factor which can lead to a combinatorial explosion, especially in a complex network 
where there are lots of compounds present in the tissue, each having multiple EMs that 
require a huge number of manipulations to calculate the cEMs. 
 Separately verify EMs for single compounds 8.3.1
This combinatorial explosion problem could be addressed by minimizing the number of 
EMs before they are combined to produce the matrix of combined EMs.  
The MCSs for the absent compounds could be used to verify the EMs for individual 
products and get rid of those EMs that are not compatible with the MCSs such that only 
the valid EMs are actually combined to determine the cEMs for forming the compounds 
present in the tissue. 
For example, for our example network ExNet, we would multiply the MCSs for 
compound F with the transpose of EMs for compound C separately and do the same 
with the EMs for compound E.  
Table 8.3-1: Binary matrix of EMs for compound C;   
R1 R2 R3 R4 R5 R6 R7 R8 
EM1 0 0 0 1 1 0 0 0 
EM2 0 0 1 0 0 0 0 0 
EM3 0 1 0 1 0 0 0 1 
EM4 1 1 0 1 0 0 0 0 
 
Table 8.3-2: Product matrix of [MCSF]*[EMsCT] 
 
EM1 EM2 EM3 EM4 
MCS1 1 0 1 1 
MCS2 0 0 1 0 
MCS3 1 0 1 1 
MCS4 0 0 1 2 
MCS5 2 0 1 2 
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Table 8.3-3: Binary matrix of EMs for compound E  
 
R1 R2 R3 R4 R5 R6 R7 R8 
EM1 0 0 0 0 1 1 0 0 
EM2 0 1 0 0 0 1 0 1 
EM3 1 1 0 0 0 1 0 0 
 
Table 8.3-4: Product matrix of [MCSF]*[EMsET] 
EM1 EM2 EM3 
MCS1 1 1 1 
MCS2 0 1 0 
MCS3 1 1 1 
MCS4 0 1 2 
MCS5 2 1 2 
The EMs incompatible with the MCSs for compound F (the greyed out column vectors 
EM3 for compound C and EM2 for compound E) are then eliminated and only the valid 
EMs combined. 
     Table 8.3-5: i) Valid EMs for compound C;        ii) Valid EMs for compound E 
EM1 EM2 EM4 EM1 EM3 
R1 0 0 1 0 1 
R2 0 0 1 0 1 
R3 0 1 0 
 
0 0 
R4 1 0 1 
 
0 0 
R5 1 0 0 
 
1 0 
R6 0 0 0 
 
1 1 
R7 0 0 0 
 
0 0 
R8 0 0 0 0 0 
Resulting Expression matrix X from combining the valid EMs from Table 8.3 and Table 
8.4 above. 
Table 8.3-6: Expression matrix X indicating cEM candidates in relation to MCSs 
 
cEM1 cEM2 cEM3 cEM4 cEM5 cEM6 
R1 0 1 0 1 1 2 
R2 0 1 0 1 1 2 
R3 0 0 1 1 0 0 
R4 1 1 0 0 1 1 
R5 2 1 1 0 1 0 
R6 1 1 1 1 1 1 
R7 0 0 0 0 0 0 
R8 0 0 0 0 0 0 
 
The above process decreases the number of cEMs that would have resulted from 
combining the initial EMs from 12 to 6. 
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 Eliminate duplicates and inactive reactions 8.3.2
An additional way of addressing the combinatorial explosion problem that would lead 
to an astronomical number of cEMs, is to only keep one copy of the same duplicates 
and get rid of the rest. For example, even our small example network, ExNet, contains 
two duplicate EMs:  
• From our first method, the product matrix V as shown in Table 8.2-3, can be 
used to identify the duplicate cEMs which are cEM3 & cEM10, as is also shown 
in the resulting Expression matrix X in Table 8.2-4 so one of the duplicates can 
be deleted; 
• The equivalent Expression matrix X resulting from our 2nd method as shown in 
above shows the duplicate cEMs as cEM2 and cEM5 so one of them can be 
deleted.  
This elimination further decreases the number of cEMs for ExNet from 6 to 5. 
Inactive reactions can also be deleted from the expression matrix and these are those 
reactions that have all zeroes e.g., as seen in Table 8.3-6 reactions R7 & R8 have zeroes 
for all cEMs which indicates they are not active in the tissue, so can be deleted from the 
Expression matrix X. 
The final binary matrix outcome from our ExNet would be: 
Table 8.3-7: Final valid expression matrix for ExNet 
  
cEM1 cEM2 cEM3 cEM4 cEM5 
R1 0 1 0 1 1 
R2 0 1 0 1 1 
R3 0 0 1 1 0 
R4 1 1 0 0 1 
R5 1 1 1 0 0 
R6 1 1 1 1 1 
 The Algorithm 8.4
The algorithm programmes are developed in MatLab (Section 1.9). 
The CellNetAnalyzer (CNA) program (Section 1.9) is used to calculate EMs and MCSs 
from the corresponding metabolic network, which constitute input for the program.  
Please refer to Attachment A for details of the programmes corresponding to the 
algorithm described below: 
116 
 
 Compile the products vector for the tissue of interest 8.4.1
• A product binary vector P for the tissue of interest, indicating whether the 
compounds are present or absent, can be constructed from literature and 
experimental evidence:  
o “1” - represents the presence of a compound; and 
o “0” - represents the absence of a compound in the tissue.  
• Compile the products table of the cellular system/tissue under scrutiny using 
experimental results to state whether a compound is present (1) or absent (0). The 
result would be related to the completeness of the information; the more complete 
the information, the better the final outcome.  
  Collect EM reactions for each product in P 8.4.2
• Program 1: collect_EMrxns.m 
• Program 3: EM_MCS_initPop.m 
• Based on the products vector, calculate the EMs for each compound in the 
products vector P and represent them in a standard binary matrix (refer to 8.2.1) 
that contains all reactions present in the network.  
  Collect MCS reactions for products absent in tissue 8.4.3
• Program 2: collect_MCSrxns.m 
• Program 3: EM_MCS_initPop.m 
• Based on the products vector, determine the MCSs of all compounds absent in 
the tissue. Compile them into the same standard binary matrix form as the EMs- to 
contain all reactions in the network (refer to 8.2.1). 
 Validate the candidate EMs 8.4.4
• Program 4: validate_EMs.m 
Validate candidate EMs for the Expression matrix, X, and at the same time avoid 
problems with combinatorial explosion by doing the following: 
• Take each of the EMs of each compound present in the tissue, and test it 
against the MCSs of each of the compounds absent from the tissue, by 
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multiplying the MCS matrix with the transpose of the EMs matrix 
(MCS*EMsT): 
o A zero (0) indicates that the MCS is compatible with the EM and the 
reactions taking place to produce the present compound are not the 
reactions being blocked to eliminate the absent compound. This means 
that the EM constitutes a valid Expression vector; 
o A one (1) in the column indicates that the EM is not compatible with the 
MCS because the reactions producing the ‘existing’ compounds also 
need to be blocked to eliminate the ‘absent’ compound. 
  Determine the Expression Matrix 8.4.5
Program 5: set_initPop.m 
Compile the Expression matrix X from valid EMs of compounds present in the 
tissue by adding the EMs that have been validated against the MCSs of compounds 
absent in the tissue (output from validate_EMs.m): these sets of combined EM 
(cEM) reactions would guarantee a production of the compounds present in the 
tissue without producing the compounds absent in the tissue. 
 Check for duplicate EMs and eliminate non-active 8.4.6
reactions 
Program 5: set_initPop.m 
Check the EMs in the cEM matrix for duplicates. Sort the resulting Expression 
matrix X and delete those reactions that are not active in the tissue (where a row 
contains all zeroes (0)). 
 Analyse the expression matrix 8.4.7
Program 6: Expression analysis.m 
The resulting cEMs in the product matrix V are the verified EMs containing 
reactions (and thus the genes being expressed) that guarantee the formation of the 
compounds present in the tissue without the absent compounds being produced. 
It is inevitable that the set of eligible cEMs in complex networks would be large so 
the analysis of the expression matrix results would be more geared towards looking 
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at patterns in the matrix and relating it to gene sets rather than individual genes. 
Cluster analysis is used for this. 
 Application of Algorithm to a “Real” Example 8.5
The algorithm was applied to floral pigmentation in Arabidopsis using the flavonoid 
subnetwork reconstructed for earlier studies and information from experimental work on 
identifying flavonoids produced by Arabidopsis thaliana wild-type and flavonoid 
biosynthetic mutant lines [201].  
 Method 8.5.1
Information from [201] is used in conjunction with our flavonoid subnetwork, FlavNet, 
to compile a product binary vector for an Arabidopsis flower, specifying which 
flavonoids are present and which are not. 
It is important to note that the compounds found present in the Arabidopsis flower from 
the results of [201], are, in effect, cast in stone and definite. However, compounds that 
are absent are not quite definite because it might be that they were just not tested for 
and/or reported on, and by applying the algorithm, we are assuming that the compounds 
are definitely absent. This case would also apply to any tissue and any other 
experimental results that are used, unless the experiment specifically sets out to check 
that compounds are actually absent from the tissue. 
The CellNetAnalyzer (CNA) program [64] is used to calculate the corresponding EMs 
needed to produce the compounds present in the flower product vector and the MCSs 
for compounds absent from the product vector. 
The CNA EMs and MCSs outputs are reformatted and, along with the product vector, 
form the inputs entered into the algorithm to determine the Expression vector X 
containing a set of valid EMs for producing all the compounds present in the tissue.  
 Results and Discussions 8.5.2
The product vector compiled for an Arabidopsis flower using FlavNet and information 
from [201] is shown in the table below: 
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Table 8.5-1: Product vector for Arabidopsis flower 
A one (1) represents the presence, and a zero (0) the absence of the compound in the flower. 
 
flower 
CPD1F-462 1 
CPDQT-26 1 
CPD-5521 1 
CPD-8011 0 
CPD-8012 1 
COUMARYL-ALCOHOL 0 
CPD-1777 0 
CPD-63 0 
PELARGONIDIN-3-GLUCOSIDE-CMPD 1 
CPD1F-766 1 
 The Expression matrix X 8.5.2.1
Applying the first 6 steps of the algorithm Section 8.4 produces the matrix X containing 
eligible EMs (columns) with their corresponding reactions (rows) as shown in Figure 
8.5-1 below.  
As predicted in Section 8.4.5, applying the algorithm to the flavonoid subnetwork 
produces an Expression matrix X containing a large number of eligible EMs such that it 
is not easy to define the role of each gene and is better to analyse X in terms of patterns 
in the matrix that could be used to determine different gene sets.  
 
Figure 8.5-1: Matrix X containing eligible EMs (columns) and their reactions (rows).  
The yellow coloured cells represent reactions constituting the EMs while 
 green indicates the reaction does not constitute the EM. 
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 There are 378 eligible EMs and 165 reactions in the Expression matrix X. The reactions 
are not included in the above tables but are kept track of during the manipulation and 
analysis of matrix X. 
 Analysing the Expression Matrix X.  8.5.2.2
To prepare for analysis, matrix X is cleaned up of reactions that are not needed. The 
eligible EMs, collectively, don’t use a lot of the reactions (yellow cells), as shown in 
Figure 8.5-2 i) below, when the matrix is sorted in the order of the total reactions 
involved in an EM. The green part corresponds to reactions not participating in any 
EMs so they can be taken out of the matrix, leaving a matrix containing only those 
reactions that constitute an eligible EM, as shown in Figure 8.5-2 ii) below. 
 
Figure 8.5-2: Cleaning Matrix X for analysis 
    i) Sorting by total reactions (rows) in EMs;        ii) without reactions involved in no EM 
The matrix shown in Figure 8.5-2 i) shows matrix X sorted in increasing order of the 
total number of EMs a reaction is involved; matrix ii) shows that 48 reactions occur in 
at least one EM, of which 20 are ubiquitous reactions occurring in all of the eligible 
EMs (plain yellow part) for the flower tissue. This means that, based on the information 
used, these 20 reactions are vital for metabolism in the Arabidopsis flower as they are 
required for all the viable EMs. These core reactions are shown in Table 8.5-2 below. 
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Table 8.5-2: The 20 ubiquitous reactions occurring in all of the eligible EMs  
for the flower tissue (plain yellow part of Figure 8.5-2 ii)) 
1 RXN1F-474 CPD1F-90 + DTDP-RHAMNOSE ==> CPD1F-461 + 
PROTON + TDP 
2 RXN1F-475 CPD1F-461 + DTDP-RHAMNOSE ==> CPD1F-462 
+ TDP 
3 RXN1F-93 DIHYDROKAEMPFEROL-CMPD + OXYGEN-
MOLECULE + 2-KETOGLUTARATE ==> CPD1F-
90 + CARBON-DIOXIDE + WATER + SUC 
4 4-COUMARATE--COA-
LIGASE-RXN 
4-COUMARATE + ATP + CO-A ==> COUMARYL-
COA + PPI + AMP 
5 NARINGENIN-3-
DIOXYGENASE-RXN 
NARINGENIN-CMPD + OXYGEN-MOLECULE + 
2-KETOGLUTARATE ==> 
DIHYDROKAEMPFEROL-CMPD + CARBON-
DIOXIDE + SUC 
6 LEUCPEL-RXN LEUCOPELARGONIDIN-CMPD + OXYGEN-
MOLECULE + 2-KETOGLUTARATE ==> 
PELARGONIDIN-CMPD + CARBON-DIOXIDE + 2 
WATER + SUC 
7 DIHYDROKAEMPFEROL-4-
REDUCTASE-RXN 
DIHYDROKAEMPFEROL-CMPD + NADPH ==> 
LEUCOPELARGONIDIN-CMPD + NADP 
8 RXN-527 CPD-474 + OXYGEN-MOLECULE + 2-
KETOGLUTARATE ==> CPD-520 + CARBON-
DIOXIDE + WATER + SUC 
9 RXNQT-4161 CPD1F-437 + UDP-L-RHAMNOSE ==> CPD-5521 
+ UDP 
10 RXNQT-4162 CPD-8013 + UDP-L-RHAMNOSE ==> CPDQT-26 + 
UDP 
11 APIGNAR-RXN APIGENIN ==> NARINGENIN-CMPD + PROTON 
12 RXN-600 CPD-474 + NADPH ==> CPD-590 + NADP 
13 TRANS-CINNAMATE-4-
MONOOXYGENASE-RXN 
CPD-674 + OXYGEN-MOLECULE + NADPH ==> 
4-COUMARATE + NADP + WATER 
14 RXN-602 CPD-590 + OXYGEN-MOLECULE + 2-
KETOGLUTARATE ==> CPD-591 + CARBON-
DIOXIDE + 2 WATER + SUC 
15 RXN-8266 CPD1F-461 + UDP-GLUCOSE ==> CPD-8012 + 
UDP 
16 RXN-8267 UDP-L-RHAMNOSE + CPD-520 ==> CPD-8013 + 
UDP 
17 PELUDP-RXN PELARGONIDIN-CMPD + UDP-GLUCOSE ==> 
PELARGONIDIN-3-GLUCOSIDE-CMPD + UDP 
18 RXN1F-775 CPD-591 + UDP-GLUCOSE ==> UDP + CPD1F-766 
19 RXN1F-462 CPD-520 + UDP-GLUCOSE ==> CPD1F-437 + UDP 
20 NARINGENIN-CHALCONE-
SYNTHASE-RXN 
COUMARYL-COA + 3 MALONYL-COA ==> 
APIGENIN + 4 CO-A + 3 CARBON-DIOXIDE 
The above 20 reactions form the core reactions occurring in all viable EMs of the 
Arabidopsis flower tissue. Looking at their position in the network, the reactions 
originate from the external trans-cinnamate substrate (refer to Figure 4.4-1) and lead to 
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the formation of kaempferol and quercetin compounds and their derivatives as well as 
anthocyanin compounds although not the anthocyanin derivatives. 
If the yellow part containing the 20 reactions in the above Table 8.5-2 is taken out, the 
remaining matrix is as shown in Figure 8.5-3 below.  
 
Figure 8.5-3: Reactions (y-axis) by viable EMs (x-axis) matrix  
Yellow indicates reaction involved in EM, green indicates reaction not involved in EM. 
The above figure is the resulting matrix containing the reactions on the vertical axis and 
the viable EMs on the horizontal axis.  A yellow area indicates a reaction is involved in 
the corresponding viable EM while a green one means the reaction is not involved in the 
corresponding EM. The 28 reactions illustrated in the matrix are shown in Table 8.5-3. 
These 28 reactions occur in some EMs but not others and the different patterns this 
creates in the matrix could be analysed for any relationship it could have to gene sets or 
information about the corresponding reactions and their related genes as well as the 
EMs and whether different patterns in the EMs could be related to certain functions or 
the state of the cell.  
For example, grouping the reactions in Table 8.5-3 according to the different patterns in 
Figure 8.5-3, discernible by eye, is provided in Table 8.5-4. 
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Table 8.5-3: The reactions corresponding to the matrix in Figure 8.5-3. 
1 RXN-8169 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7138 
2 RXN-8170 COUMARYL-COA + CPD-7138 ==> CO-A + CPD-7714 
3 RXN-8204 COUMARYL-COA + CPD1F-766 ==> CO-A + CPD-7866 
4 RXN-8205 UDP-GLUCOSE + CPD-7866 ==> UDP + CPD-7714 
5 RXN-8176 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7842 
6 RXN-7828 UDP-GLUCOSE + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> UDP + CPD-7137 
7 RXN-7834 MALONYL-COA + PROTON + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> CO-A + CPD-7149 
8 RXN-8089 CINNAMALDEHYDE + OXYGEN-MOLECULE + WATER ==> CPD-674 + HYDROGEN-PEROXIDE 
9 3-DEHYDROQUINATE- DEHYDROQUINATE ==> 3-DEHYDRO-SHIKIMATE + WATER 
10 SHIKIMATE-KINASE-RXN SHIKIMATE + ATP ==> SHIKIMATE-5P + ADP 
11 3-DEHYDROQUINATE- 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P ==> DEHYDROQUINATE + Pi 
12 CINNAMYL-ALCOHOL- NADP + CINNAMYL-ALC ==> CINNAMALDEHYDE + NADPH 
13 PREPHENATE-TRANSAMINE-RXN PREPHENATE + GLT ==> CPD-659 + 2-KETOGLUTARATE 
14 PHEAMINOTRANS-RXN GLT + PHENYL-PYRUVATE ==> PHE + 2-KETOGLUTARATE 
15 2.5.1.19-RXN SHIKIMATE-5P + PHOSPHO-ENOL-PYRUVATE ==> 3-ENOLPYRUVYL-SHIKIMATE-5P + Pi 
16 SHIKIMATE-5-DEHYDROGENASE- 3-DEHYDRO-SHIKIMATE + NADPH ==> SHIKIMATE + NADP 
17 CHORISMATEMUT-RXN CHORISMATE ==> PREPHENATE 
18 CHORISMATE-SYNTHASE-RXN 3-ENOLPYRUVYL-SHIKIMATE-5P ==> Pi + CHORISMATE 
19 CARBOXYCYCLOHEXADIENYL- CPD-659 ==> PHE + CARBON-DIOXIDE + WATER 
20 DAHPSYN-RXN ERYTHROSE-4P + WATER + PHOSPHO-ENOL-PYRUVATE ==> 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P + Pi 
21 RXN-5481 CPD-663 + NADPH ==> UDP-L-RHAMNOSE + NADP 
22 RXN-5482 NADPH + UDP-GLUCOSE ==> UDP-L-RHAMNOSE + NADP + WATER 
23 RXN-525 DIHYDROKAEMPFEROL-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-474 + NADP + WATER 
24 RXN-7652 NARINGENIN-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-6994 + NADP + WATER 
25 RXN-7775 CPD-6994 + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> CPD-474 + CARBON-DIOXIDE + SUC 
26 UDP-GLUCOSE-4,6- UDP-GLUCOSE ==> CPD-663 + WATER 
27 RXN-8171 MALONYL-COA + CPD-7714 ==> CO-A + CPD-7708 
28 PHENYLALANINE-AMMONIA- PHE ==> CPD-674 + PROTON + AMMONIA 
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Table 8.5-4: Grouped reactions according to patterns in matrix in Figure 8.5-3 
1 RXN-8169 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7138 
2 RXN-8170 COUMARYL-COA + CPD-7138 ==> CO-A + CPD-7714 
3 RXN-8204 COUMARYL-COA + CPD1F-766 ==> CO-A + CPD-7866 
4 RXN-8205 UDP-GLUCOSE + CPD-7866 ==> UDP + CPD-7714 
5 RXN-8176 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7842 
27 RXN-8171 MALONYL-COA + CPD-7714 ==> CO-A + CPD-7708 
6 RXN-7828 UDP-GLUCOSE + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> UDP + CPD-7137 
7 RXN-7834 MALONYL-COA + PROTON + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> CO-A + CPD-7149 
8 RXN-8089 CINNAMALDEHYDE + OXYGEN-MOLECULE + WATER ==> CPD-674 + HYDROGEN-PEROXIDE 
12 CINNAMYL-ALCOHOL-DEHYDROGENASE-RXN NADP + CINNAMYL-ALC ==> CINNAMALDEHYDE + NADPH 
9 3-DEHYDROQUINATE-DEHYDRATASE-RXN DEHYDROQUINATE ==> 3-DEHYDRO-SHIKIMATE + WATER 
10 SHIKIMATE-KINASE-RXN SHIKIMATE + ATP ==> SHIKIMATE-5P + ADP 
11 3-DEHYDROQUINATE-SYNTHASE-RXN 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P ==> DEHYDROQUINATE + Pi 
13 PREPHENATE-TRANSAMINE-RXN PREPHENATE + GLT ==> CPD-659 + 2-KETOGLUTARATE 
14 PHEAMINOTRANS-RXN GLT + PHENYL-PYRUVATE ==> PHE + 2-KETOGLUTARATE 
15 2.5.1.19-RXN SHIKIMATE-5P + PHOSPHO-ENOL-PYRUVATE ==> 3-ENOLPYRUVYL-SHIKIMATE-5P + Pi 
16 SHIKIMATE-5-DEHYDROGENASE-RXN 3-DEHYDRO-SHIKIMATE + NADPH ==> SHIKIMATE + NADP 
17 CHORISMATEMUT-RXN CHORISMATE ==> PREPHENATE 
18 CHORISMATE-SYNTHASE-RXN 3-ENOLPYRUVYL-SHIKIMATE-5P ==> Pi + CHORISMATE 
19 CARBOXYCYCLOHEXADIENYL-DEHYDRATASE-RXN CPD-659 ==> PHE + CARBON-DIOXIDE + WATER 
20 DAHPSYN-RXN ERYTHROSE-4P + WATER + PHOSPHO-ENOL-PYRUVATE ==> 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P + Pi 
21 RXN-5481 CPD-663 + NADPH ==> UDP-L-RHAMNOSE + NADP 
22 RXN-5482 NADPH + UDP-GLUCOSE ==> UDP-L-RHAMNOSE + NADP + WATER 
26 UDP-GLUCOSE-4,6-DEHYDRATASE-RXN UDP-GLUCOSE ==> CPD-663 + WATER 
23 RXN-525 DIHYDROKAEMPFEROL-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-474 + NADP + WATER 
24 RXN-7652 NARINGENIN-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-6994 + NADP + WATER 
25 RXN-7775 CPD-6994 + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> CPD-474 + CARBON-DIOXIDE + SUC 
28 PHENYLALANINE-AMMONIA-LYASE-RXN PHE ==> CPD-674 + PROTON + AMMONIA 
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 Analysis of grouped reactions 8.5.2.3
Table 8.5-5: Reaction groups and related functions 
Group Reactions Function/Relationship 
1 [1, 2, 3, 4, 5, 27] Reactions related to the anthocyanin cyanidin-3-0-
glucoside and its derivatives 
2 [6, 7] Reactions connecting the anthocyanin pelargonidin-3-
glucoside to its 2 derivatives  
3 [8, 12] Reactions linking the external substrate cinnamyl-alc 
to trans-cinnamate 
4 [9, 10, 11, 13, 14, 15, 
16, 17, 18, 19, 20] 
The 11 reactions that lead from the 2 external 
substrates erythrose-4P and phenyl-pyruvate to L-
phenylalanine (PHE) 
5 [21, 22, 26] Reactions from UDP-glucose to UDP-L-rhamnose 
6 [23, 24, 25] Reactions connecting Dihydrokaempferol and 
Naringenin to the production of dihydroquercetin. 
7 [28] The Phenylalanine-ammonia-lyase-rxn linking PHE 
from Group 4 to trans-cinnamate. 
The above is a simple grouping of the reactions according to the different patterns that 
can be seen in Figure 8.5-3: the results show that reactions sharing the same pattern 
actually share a related function and so their corresponding genes would form gene sets 
related to a certain function e.g., those corresponding to Group 1 would form the set of 
genes related to the formation of derivatives of the anthocyanin cyanidin-3-0-glucoside.  
Some reactions do not quite fit into their group (in relation to Figure 8.5-3), either 
because their patterns are a bit different or they are not involved in a relatively similar 
number of EMs, e.g., Reaction 27 from Group 1 and Reaction 28 from Group 7 which 
would fit in with Group 4. These reactions and their corresponding genes could be 
studied further to see if they are actually different in some way. 
 Analysis of grouped EMs 8.5.2.4
Looking at vertical patterns in Figure 8.5-3 related to EMs, there are four obvious 
patterns which could be used to group the EMs: 
Group 1: [EM1 – EM54], Group 2: [EM55 – EM162], Group 3: [EM163 - EM270] and 
Group 4:[EM271 – EM378] 
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The most obvious difference in these groups is in whether the reactions leading from 
Erythrose-4P to L-Phenylalanine are used (Grp 2 & 4) or not (Grp 1 & 3) but the four 
groups of EMs could be analysed in detail, e.g., to see which reactions are involved and 
what products they form, to determine if there is a relationship between them, such as 
what kind of metabolite products are being synthesised and through which EMs? This 
could provide an idea of the state of the Arabidopsis flower and the biological processes 
in the tissue. This would involve extensive analysis of the 378 EMs which was not 
possible in this thesis due to time constraint but it could form a basis for future work, 
The above exercises are simple examples of analysing the matrix patterns but the next 
step is to make use of tools, such as clustering methods, that could further analyse the 
Expression matrix in detail and elucidate gene sets and related biological processes in 
the tissue. 
 Conclusion 8.5.3
The above exercise shows that the developed algorithm and program work to determine 
an Expression matrix containing reactions expressed in the tissue, from experimental 
information about compounds that are present.  
The 20 core reactions that occur in all the viable EMs of the Arabidopsis flower tissue 
originate from the trans-cinnamate compound (refer to Figure 4.4-1) and lead to the 
formation of kaempferol and quercetin compounds and their derivatives as well as 
anthocyanin compounds although not the anthocyanin derivatives.  
Analyses of the matrix patterns show that these correspond to reaction sets related to 
certain functions such as the formation of derivatives of the two anthocyanin 
compounds present, as well as the reactions leading from the network’s external 
substrate erythrose-4P to L-Phenylalanine, cinnamyl-alc to trans-cinnamate (Figure 
4.4-1) and so on. The results provide credibility to the program being able to determine 
reaction sets, from which their corresponding gene sets can be established. 
The results have provided useful information about the Arabidopsis flower despite 
being preliminary in the sense that the information used is not guaranteed because: 
• The information about which compounds were present and which were not, 
could be incomplete: there might be other compounds present that were just not 
tested for, so were not included; 
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•  The fact that a compound did not appear in the results of the experiment could 
have been just because the study was concentrating on other compounds; 
• The information used was from experimental work that did not specifically look 
at compounds that were present and absent in the Arabidopsis flower.  
The idea would work best in collaboration with experimental scientists to specifically 
look at compounds present and absent in a tissue of interest. This idea needs to be 
further developed in subsequent work. 
The method would be appropriate to use for multiple solutions but not if there are no 
EMs for a certain present compound that proves compatible with the MCSs for an 
absent one, in other words, a situation where all the different routes that guarantee the 
formation of a present compound end up producing an absent compound. In this case it 
would be necessary to retreat to the possibility that there is missing information 
somewhere and an absent compound might actually be present. In this case, the genetic 
algorithm could be used to get an optimal solution and identify the best compound that 
could actually be present in the tissue. 
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: Conclusions and future Chapter 9
prospects.   
 Conclusions 9.1
The research has been successful in employing mathematical and in silico methods to 
gain a better understanding of the metabolism of plants using  genome scale metabolic 
data of the model plant Arabidopsis. This success emanates from three levels of work 
that contribute to the body of knowledge of systems biology as well as to plant 
physiology:  
• The first level involves studying an existing method- the concept of minimal cut 
sets (MCSs). A review (Chapter 3) of this fairly new concept is undertaken and 
contributes the first published review on MCSs in the special ‘Metabolism and Systems 
Biology’ issue of the Metabolites journal [66]. This review improves the knowledge and 
understanding of the MCS concept and its relation to other similar ideas. 
• The second level of work involves applying the MCS concept, together with 
other metabolic pathway analysis (MPA) methods (Section 2.4), to an applicable 
network, which means first addressing the problem posed by the complexity of the 
Arabidopsis network. This is done by extracting a self-contained flavonoid subnetwork 
(Chapter 4) which is representative of the full Arabidopsis network and to which 
holistic constraints-based methods (Section 1.5) can be applied to elucidate the 
functionality of a flavonoid compound in relation to other flavonoids and other 
biological processes in the plant cell. The specific study is in relation to loss of colour 
pigmentation and thus focusses on anthocyanins, but the same study can be applied to 
other flavonoid compounds. MCSs and other MPA methods are used to identify 
correlated gene targets for the loss of colour pigmentation in plants (Chapter 6) and the 
essentiality of the ABP genes. The results correlate with, and provide quantified support 
to, certain experimental results (Sections 6.6). 
Experimental information from the literature is used throughout the research, especially 
in establishing a realistic reference state (Chapter 7) for the use of FBA to simulate 
fluxes through individual reactions for certain anthocyanin MCSs of interest. The 
enzyme fluxes are analysed and compared to gain in-depth understanding, and make 
predictions of, the functional capacity of the anthocyanin-related genes and their 
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interplay with other flavonoids and related compounds. The predictions are compared 
with available experimental literature and correspond with certain experimental results 
(Section 7.4).  
The results from this second level of work provide validation and credence to the model 
for use in studying other flavonoid compounds and other less understood pathways. All 
these studies were compiled together into an article which is published in the BMC 
Bioinformatics journal [68]. 
• The third and last level of work develops a new method (Chapter 8). This part of 
the research brings experimental observations and genome-scale metabolic data 
together, by developing an algorithm and writing a program that uses MCSs and EMs to 
determine reactions taking place in a tissue using knowledge from experimental 
observations. These reactions can be used to identify the corresponding genes expressed 
in the tissue.  
The algorithm and program worked both on an example network and on the flavonoid 
network to which the program was applied to determine reactions taking place in the 
Arabidopsis flower using results from experimental observation (Section 8.5). The 
resulting reaction/gene expression matrix provided information on reactions that were 
critical to the flower as well as reaction sets which would represent gene sets. It was 
also possible to use the matrix to study EM sets which could provide information on the 
state of the tissue and the related biological processes. Despite limited information from 
the experimental results, the program is able to produce results that made sense in 
relation to the flower. The program needs further development to incorporate analytical 
clustering methods and a user-friendly interface. 
 Future Prospects 9.2
 Gene expression from observed compounds 9.2.1
Continue to develop the idea and algorithm presented in Chapter 8. This would involve: 
• working with experimental scientists to carry out a specific study that identifies 
which compounds are present or absent in a certain tissue of interest. The 
results could then be used with the algorithm to produce a reliable gene 
expression matrix; 
• incorporating clustering methods to analyse patterns in the resulting matrix; 
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• Developing a user- interface for the program so it can be more easily used. 
 Metabolic network analysis: applied to 9.2.2
proanthocyanidins 
The proanthocyanidins (PAs) are present in many plants and important for their role in 
plant defence against diseases and seed dormancy. Increasing their constituent in 
important forage crops like alfalfa could protect ruminants against pasture bloat, reduce 
greenhouse gas, and increase plant disease resistance. PAs are also present in many 
fruits and plant products like wine, fruit juices, and teas and contribute to their taste and 
health benefits. They act as potential dietary antioxidants with beneficial effects for 
human health, including protection against free radical-mediated injury and 
cardiovascular disease. There is also considerable interest in the PAs found in grapes 
because of their importance for the taste and astringency of red and white wine.  
The biosynthesis of PAs shares common steps with anthocyanins, and flavonols so the 
flavonoids subnetwork can be used to study and investigate the metabolism of 
proanthocyanidins. 
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Appendix A: Computer programmes for 
Chapter 8 
Program 1: collect_EMrxns.m 
%Script file: collect_EMrxns.m 
% 
%This script does two things: 
%1) It takes the EM for each compound in the products table and 
represents  
    %them in a standard format that contains all reactions present in  
    %the network. 
%2) It stores the formatted EMs in the EMs cell of a structure called 
Mode. 
    %Because of the way that the EMs are represented from CNA, the EMs 
are  
    %saved as Excel files for input into the collectEMrxns.m  program   
% 
%% Import the reactions matrix for the network 
% 
clear; clc; 
importfile('reactions.xlsx'); 
reactions = strtrim(reactions(1,:));  
totRxns = size(reactions,2); % the number of columns in reactions 
save ('reactions', 'reactions'); %save the reactions file 
  
%% Import the products matrix; 
prods_file = input('Enter the products file: ', 's'); 
if isempty(prods_file) 
    prods_file = 'flower_P'; 
end 
% 
Product = importdata( [prods_file '.xlsx']); 
comPresence = Product.data.Sheet1; % 1 if the compound is present and 
0 if not 
compNames = Product.textdata.Sheet1; % stores the compound names in 
compNames 
tissue1_P = (single(comPresence))'; % stores the products file data as 
single...  
save('tissue1_P','tissue1_P'); %although the file is not needed in 
this process) 
numComps = length(compNames)-1; 
compounds = cell(1, numComps); 
clear Product 
for x = 1:numComps; 
    index = x+1; 
    compounds{1,x} = compNames{index}; 
end 
clear compNames x index 
% 
%% Import EM files 
% This code imports the EMs for each of the compounds in the  
% products matrix flower_P 
% 
Mode = struct('name', {}, 'EMrxns', {}, 'EMs', {}); %creates an empty 
structure with fields field1, field2, ... 
for y = 1:numComps % 
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    %compounds = [compounds{y}] 
    temp = importdata([compounds{y} '.xlsx'],' ');%import EMs for 
compound y 
    EMrxns = temp.textdata; 
    EMnums = size(EMrxns,1);% number (rows) of EMs for product y 
    % 
    % gets rid of the empty columns between the rxns 
    numRxns = size(EMrxns,2); 
    x = 1:2:numRxns; 
    EMrxns(:,x) = []; 
    % 
    Mode(y).name = compounds{y}; %store name of compound in Mode 
structure 
    Mode(y).EMrxns = strtrim(EMrxns);%cleans/stores the reaction data 
for the EMs 
    % 
    clear x; 
    % 
    %%  Setting up the EM matrix for compound y 
    % Since the number of rxns EMwidth is different for each EM, 
    %we need to take each EM separately and compare with the reactions 
    % to set up the EM matrix to contain all reactions 
    %This code writes the EM matrix in a form that 
    %includes all the reactions in the network 
    %Each EM (row) has a unique number of reactions (width) 
    %so we need to deal with each row individually 
    % 
    EMs = zeros(EMnums,totRxns); 
    %EMs = cell(EMnums,totRxns); % Preallocates cell arrays for all 
reactions 
    yes = 1; %'Yes' counter 
    no = 1; %'No'counter 
    % 
    %the following is performed on each EM (row) 
    for EM = 1: EMnums %goes through each EM (row)individually 
        EMwidth = size(EMrxns(EM,:),2); % number of reactions 
(columns) in first EM 
        % 
        EMcol = 1; 
        Rcol = 1; 
         
        %Mrxn = EMrxns{EM,EMcol}; 
        %Rrxn = reactions{1,Rcol}; 
        while EMcol <= EMwidth && Rcol <= totRxns 
            %Rcol = Rcol + 1; 
            Rrxn = reactions{1,Rcol}; 
            Mrxn = EMrxns{EM,EMcol}; 
            if isempty(Mrxn) 
                %EMcol = EMwidth + 1; 
                break; 
            elseif(strcmpi(Rrxn,Mrxn) == 1); %if the reactions (EM & 
rxn) are same              
                yes = yes+1; 
                EMs(EM,Rcol) = 1; %the corresponding EM value is set 
to 1 
                 
                EMcol = EMcol + 1; %move on to the next EM reaction 
                Rcol = Rcol + 1; 
            else % 
                no = no+1; 
                %display('No') 
                EMs(EM,Rcol) = 0; 
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                Rcol = Rcol + 1; 
            end 
         
        end 
        %if EMcol > EMwidth && Rcol <= EMcol 
        %    Rcol = EMcol + 1; 
        %end 
        if Rcol <= totRxns 
            for remainingRxns = Rcol:totRxns 
                EMs(EM,remainingRxns) = 0; 
                %EMs{EM,remainingRxns} = 0; %the rest of the EMs are 0 
            end 
        end 
    end 
    Mode(y).EMs = single(EMs); 
end 
disp(['Yes count = ', num2str(yes)]); 
disp(' '); 
disp(['No count = ', num2str(no)]); 
save('Mode', 'Mode'); 
clear EM EMcol EMnums EMrxns EMs EMwidth 
clear Mrxn Rcol Rrxn y remainingRxns temp 
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Program 2: collect_MCSrxns.m 
%Script file: collect_MCSrxns.m 
%  
% This program prepares the minimal cut sets (MCS) data for use in the  
% algorithm. 
% Make sure you have the MCS files in the current directory named as 
their 
% corresponding compounds. These are the otuput text files saved from 
CNA 
%  
  
%% Import the reactions matrix for the network 
%clear; clc; 
%importfile('reactions.xlsx'); 
%load reactions 
Rxns = strtrim(reactions(1,:)); 
rxns = size(Rxns,2); 
  
%% Import the products matrix; 
% 
% 
products = [prods_file '.xlsx']; 
Product = importdata(products); 
data = Product.data.Sheet1; 
textdata = Product.textdata.Sheet1; 
tissue1_P = single(data); 
save('tissue1_P','tissue1_P'); 
% 
compounds = cell(1, numComps); 
% 
for x = 1:numComps; 
    index = x+1; 
    compounds{1,x} = strtrim(textdata{index}); 
end 
save ('compounds', 'compounds') 
% 
MCSets = struct('name', {}, 'MCSs', {}); 
%% Import MCS files 
% This code imports the MCSs for each of the compounds in the  
% products matrix tissue1_P 
  
for y = 1:numComps 
    %compounds = [compounds{y} 
    C = importdata([compounds{y} '.txt'],' '); 
    % 
    MCSets(y).name = compounds{y}; 
    MCSets(y).MCSrxns = Rxns; 
    % 
    temp = C.data; 
    length = size(temp,1); % number of sets (rows) in mcs 
    width = size(temp,2); % number of mcs reactions (columns) 
    % 
    % This code writes the MCS matrix in a form that 
    % includes all the reactions in the network 
    % 
    MCSets(y).MCSs = cell(1,rxns); 
    %mcs = cell(1,rxns); % Preallocates cell arrays for all reactions 
    mcsCol = 1;     % the first MCS column 
    for rxnCol = 1:rxns; 
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        R_header = Rxns{1,rxnCol}; 
        while mcsCol <= width; 
            C_header = C.textdata{1,mcsCol}; 
            %C_header = colheader{1,mcsCol}; 
            if(strcmpi(R_header,C_header) == 1); 
                MCSets(y).MCSs{1,rxnCol} = single(C.data(:,mcsCol)); 
                %mcs{1,rxnCol} = C.data(:,mcsCol); 
                % display('Yes') 
                mcsCol = mcsCol+1; 
                break 
            else 
                MCSets(y).MCSs{1,rxnCol} = single(zeros(length,1)); 
                %mcs{1,rxnCol} = zeros(length,1); 
                % display('No') 
                break 
            end 
        end 
        if rxnCol == rxns 
            break 
        elseif(mcsCol > width); 
            % display('test'); 
            MCSets(y).MCSs{1,rxnCol+1} = single(zeros(length,1)); 
            %mcs{1,rxnCol+1} = zeros(length,1); 
        else 
            % display('not yet'); 
        end 
    end 
    MCSets(y).MCSs = cell2mat(MCSets(y).MCSs); 
    % Save minimal cut set 
    %----------------------------------- 
    % 
    % 
    % 
     
end 
save('MCSets','MCSets') 
clear temp C x y index no yes 
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Program 3: EM_MCS_initPop.m 
%Script file: EM_MCS_initPop.m 
% 
%This script sets up the initial population of EMs for compounds 
present 
    %in the tissue. Since the EMs are needed to set up the initial 
    %population, the collect_EMrxns program needs to be run first 
% 
presentComp = struct('name', {}, 'EMs', {}); %creates a structure 
called  
    %presentComp for storing EMs of all compounds present in tissue 
absentComp = struct('name', {}, 'MCSs', {}); %creates a structure 
called  
    %absentComp for storing MCSs of all compounds absent from tissue 
% 
% 
x = 0; 
y = 0; 
for prod = 1: numComps 
    if comPresence(prod,1) == 1 
        x=x+1; 
        presentComp(1,x).name = Mode(1,prod).name; 
        presentComp(1,x).EMs = Mode(1,prod).EMs;  
    else 
        y=y+1; 
        absentComp(1,y).name = MCSets(1,prod).name; 
        absentComp(1,y).MCSs = MCSets(1,prod).MCSs; 
        % 
    end 
    % 
end 
% 
% 
save('presentComp', 'presentComp') 
save('absentComp', 'absentComp') 
clear x y 
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Program 4: validate_EMs.m 
%Script file: validate_EMs.m 
% 
%This program serves two purposes: 
%   -it validates candidate EMs for the Expression matrix and 
%   -avoids the combinatorial explosion problem when combining EMs of 
the  
%       compounds present in the tissue. 
%                
%This program works by taking the EMs of each present compound, and 
testing  
%it against the MCSs of each of the compounds absent from the tissue, 
by  
%multiplying the two: MCS*EMs': 
  
%   -A zero 0 indicates that the MCS is compatible with the EM and the  
%       reactions taking place to produce the present compound are not 
the  
%       reactions being blocked to eliminate the absent compound. This  
%       means that the EM is a valid Expression vector  
%   -A 1 in the column (EM)indicates that the EM is not compatible 
with 
%       the MCS. The reactions producing the present compounds also 
need 
%       to be blocked to eliminate the absent compound 
        %============================================= 
         
present = size(presentComp, 2); %number of compounds present in tissue 
absent = size(absentComp, 2); %number of compounds absent 
% 
% 
tempop = struct('name', {}, 'EMs', {}); 
pop = struct('name', {}, 'EMs',{}); 
index = 0; 
% 
for x = 1 : present 
    tempop(1,x).name = presentComp(1,x).name; 
    % 
    % 
    EM = (presentComp(x).EMs)'; % transposes EMs to multiply with MCSs 
    newEMcol = 0; 
    %EM = EM' 
    for y = 1 : absent 
        MCS = absentComp(y).MCSs; 
        prodMatrix = sign(MCS*EM); 
        % 
        MCSrow = size(prodMatrix,1); 
        CEMcol = size(prodMatrix,2); 
        for CEMi = 1:CEMcol 
            % 
            for MCSj = 1:MCSrow 
                if prodMatrix(MCSj,CEMi)== 0 
                    newEMcol = newEMcol + 1; 
                    % 
                    tempop(1,x).EMs{1,newEMcol}= EM(:,CEMi); 
                    % 
                    break 
                else 
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                end 
                if MCSj == MCSrow && size((tempop(x).EMs),2)>CEMi 
                tempop(x).EMs(:,CEMi) = []; 
                % 
                else 
                end 
            end 
             
            continue 
        end 
        pop(x) = tempop(x); 
        EM = cell2mat(tempop(x).EMs); 
        newEMcol = 0; 
        if isempty(EM) 
            beep; 
            % 
            disp('There is no valid EM for ', pop(1,x).name); 
            quit; 
        end 
    end 
    % 
end 
% 
% 
save('pop', 'pop') 
clear x y newEMcol EMsindex 
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Program 5: set_initPop.m 
%Script file: set_initPop.m 
% 
%This program compiles the Expression matrix from valid EMs of 
compounds 
%present in the tissue 
% 
%It does this by taking the EMs that have been validated against the 
MCSs 
%of compounds absent in the tissue (output from validate_EMs.m) and  
%combining them together to form the Expression matrix in terms of EMs 
or 
%the set of reactions that would guarantee a production of the 
compounds 
%present in the tissue without producing the compounds absent in the 
tissue 
% 
% 
prod1 = 1; %product index 
numComps = size(pop,2); 
prod1Pop = single(cell2mat(pop(1,prod1).EMs)); %change values to input 
names when converted to function 
prod1EMs = size(prod1Pop,2); 
% 
Expression = single([]); 
% 
for prod2 = 2: numComps 
    % 
    counter = 0; 
    prod2Pop = single(cell2mat(pop(1,prod2).EMs)); 
    prod2EMs = size(prod2Pop,2); 
    prodsPop = zeros(totRxns,prod1EMs*prod2EMs); 
    % 
    for x = 1:prod1EMs 
        % 
        for y = 1:prod2EMs 
            counter = counter + 1; 
            % 
            prodsPop(:,counter) = prod1Pop(:,x)+ prod2Pop(:,y); 
        end 
        % 
    end 
    %the following short code eliminates duplicate solutions for the 
    %product matrix 
    exp = single(sign(prodsPop));%allocates the prodsPop matrix to exp 
    exp = exp';%transposes the exp matrix 
    expr = unique(exp, 'rows');%eliminates duplicate combined EMs 
(rows) 
    Expression = expr';%transposes back to Expression matrix 
    % 
    prod1Pop = sign(prodsPop); 
    prod1EMs = size(prod1Pop,2); 
    % 
    % 
end 
% 
% 
save('Expression', 'Expression') 
clear x y index counter 
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Program 6: Expression analysis.m 
%Script file: expression_analysis.m 
% 
%The Expression matrix is obtained using available information on the 
%metabolism of compounds, their interplay and how they are connected 
to  
%each other through the network of reactions that forms the structure 
of  
%the metabolic network. 
%  
%Using experimental information that specifies whether a compound is 
%present in a tissue or not, the structure of the network is used to 
%identify EMs or a combination of EMs that could produce compounds 
found in 
%the tissue without producing those compounds that are not. The 
resulting  
%output is an Expression matrix. This is a binary matrix containing 
columns 
%of combined EMs and rows representing reactions where a 1 represents 
%the presence and a 0 represents the absence of the reaction. 
%  
%The next step is to use this output to extract information that can 
prove  
%useful, for example, be used for experimental research.  
% 
% 
%This program attempts to extract useful information from the output. 
%In most cases, the set of eligible combined EMs is quite large. The 
%program studies the Expression matrix and sorts it to get rid of 
those 
%reactions that are not active in the tissue. 
% 
%=====================================================================
==== 
  
%% Loading Expression matrix and showing an image of it  
clear all; clc; 
load Expression; 
expSize = size(Expression); 
imagesc(Expression); figure(gcf); 
saveas(gcf,'Expression.fig') 
load reactions; 
rxns = reactions'; 
% 
%% Sort rows method I 
% Note! columns are not sorted  
% 
%This sort method sorts the rows according to the sum of the rows.  
%In this respect, the rows are rearranged in order of how many 
combined EMs  
% (cEMs) a reaction is involved in, with the ones involved in the 
least  
%number of cEMs at the top. 
%sumRow = sum(sortedColExp,2); %sums up the rows of the Expression 
matrix; 
    %each row of the Expression matrix corresponds to a reaction and 
each  
    %column a cEM, so the sums indicate the number of cEMs 
    %each reaction is involved in.  
  sumRow = sum(Expression,2);  
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%Cols = size(sortedColExp,2); %counts the no of columns in the matrix 
Cols = size(Expression,2); 
sumRow_col = Cols + 1; %the row where the sums of cEMs are 
%summedRowExp = [sortedColExp sumRow]; %concatenates the sum column  
    %(no of EMs a reaction participates in) and the Expression matrix 
   summedRowExp = [Expression sumRow]; 
[sortedExpMat,expIndx] = sortrows(summedRowExp,sumRow_col); %sorts the  
    %rows in increasing order of the sum of the rows (sumRow) 
sortedSumRow = sortedExpMat(:,sumRow_col); 
sortedRxns = rxns(expIndx); %uses the sort order of the rows to sort   
    %the corresponding reactions 
%No_usedRxns = size(find(sumRow),1); %counts the non-zero rows 
Nos_in_all_cEMs = find(sortedSumRow==Cols); 
Rxns_in_all_cEMs = sortedRxns(Nos_in_all_cEMs); 
save('Rxns_in_all_cEMs','Rxns_in_all_cEMs'); 
rxnsToElim = find((sortedSumRow==0)|(sortedSumRow==Cols)); %identifies 
    %the rows to eliminate: zero rows or rows containing all cEMs 
analysisRxns = sortedExpMat; 
analysisRxns(rxnsToElim,:)=[];%zooms in on the part of the  
    %Expression matrix that will be analyzed: the middle part; 
reactions 
    %not involved in any cEMs or involved in all, are left out. 
%cEMs = analysisRxns; 
%cEMs = sortedExpMat(1:No_usedRxns,:); %zooms in on the part of the  
    %Expression matrix that contains reactions involved in cEMs. The  
    %reactions not involved in any cEMs are left out. 
usedRxns = sortedRxns; %notes the reactions used 
usedRxns(rxnsToElim,:)=[]; 
sortedExpMat(:,sumRow_col) = []; %gets rid of the sum column 
analysisRxns(:,sumRow_col) = []; 
imagesc(sortedExpMat); figure(gcf); %shows the image of the sorted  
    %Expression matrix (sortedExpMat) 
imagesc(analysisRxns); figure(gcf); 
%delete('sortedExpMat.fig'); 
%saveas(gcf,'sortedExpMat.fig') %saves the sortedExpMat image 
saveas(gcf,'analysisRxns.fig') 
% 
  
%% Cluster Reactions 
%   
clustHeader = 
{'name','sortedIDX','sortedClustrRxns','silh','mean_silh'}; 
clustNo = 10; %can change the no of clusters used. The details from 
each  
    %cluster will be saved in a cell called 'clustr'. These can be 
compared 
    %to determine the best cluster to use 
indx = clustNo-1; 
RxnClustr{indx,1} = ['clust',int2str(clustNo)]; 
[IDX] = kmeans(analysisRxns,clustNo,'dist','sqEuclidean','display',... 
    'final','replicates',clustNo*3); 
cEMs_cols = size(analysisRxns,2)+ 1; 
clust_rxns = [analysisRxns IDX]; %concatenates the cEMs matrix with 
the  
% cluster column (IDX) 
[clust_rxns,clustIndx] = sortrows(clust_rxns,cEMs_cols); %sorts the  
    %rows into clusters 
sorted_clustRxns = usedRxns(clustIndx); %orders the reactions to match 
    %clusters 
RxnClustr{indx,3} = sorted_clustRxns; 
sortedIDX = clust_rxns(:,cEMs_cols); 
RxnClustr{indx,2} = sortedIDX; 
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clust_rxns(:,cEMs_cols) = []; 
imagesc(clust_rxns); figure(gcf);%shows the image of the cEM clusters 
%delete('sortedExpMat.fig'); 
saveas(gcf,'clust_rxns.fig'); %saves the sortedExpMat image 
[silh,h]=silhouette(clust_rxns,sortedIDX,'sqEuclidean'); 
RxnClustr{indx,4} = silh; 
%close; 
RxnClustr{indx,5} = mean(silh); 
%open clust_cEMs.fig; 
 
%% Naming cEMs 
% 
%size(cEMs); 
  
cEM_no = size(clust_rxns,2); 
cEM_names = cell(1,cEM_no); 
for count = 1:cEM_no 
    cEM_names{count} = ['cEM', int2str(count)]; 
end 
 % 
 %% 
cEM_clustHeader = {'clustName','sorted_cEMs_IDX','sorted_cEMs',... 
    'cEMsilh','mean_cEMsilh'}; 
for rxnClustr = 1:clustNo 
    %indx = clustNo-1; 
    cEM_clustr = find(RxnClustr{clustNo-1,2} == rxnClustr); 
    cEMcount = size(cEM_clustr,1); 
    if cEMcount == 1 
        continue 
    else 
    cEMrxns = clust_rxns(cEM_clustr,:); 
    cEM_clusts{rxnClustr,1} = ['cEM_clusts',int2str(rxnClustr)]; 
    cEM_clusts_trans{rxnClustr,1} = 
['cEM_clusts_trans',int2str(rxnClustr)]; 
    cEMs = cEMrxns'; 
    [cEM_IDX] = 
kmeans(cEMs,2,'dist','sqEuclidean','display','final',... 
        'replicates',cEMcount*2); 
    cEMs_cols = size(cEMs,2)+ 1; 
    clustr_cEMs = [cEMs cEM_IDX]; %concatenates the cEMs matrix with  
        %the cluster column (cEM_IDX) 
    [clustr_cEMs,cEMclustIndx] = sortrows(clustr_cEMs,cEMs_cols); 
%sorts the 
        %rows into clusters 
        cEM_clusts_names = cEM_names'; 
    sorted_cEMs = cEM_clusts_names(cEMclustIndx); %orders the cEMs 
(cEM_names)  
        %to match clusters 
    cEM_clusts{rxnClustr,3} = sorted_cEMs; 
    sorted_cEMs_IDX = clustr_cEMs(:,cEMs_cols); 
    cEM_clusts{rxnClustr,2} = sorted_cEMs_IDX; 
    clustr_cEMs(:,cEMs_cols) = []; 
    clustr_cEMs_trans = clustr_cEMs'; 
    imagesc(clustr_cEMs); figure(gcf);%shows the image of the cEM 
clusters 
     
    saveas(gcf,[cEM_clusts{rxnClustr,1} '.fig']); 
    %delete('sortedExpMat.fig'); 
    %imgName = [cEM_clusts{rxnClustr,1} '.fig']; 
    imagesc(clustr_cEMs_trans); figure(gcf); 
    saveas(gcf,[cEM_clusts_trans{rxnClustr,1} '.fig']); %saves the 
sortedExpMat image 
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[cEMsilh,h]=silhouette(clustr_cEMs,sorted_cEMs_IDX,'sqEuclidean');% 
    cEM_clusts{rxnClustr,4} = cEMsilh; 
    %close; 
    cEM_clusts{rxnClustr,5} = mean(cEMsilh); 
    end 
end 
% 
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Appendix B: Glossary 
Term Definition 
Agronomy The science and study of crops and soils. 
Allergen 
Any substance (antigen), most often eaten or inhaled, that is 
recognized by the immune system and causes an allergic 
reaction. 
Anabolism 
Process in which a cell uses energy and reduces power to 
construct complex molecules and perform other life functions 
such as creating cellular structure. 
Anthocyanins A water-soluble pigment that produces blue, violet, and red 
colours in flowers, fruits, leaves, and other plant parts 
a priori 
'a priori knowledge' is known independently of experience, 
e.g., 'All bachelors are unmarried' (a posteriori knowledge or 
justification is dependent on experience or empirical evidence 
(for example 'Some bachelors are very happy').) 
Bioinformatics 
The use of computer science, mathematics, and information 
theory to model and analyze biological systems, especially 
systems involving genetic material. 
Biosynthesis Formation of a chemical compound by a living organism. 
Carcinogens Any substance or agent that promotes cancer. 
Catabolism Process in which a cell breaks down complex molecules to yield energy. 
Catalysis 
In chemistry and biology, it is the acceleration (increase in 
rate) of a chemical reaction by means of a substance, called a 
catalyst, that is itself not consumed by the overall reaction. 
Causality The principle of or relationship between cause and effect 
Chemical/reaction 
kinetics Study reaction rates in a chemical reaction. 
Cofactor 
(biochemistry) 
A substance that needs to be present in addition to an enzyme 
for a certain reaction to take place. 
Combinatorial 
explosion 
The rapidly accelerating increase in lines of communication as 
organizations are added in a process. (Casually described as 
"exponential" it is actually strictly only polynomial) 
Connectivity The number of reactions in which a compound participates 
Convex analysis 
The branch of mathematics devoted to the study of properties 
of convex functions and convex sets, often with applications in 
convex optimization, a sub-domain of optimization theory.  
Convex functions 
A function ƒ(x) is considered to be convex over the interval a,b 
if for any three points x1, x2, x3 such that a <x1 <x2 <x3 <b, 
ƒ(x2)≤L(x2), where L(x) is the equation of the straight line 
passing through the points [x1, ƒ(x1)] and [x3, ƒ(x3)]. 
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Convex set 
In Euclidean space, an object is convex if for any pair of points 
within the object, any point on the straight line segment that 
joins them is also within the object. For example, a solid cube 
is convex, but anything that is hollow or has a dent in it is not 
convex. 
CoSets Correlated reaction subsets – reaction pairs that participate in 
all extreme pathways (off diagonal elements of RPM.) 
Curation The process of examining, testing and selecting information to go in a collection database. 
de novo Over again, anew 
Deterministic 
No randomness is involved; a deterministic algorithm is an 
algorithm which, given a particular input, will always produce 
the same output 
DNA Deoxyribo-nucleic acid – genetic material 
Down-regulation 
The process by which a cell decreases the number of receptors 
to a given hormone or neurotransmitter to reduce its sensitivity 
to this molecule. This is a locally acting negative feedback 
mechanism. An increase of receptors is called up regulation. 
Edaphic Relating to or being affected by soil, especially as it affects living organisms  
Elements Substances that cannot be broken down further by ordinary 
means 
Empirical Empirical pathways are determined from perceived ideas of 
how metabolic compounds are formed 
Enzyme kinetics 
The study of the chemical reactions that are catalysed by 
enzymes. In enzyme kinetics, the reaction rate is measured and 
the effects of varying the conditions of the reaction is 
investigated. 
Enumeration enumeration of a set is an exact listing of all of its elements (perhaps with repetition). 
Escherichia coli 
(E.coli) 
Common bacterium that normally inhabits the intestinal tracts 
of humans and animals, but can cause infection in other parts 
of the body, especially the urinary tract. They are necessary for 
the proper digestion of food. In genetic engineering it is the 
microorganism preferred for use as a host for the gene-splicing 
techniques used to clone genes. 
Facultative Biology: able to live or take place under a range of external 
conditions – facultative parasite 
FBA Flux balance analysis 
Flavonoids 
Ubiquitous secondary plant metabolites which function as 
protectants against UV light and pathogens and are involved in 
the attraction of pollinators as well as seed and fruit dispersers.  
Also called bioflavonoid. 
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Flux 
Metabolic flux refers to the rate of flow of metabolites along a 
metabolic pathway, or even through a single enzyme. A 
calculation may also be made of carbon (or other elements, e.g. 
nitrogen) flux. It is dependent on a number of factors, 
including: enzyme concentration; the concentration of 
precursor, product, and intermediate metabolites; post-
translational modification of enzymes; and the presence of 
metabolic activators or repressors. Metabolic control analysis 
provides a framework for understanding metabolic fluxes and 
their constraints.  
Gene expression Process of using the information stored in the DNA to make an RNA molecule and then a corresponding protein. 
Genes Units that govern characteristics at the genetic level. Contain a 
specific sequence of nucleotides. 
Genome 
The whole hereditary information of an organism that is 
encoded in the DNA (or, for some viruses, RNA) This includes 
both the genes and the non-coding sequences. 
Genotype 
The inherited instructions that an organism carries within its 
genetic code; a set of alleles determining the expression of a 
particular characteristic or trait (phenotype) 
Heuristic 
Computer Science- relating to or using a problem-solving 
technique in which the most appropriate solution of several 
found by alternative methods is selected at successive stages of 
a program for use in the next step of the program.  
Homeologs duplicate gene pairs 
Homeostasis 
The balanced internal environment of the body/cell and the 
automatic tendency of the body/cell to maintain this internal 
"steady state."  
Homogeneous 
1.       Of the same or similar nature or kind: “a tight-knit, 
homogeneous society” (James Fallows).  
2.       Uniform in structure or composition throughout.  
3.       Mathematics. Consisting of terms of the same degree or 
elements of the same dimension. 
in silico An expression used to mean "performed on computer or via 
computer simulation." 
in vivo Within a living organism: metabolic studies conducted in vivo; in vivo techniques; in nature. 
Intercellular Located among or between cells: intercellular fluid. 
Intracellular occurring or situated within a cell or cells: intracellular fluid. 
Invariant 
1.    Not varying; constant.  
2.    Mathematics. Unaffected by a designated operation, as a 
transformation of coordinates. 
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Kinetics 
1.       The branch of mechanics concerned with the effects of 
forces on the motion of a body or system of bodies, especially 
of forces that do not originate within the system itself. Also 
called dynamics.  
2.       The branch of chemistry concerned with the rates of 
change in the concentration of reactants in a chemical reaction.  
Metabolism 
The chemical processes occurring within a living cell or 
organism that are necessary for the maintenance of life. In 
metabolism some substances are broken down to yield energy 
for vital processes while other substances, necessary for life, 
are synthesized.  
Metabolomic 
The "systematic study of the unique chemical fingerprints that 
specific cellular processes leave behind" - specifically, the 
study of their small-molecule metabolite profiles 
Molecules Atoms interact and bond with other atoms to form molecules 
Monomer A molecule that can combine with others to form a polymer 
Nucleotides 
Complex groups consisting of a phosphate group, nitrogenous 
base and a five-carbon sugar. 4 nitrogenous bases: Guanine, 
Adenine, Thymine, Cytosine (G, A, T, C). Difference in the 
nucleotides is which nitrogenous base is contained. 
Parse Have a computer program split a file or other input into bits of data that can be easily stored or manipulated. 
Phylogenetics The study of evolutionary relatedness among various groups of 
organisms (e.g., species, populations). 
Phenomenon Refers to any incident deserving of inquiry and investigation; the science or study of things as they are perceived. 
Phenotype An organism’s observable characteristics or traits resulting from its genetic makeup and environment. 
Physicochemical  
Physical property: any measurable property whose value 
describes a physical system's state; does not change the 
chemical nature of matter. 
Chemical property: Determines the way a material behaves in a 
chemical reaction 
Physiology 
The branch of biology that deals with the internal workings of 
living things, including such functions as metabolism, 
respiration, and reproduction, rather than with their shape or 
structure 
Pleiotropic Referring to a gene or mutation that has multiple effects or phenotypic traits. 
Polymorphism 
1.      Biology. The occurrence of different forms, stages, or types 
in individual organisms or in organisms of the same species, 
independent of sexual variations.  
2.      Chemistry. Crystallization of a compound in at least two 
distinct forms. Also called pleomorphism. 
Gene silencing Occurs when RNA is unable to make a protein during 
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translation. 
Primary Metabolites  
Found across all species and are more or less used or produced 
using similar pathways in the species. However, secondary 
metabolites are often specific to species. 
Reductionist 
approach studying parts of a system in isolation 
Redundancy gene redundancy- is a situation in which many copies of the 
same gene exist in a genome.  
Reverse genetics 
while forward genetics seeks to find the genetic basis of a 
phenotype or trait, reverse genetics seeks to find the possible 
phenotypes that may derive from a specific genetic sequence 
obtained by DNA sequencing 
Steady state Unchanging state 
Stoichiometry The quantitative relationship between reactants and products in 
a chemical reaction.  
Synthesis Formation of a compound from simpler compounds or 
elements. 
Thermodynamics Characteristic of, or resulting from, the conversion of heat into 
other forms of energy.  
Topoloy The arrangement of the various elements (links, nodes, etc.) of 
a biological (or computer) network 
Transgenic 
Transgenic plants are plants that possess a gene or genes that 
have been transferred from a different species. Such 
modification may be performed through ordinary hybridization 
through cross-pollination of plants, but the term today refers to 
plants produced in a laboratory using recombinant DNA 
technology in order to create plants with specific 
characteristics by artificial insertion of genes from other 
species, and sometimes entirely different kingdoms. 
Ubiquity Existence or apparent existence everywhere at the same time (or seeming to be everywhere at once) 
Up-regulation 
The process by which a cell increases the number of receptors 
to a given hormone or neurotransmitter to improve its 
sensitivity to this molecule. A decrease of receptors is called 
downregulation. 
 
